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ABSTRACT
Ethanolic extracts from Agaricus bisporus, the most extensively cultivated and 
consumed type of mushroom in the Western hemisphere, displayed a direct-acting 
mutagenic response in various Salmonella typhimurium strains, TA 104 being clearly 
the most sensitive. Ethanolic extracts from two other edible mushrooms, namely 
Pleurotus ostreatus and Lentinus edodes, were also screened for mutagenic activity in 
the Ames test. Pleurotus ostreatus extracts exhibited weak, direct-acting mutagenicity 
towards all bacterial strains studied. Extracts from Lentinus edodes were bacteriocidal 
when tested at concentrations similar to those of Pleurotus ostreatus extracts.
Incorporation of hepatic S9 activation systems (i.e., microsomes and soluble 
fractions) from laboratory animals, control or induced, did not alter the mutagenic 
response of the extracts from Agaricus bisporus. The mutagenic potential was also 
unaffected by purified prostaglandin H synthase. The mutagenicity was, however, 
markedly enhanced in the presence of a rat activation system containing hepatic 
cytosolic fraction, i.e., in the absence of microsomes. This cytosol-mediated 
potentiation in mutagenicity was dependent on NADPH, was inhibited by NADH and 
was abolished by heat-treatment. Moreover, the cytosolic-mediated mutagenic response 
was inhibited by dicoumarol and menadione, implicating the cytosolic enzyme, DT- 
diaphorase, in the cytosolic activation of the mushroom extracts.
Factors such as mushroom strain, break, and time of harvest did not have any 
significant effect on the mutagenic potential of the extracts from Agaricus bisporus. In 
contrast, the mutagenicity decreased with the age of the fruit body and enhanced with 
storage. Moreover, cooking of mushrooms resulted in a reduction of the mutagenic 
response. Non-polar solvents such as chloroform and ethyl acetate failed to extract
the mushroom mutagens whereas methanolic and water extracts from Agaricus 
bisporus exhibited mutagenicity of the same magnitude as the ethanolic extracts.
Agaritine, the postulated mutagenic/carcinogenic component of Agaricus 
bisporus, was mutagenic in a narrower range of Salmonella strains than the ethanolic 
extracts from the mushroom. Moreover, the mutagenic potency of ethanolic extracts 
from various types of mushroom containing markedly different amounts of agaritine did 
not correlate with the agaritine content. Finally, y-glutamyl transpeptidase, did not 
enhance the mutagenic response. It is, therefore concluded that agaritine does not 
mediate the mutagenicity of the fungal extracts to TA 104.
Incubation of the ethanolic extracts from Agaricus bisporus with purified 
mushroom tyrosinase, the enzyme responsible for the conversion of phenols to 
quinones within the mushroom, markedly enhanced the mutagenic activity. The 
enzymes superoxide dismutase and catalase, that detoxicate 0 2 *" and H2O 2 
respectively, glutathione, which breaks down H2O2 to H2O, and the OH- scavenger 
DMSO, significantly decreased mutagenicity. These findings indicate that the fungal 
phenols/quinones and reactive oxygen species make important contributions in the 
mushroom mutagenicity.
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CHAPTER 1
INTRODUCTION
1.1 Diet and cancer
Most cancers today are claimed to be induced by environmental factors (Wynder 
and Gori, 1977). Indeed, epidemiological studies suggested that as much as 90% of 
human cancer incidence can be ascribed to factors in man's environment (Higginson, 
1969). Undoubtedly diet and nutrition play a major role in human 
mutagenicity/carcinogenicity (Parke and loannides, 1981). Lilienfeld showed, for 
example, that gastric cancer rates decline as countries improve their dietary habits 
(Lilienfeld, 1972).
The evidence linking diet to cancer is mainly derived from international studies 
in which the nutritional habits were compared with the rates of specific cancer 
incidences among different countries or population groups. Such studies indicated, for 
example, that diets high in meat and fat are associated with cancer of the colon, breast, 
pancreas and prostate (Armstrong and Doll, 1975; Weisburger et a l,  1977), while a 
lower incidence of diet-related cancer has been observed in vegetarian populations 
(Phillips et aL, 1980). It has also been suggested that nutritional deficiencies and/or 
excesses, as well as certain other dietary patterns, are more important in the 
development of cancer rather than "specific carcinogens" ( Wynder and Gori, 1977).
Although diet does contain a variety of mutagens/comutagens, carcinogens/ 
cocarcinogens, it also contains many natural antimutagens and anticarcinogens (e.g., 
vitamin E, ascorbic acid, 6-carotene etc.) and other dietary factors that may have a 
protective role (Ames, 1983; Peto et a l, 1981; Parke and loannides, 1981). Therefore, 
characterisation of the mutagens/carcinogens and antimutagens/anticarcinogens and 
optimisation of the natural defence mechanisms may be an important part of a strategy of 
minimising diet-related cancer.
Doll and Peto have recently discussed five ways or means whereby diet may 
affect the incidence of cancer (Doll and Peto, 1981), which are listed below:
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Possible mechanisms Example
1. Affecting the formation (a)
of carcinogens in the body
(b)
(c)
2. Affecting transport, activation (a)
or deactivation of carcinogens
(b)
(c)
(d)
3. Affecting "promotion" of (a)
cells (that are already initiated)
(b)
(C)
Providing substrates for the 
formation of carcinogens in the 
body
Altering intake or excretion of 
cholesterol and bile acids from 
the body (hence production of 
carcinogenic metabolites in the 
bowel)
Altering the bacterial flora of the 
bowel (and hence the capacity to 
form carcinogenic metabolites)
Altering carcinogen concentration 
in, or duration of contact with 
faeces (fibre)
Altering transport of carcinogens 
to stem cells
Induction or inhibition of 
enzymes which mediate 
carcinogen metabolism
Deactivation, or prevention of 
formation of short-lived 
intracellular species (e.g., by 
using Se, vitamin E or otherwise 
trapping free radicals, by use of
[3-carotene or otherwise 
quenching singlet oxygen, by use 
of other antioxidants)
Vitamin A deficiency
Retinol binding protein (RBP) 
(hormonal and other factors 
determine blood RBP though 
vitamin A intake may not affect 
it much)
Otherwise affecting stem cell 
differentiation (carotenoids?)
3
4. Ovemutrition (a) Adipose tissue-derived oestrogens
(b) Other effects
5. Ingestion of powerful, 
direct-acting carcinogens 
or their precursors
(a) Carcinogens in natural 
foodstuffs
(b) Carcinogens produced by 
cooking
(c) Carcinogens produced in
stored food by microorganisms 
(bacterial and fungal)
The first aspect in the list can be exemplified by the formation of N-nitroso 
compounds in the body which are among the most powerful chemical carcinogens in 
laboratory animals. Such compounds may be formed by the reaction of nitrite with 
various nitrosatable compounds (e.g., secondary amines or N-substituted amides), 
neither of which can easily be avoided. Nitrosatable compounds occur naturally in 
many foods, particularly in fish and meat, may be ingested as drugs or formed from 
amino acids. Nitrite may either be derived directly from food (since it is often used in 
cured meat as a preservative, colour and flavour enhancer) or can be formed from nitrate 
which is ingested in vegetables and drinking water.
The last aspect in the list is the ingestion of direct acting mutagens/carcinogens 
or their precursors. Among these are carcinogens that can be produced in stored food 
by microorganisms, exemplified by aflatoxin Bi, a product of the fungus Aspergillus 
flavus. This compound contaminates peanuts and other staple carbohydrate foods stored 
in hot and humid climates and is the major factor causing liver cancer in certain tropical 
countries (Doll and Peto, 1981). Moreover, chemicals that are added to food to 
preserve it and to give it colour, flavour and consistency could also contribute to food
4
carcinogenicity. Established carcinogenic additives which have been used for a time and 
now have been withdrawn include thiourea and in Japan the preservative AF-2 [2- 
(2-furyl)-3-(5-nitrofuryl)-acrylamide], while others still in use {e.g., saccharin and 
butylated hydroxytoluene) require special consideration (Doll and Peto, 1981; 
Sugimura, 1982). Another possible source of such substances is the production of 
carcinogens by cooking. Benzo(a)pyrene and other polycyclic hydrocarbons can be 
produced either when fat from open-flame charcoal-broiled meat drips onto hot coal and 
the smoke of its incineration adsorbs onto the surface of the meat (Lijinski and Shubik, 
1964) or by pyrolysis when meat or fish is broiled or smoked, or when any food is 
fried in fat that is used repeatedly. More recent investigations showed that proteins and 
several amino acids produce powerful mutagens when pyrolysed above 300°C 
(Matsumoto et al., 1978; Nagao et al., 1977a) and that well-cooked, protein-rich food 
(e.g., broiled fish and particularly sardines, fried beef, egg fried at high temperatures, 
extended boiled beef stock) contain mutagens that cannot be accounted for by the 
production of benzo(a)pyrene or the related polycyclic hydrocarbons (Yoshida et al., 
1978; Commoner et a i, 1978; Kasai et al., 1980; 1981; Bjeldanes erti/., 1982 a,b). 
Subsequently it was demonstrated that the mutagens in certain cooked foods are a series 
of heterocyclic aromatic amines formed by the pyrolysis of food during cooking, such 
as 2-amino-3-methylimidazo-[4,5-f]-quinoline (IQ), 2-amino-3,4-dimethylimidazo- 
[4,5-f]-quinoline (MelQ), 3-amino-l,4-dimethyl-5H-pyrido-[4,3-b]-indole (Trp-P-1) 
and 2-amino-6-methyldipyrido-[ 1,2-a: 3',2'-d]-imidazole (Glu-P-1) (Sugimura and 
Sato, 1983; Pariza et al., 1983).
The simplest and most obvious dietary mechanism is the ingestion of natural 
foodstuffs that are themselves direct-acting carcinogens/mutagens or which may be 
converted into such carcinogens by metabolism in the body. Indeed man's diet contains 
a wide variety of naturally-occurring mutagens, carcinogens and tumour promoters 
(Sugimura, 1982; Ames, 1983). Such compounds include a group of flavonoids, 
exemplified by quercetin (Brown, 1980), chlorogenic acid present in coffee, both in 
green and roasted beans, potatoes and apples (Stich et a i, 1981; Hanham et a i, 1983;
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Clifford, 1975; Clifford and Wight, 1976; Matheis and Belitz, 1977; Van Buren et al., 
1973), cycasin in cycad nuts (Laqueur, 1965), anthraquinones, other quinones and their 
phenol precursors (Brown, 1980; Ames, 1983), and hydrazines.
Hydrazines are present in considerable amounts in edible mushrooms such as 
the false morel Gyromitra escullenta (List and Luft, 1967; 1968; 1969; Schmidlin- 
Mészâros, 1974; Pyysalo and Niskanen, 1977; La Rue, 1977; Toth, 1979a) and in the 
most commonly cultivated and consumed mushroom Agaricus bisporus (Levenberg, 
1960; 1961; 1964; Daniels et a l, 1961; Kelly et a i,  1962; Chauhan et a i, 1984; 1985 
a,b). Agaricus bisporus contains about 500 mg/kg fresh weight of various 
phenylhydrazines, and at least five of them have been isolated (Cry and Kirsten, 1991). 
Most of these hydrazines or their derivatives, as well as the fresh mushroom itself have 
displayed carcinogenic activity when administered to mice in a series of long-term 
studies (Toth et aL, 1978; 1981 a,b; 1982; Toth, 1977; 1979 a,b; 1983; 1985; 1986; 
Toth and Nagel, 1981; Toth and Sornson, 1984; Lawson et aL, 1984; 1988; Shephard 
et aL, 1986; McManus et aL, 1987; Toth and Erickson, 1986; Schlatter, 1986). 
Moreover, these hydrazines or the mushroom extracts were mutagenic in various 
Salmonella typhimurium strains in the Ames test and in other short-term mutagenicity 
tests (Kellman and Berstein, 1978; De Flora er aL, 1979; Kuszynski et aL, 1981; 
Toth, 1980; Rogan et aL, 1982; Sterner et aL, 1982; von Wright et aL, 1982; 
Friederich et aL, 1986; Ueijma et aL, 1986; Mori et aL, 1988; Morales et aL, 1990 a,b; 
Grüter et aL, 1991). Although hydrazines were considered to be the most hazardous 
compounds to be isolated from this fungus, the presence of toxic quinones and phenols 
in this mushroom (Weaver et aL, 1970; 197la,b; Vogel et aL, 1974; 1975; Tiffany et 
aL, 1978; Boekelheide et aL, 1980 a,b; Mize et aL, 1980; FitzGerald et aL, 1984; 
Wheeler et aL, 1982), raises also the possibility that these chemicals may be equally or 
even more hazardous than hydrazines. These published toxicological studies give rise 
to a serious concern as to a possible human health risk from the consumption of this 
cultivated mushroom.
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1.2 Asaricus bisporus
1 .2 .1  Physiology/m orphology
Agaricus bisporus is one of at least 20,000 species of basidiomycetes, the 
developmentally most advanced class of fungi and belongs to the family of Agaricaceae 
Svrcek, 1983 ). Over the years this species has been known variously as Psalliota 
arvensis, P. hortensis, P. bispora, Agaricus campestris, A. hortensis,A. arvensis 
and A. brunnensces (Flegg, 1985). Agaricus bisporus has two-spored basidia 
whereas the rest of this genus have four-spored basidia. It is believed to be the wild 
"parent" of many of the cultivated crop varieties (Phillips, 1981). Agaricus bisporus is 
a medium-sized mushroom, with a cap rarely exceeding 10cm in width, firm in texture 
and thick-fleshed, globular at first, then flatly bell-shaped, with a central navel-like 
depression, expanded in older specimens. The cap cuticle is dingy brownish to deep 
dark brown, smooth in the centre, with in-grown radially arranged brown fibres near 
the margin, eventually cracking into appressed brown scales. The cap's margin usually 
bears soft, wool-like veil remnants. The originally white gills soon turn a vivid pink, 
then reddish chocolate, finally almost black with whitish edges. Along the gills are the 
reproductive structures of the mushroom, called basidia. Each of these structures form 
two basidiospores. The stipe is cylindrical, 3-6 cm long, 1-2 cm thick, glabrous, white. 
The membranous white veil leaves behind a ring; this, however, is not attached to the 
apex of the stipe but to its lower part - hence it is detachable in the downward direction. 
The flesh is white, pale flesh-red where cut, then becoming rusty, without a distinctive 
odour and taste. The characteristics of this fungus can be seen in Figure 1.1 (Svrcek, 
1983).
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Figure 1.1: Characteristics of Agaricus bisporus
Spores: 6 .5—7.5 x  5 —6 urn. 
broadly ovoid to subglobose, brown
Basidia
Basidiospores
1 .2 .2  Production/consum ption
The cultivation of Agaricus bisporus, pioneered in France, originated early in the 
seventeenth century (Flegg, 1985) and the first written accounts of how to grow 
cultivated mushrooms date from around 1650 (Mushroom Growers' Association, 
1991). While the growing of other edible mushrooms is somewhat localised, Agaricus 
bisporus is cultivated worldwide and is therefore considered as the mushroom of
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commerce in the Western hemisphere, being the most important cultivated species in 
Europe, the Americas and Australasia. Of the total world production of edible 
mushrooms, which is around 1.4-1.5 million tonnes annually, the current global annual 
production of Agaricus bisporus accounts for nearly 1.3 million tonnes (Flegg, 1985; 
Gry and Kirsten, 1991). The most important producers of this fungus are shown in 
Table 1.1 (Gry and Kirsten, 1991; Whitehall, 1990).
Table 1.1: Most im portant producers of Agaricus bisporus worldwide
Producers Annual production 
(tonnes)
U.S. A 261,000
China 210,000
France 210,000
Netherlands 120,000
U.K. 111,000
Italy 85,000
Taiwan 55,000
Canada 51,000
Germany 36,000
E.E.C. (total) 520,000
From Gry and Kirsten, 1991
In the U.K. this mushroom is the most valuable horticultural crop. There are 
more than 250 mushroom farms and the mushroom industry has expanded consistently 
over the past 20 years, more than doubling since the mid-1970s. The total consumption 
of U.K. and imported mushrooms is estimated to be worth £350 million, representing 
just under 150,000 tonnes. Per capita annual consumption of mushrooms in the U.K. 
has risen from 2.5 lbs in 1983 to nearly 6 lbs in 1990. Mushrooms are third, in terms 
of household expenditure on fresh vegetables, after potatoes and tomatoes. Over 90% 
of mushrooms sold are freshly grown, 99% of these being the white cap Agaricus 
bisporus and the remaining 1% the brown mushroom. In 1990 the U.K. imports of
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canned mushrooms was 8,300 tonnes and of frozen mushrooms 5,100 tonnes 
(Whitehall, 1990).
1 .2 .3  Cultivation
The various stages in the development of Agaricus bisporus, and the four stages 
in its growing cycle are illustrated in Figures 1.2 and 1.3, respectively (Mushroom 
Growers' Association); the principal steps in growing a crop of mushrooms are 
outlined in Table 1.2 (Randall, personal communication and observation). Crop 
production is maintained throughout the year, the production of a new crop usually 
beginning each week so attaining about 50 crops per annum. The mushrooms are 
generally grown in wooden trays or on shelves, called beds, in the growing houses. 
The conditions within the growing houses are controlled in order to put the mushroom 
under nutritional stress, thus encouraging growth upwards throughout the compost. 
Therefore the compost is "shocked" into producing fruit bodies. Not all the fruit bodies 
develop at once. Mushrooms appear on the beds at intervals of about 7-10 days, each 
fresh batch being known as a "flush" or a "break". The first flush is usually picked 
approximately 56 days after the initial composting while the last mushrooms of the crop, 
i.e., the fourth flush, four weeks later. With each break the harvest size decreases. The 
yield of mushrooms is often quoted per tonne of compost spawned and this is a measure 
of the quality of the compost {i.e., the growth substrate for the mushrooms) as well as 
its suitability in nutritional value and physical characteristics.
Very recently a "hot weather" mushroom, which stays eatable twice as long as 
the conventional commercial varieties, has been developed by British government 
scientists. Unlike the current mushrooms of commerce, which grow best between 16- 
18°C (Table 1.2), the new strain thrives at temperatures up to 30°C, a property that 
could cut the costs of cooling the growings sheds ("The Daily Telegraph", 8th August 
1991, U.K.).
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Figure 1.2: The various stages in the development of Agaricus bisporus
Figure
Fmii body, the main part of the grown 
mushroom. Contains the reproductive 
structures which produce spores.
fruit body
Fruit body begins to 
form from mycelium V
Spore germination
fy'celium. The vegetative 
part of fungus, consisting of 
long, fine white-grey threads 
which grow in specially 
prepared compost to form 
fruit bodies.
1.3: The four stages of Agaricus bisporus development during 
its growing cycle
Stipe. The stalk or stem Disc. Central part of the cap Cap (Latin name pileus). 
of the mushroom
Cosed CupButton
\&l or ring (Latin name velum).
The point around the upper part 
of the stipe where the fine skin 
breaks to reveal the gills
The head of the fruit body
Open Cup
Gills (Latin name lamellae).
The pink-brown underside of the 
fruit body which is Increasingly 
revealed as the mushroom opens.
1 1
Table 1.2: Mushroom crop production processes
Operation Process Duration
outline (days)
A. Composting
(a) Phase 1 : Mixing and wetting
(i) Straw, hay, chicken manure, 2 
mushroom wastes (stem and stalk 
trimmings) and water are mixed
and left in piles for 48 hours
(ii) The mix is aerated by being turned 8-9 
every 2 days
(iii) Horse and pig manure is mixed 2 
in. The temperature increases
to 75-80°C by the action of the 
microorganisms
(iv) The compost is transferred to a 7 
covered area where it is arranged
in piles/stacks . It is turned and 
mixed with water every 2 days
(b) Phase 2: Pasteurisation/Conditioning
(i) The compost is transferred to 
insulated, computer-controlled ovens
(ii) Air is blown for 12-16 hours until a <1
uniform temperature is attained.
The temperature of the compost is then
raised to 60°C by microorganisms of
the compost for the pasteurisation process 1/3
(iii) The compost is cooled to 48-50°C with 7
fresh/cool air for the conditioning phase
and is maintained at this temperature 
by thermophilic actinomycetes.
Actinomycetes and fungi use up 
simple sugars and NH^ to produce a
biomass specific for mushroom growth
(iv) The compost is cooled down
Total compost preparation 25-28
B . Spawning The compost is transferred to a box-filling <1
area. Cracked soya and maize (nutrient 
supplements) are added during filling.
The mushroom spawn inoculum 
(i.e., mushroom mycelium) is also added 
along with rye grain and a pH-buffer
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C. Spawn-running The boxes are stocked and stored in dark 
incubator rooms (at 25°C). Air is blown to 
ensure adequate aeration. The mycelium 
colonises
Total compost colonisation
D. Casing
E. Pre-cropping
F. Cropping
15
15
<1
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A mixture of peat, chalk (a pH buffer) and 
water is layered on top of the colonised 
composed. The compost is transferred to 
the growing houses
(i) In the growing houses the casing layer is 
colonised by mycelium. The temperature 
is brought down to 18°C and "pinhead" 
mushrooms (pea-size) appear
(ii) The temperature is increased by few 
degrees and the surface of the boxes is 
watered. The fruit bodies are developed .
The first and successive "flushes" 30-35
(breaks) are harvested at 7-10 days intervals
G . Cook-out The growing houses are heated with 
steam at 60°C
1-2
H. Emptying The compost and the beds are removed 
and the growing house is cleaned up 
for the next crop
1-3
1.2.4 Nutritional value and induced biological effects
1.2.4.1 Nutritional value
Agaricus bisporus has good nutritional value and is considered an important part 
of today's "healthy diet". It has a high percentage of essential amino acids, contains 
more protein than the majority of other vegetables, and 70-90% of the protein can be 
easily digested. It is richer than most other vegetables in water soluble vitamins, is low 
in calories, almost fat-free and contains only traces of sugar and no cholesterol. The full 
nutritional value is obtained when it is eaten raw or lightly cooked while overcooking 
causes loss of flavour, texture and nutrients.
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1.2.4.2 Induced biological effects
Agaricus bisporus or some of its components have been demonstrated to induce 
a number of biological effects in mammals and man, some of which are outlined in 
Table 1.3.
Table 1.3: Biological effects induced by Agaricus bisporus or A g a r icu s  
bisporus components
Inducer Effect
Cooked mushrooms Decrease in the serum cholesterol level and increase in 
the urinary excretion of uric acid in rats (Brûlé et a i, 
1990)
Dried powder Asthma (O'Neil, 1990).
Spore or cap Asthma, hypersensitivity pneumonitis (mushroom
allergens workers' lung) and hand eczema (O'Neil, 1990; 
Korstanje and van de Staak, 1990).
Lectin ABL Suppression of human lymphocyte metabolism 
(Greene et aL, 1981).
Lectin PHA-B Stimulation of glucagon and insulin release,increase 
in Ca2+ uptake by islets of Langerhans, enhanced 
thrombin-like effects on platelets and insulin-like 
activity in fat-cells (Ewart et al.y 1975; Ahmad et 
a l, 1984 a,b; Khalid et al., 1989).
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1.3 Potentially toxic compounds present in
Aparicus bisporus
Like many higher plants and other fungi, Agaricus bisporus exhibits the 
enigmatic process of secondary metabolism. Whatever the reason behind the 
production of secondary compounds, the end result is that a diversity of natural 
products may accumulate within this fungus and thus be consumed by humans. To date 
many secondary metabolites have been isolated from this mushroom (Claydon, 1985), 
most of which are of unknown toxicity. Among the first isolated compounds of this 
fungus was the hydrazide agaritine (Levenberg, 1960; 1961; 1964). The subsequent 
discovery that other hydrazines also occur in Agaricus bisporus (Levenberg, 1961; 
Chauhan et a i, 1984; 1985 a,b; Gry and Kirsten, 1991) and the fact that almost all 
hydrazines are toxic or tumourigenic (Roe et a l, 1967; Toth, et a l, 1975,a,b; Toth, 
1975; 1980; 1988) prompted the group of Toth to study the possible carcinogenicity of 
these mushroom hydrazines, believed to be the most hazardous components in this 
edible mushroom species.
1.3.1 Hydrazine and its derivatives
Hydrazine (Figure 1.4), first identified in 1875 by Fischer, isolated in 1887 by 
Curtins and synthesised in 1907 by Rasching (Juchau and Horita, 1972) is one of the 
simplest N-N bond-containing chemicals and reacts readily with inorganic and organic 
compounds to form various derivatives (Figure 1.4).
Since 1957, when for the first time a hydrazine derivative, namely isonicotinic 
acid hydrazide (isoniazid), was demonstrated to be tumourigenic in mice, many 
investigators have studied the carcinogenic potential of a series of hydrazines most of 
which were found to be carcinogenic (Toth 1975; 1980; 1988; Toth et a l, 1975b). 
Moreover, 60 carcinogenic hydrazines, hydrazides and hydrazones exhibit toxicity in 
many animal and human tissues (Toth, 1988).
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Figure 1.4: Structure of hydrazine and its derivatives
r ' ^ n -n ^ r 4 r ' r 2n - n h c r  r ’r 2n - n = c r 3r 4
II
o
Hydrazine (R1, R2, R3, R4 = H)
or Hydrazide Hydrazone
substituted hydrazines
R N=NR R N=NR
I
O
Azo
or Azoxy
diazene (R2=H)
1.3.1.1 Chemistry of hydrazines
The chemical properties of hydrazines were summarised by Prough and 
Moloney (1985) and are shown in Table 1.4.
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1.3.1.2 Metabolism of hydrazines
The parent compound is extensively metabolised by few animal species, 
whereas in others, such as the dog and rabbit, it is excreted largely unchanged. In all 
animals studied, except the dog, hydrazine is primarily metabolised to 1,2- 
diacetylhydrazine via the monoacetyl intermediate, though some hydrazine is also 
degraded to ammonia in vivo (McKennis et a i, 1955; 1956; 1959; Dambrauskas and 
Cornish, 1964; Write and Timbrell, 1978). The metabolic pathways of hydrazine in 
man have not been elucidated. However, genetic variability in the capacity of humans to 
acetylate some hydrazine derivatives, such as isoniazid, phenylhydrazine and 
hydralazine, has been defined (Dufour et a i, 1964; Evans, 1968; Juchau and Horita, 
1972). This variability is due to a polymorphism of the hepatic N-acetyltransferase per 
se. A subsequent study showed that the acétylation of monoacetylhydrazine follows the 
same genetic pattern as acétylation of isoniazid (Ellard and Gammon, 1976). The fate of 
hydrazine derivatives is also important, not only because some of them may be toxic per 
se (Toth, 1988) but also because their toxicity may be related to either the release of 
hydrazine or their metabolism to other toxic intermediates. Colvin (1969) identified 
two major mechanisms for the detoxication of hydrazines, the first being N-acetylation 
of the parent compound and the other the release of the hydrazino group through 
cleavage of the C-N bond, the latter being also related to the extent of metabolism. 
Juchau and Horita (1972) stressed that the metabolism of hydrazines may involve 
oxidative transformation of the hydrazine functional group. Indeed, Prough and 
Moloney (1985) suggested that many of the toxic and/or carcinogenic effects of 
hydrazines could occur as a result of oxidation to azo or diazene intermediates or as a 
result of hydrazone formation. Moreover, these authors provided evidence establishing 
that the metabolism of these compounds can lead to various intermediates which alter 
normal cell metabolism (Table 1.5).
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Table 1.5: Fate of reactive intermediates of hydrazines
Cellular component Alteration
Enzymes Inhibition of the enzyme due to
pyridoxal phosphate formation of the hydrazone of
as prosthetic group pyridoxal phosphate (and hence 
inhibition of the intermediary 
metabolism)
Flavin-dependent Inhibition of mammalian
enzymes monoamine oxidase due to 
alkylation of the enzyme
Thiols Nucleophilic attack of thiols on azo 
linkages substituted with electron 
withdrawing groups or alkylation of 
thiols
Nucleic acids Alkylation of nucleic acids
Haemoproteins (a) Inhibition of horseradish 
peroxidase and catalase due to 
alkylation of the enzymes
(b) Inactivation of cytochrome 
P450 due to the formation of 
abortive complexes
Both the microsomal cytochrome P450 enzyme system and the microsomal 
FAD-dependent monooxygenase enzymes are involved in the oxidation reactions of 
many hydrazines. For example, the microsomal metabolism of 1,1 -dimethylhydrazine, 
and perhaps other 1,1-disubstituted hydrazines, is catalysed by the liver microsomal i! 
FAD-containing enzymes (Prough et a l, 1981). However, certain classes of hydrazine 
derivatives, including monosubstituted hydrazines and hydrazides, 1,1- and 1,2- 
disubstituted hydrazines, could interact with cytochrome P450 eliciting type II spectral 
interactions. They also have the ability to modify the function of cytochrome P450 as a 
terminal oxidase by one of the following mechanisms: a) competition for substrate
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binding site, b) formation of an abortive complex, c) haem destruction (Moloney et al., 
1984).
1.3.1.3 Mutagenicity of hydrazines
Hydrazine exerts a weak mutagenic action in both prokaryotes and eukaryotes 
(Kimball, 1977) although potent mutagenicity in Haemophilus influenza was reported 
by Kimball and Hirsch (1975). Its mutagenicity is believed to be the consequence of 
interactions with the pyrimidines in DNA (Kimball, 1977). Some of the substituted 
hydrazines can also react in much the same way and others, especially the methyl 
derivatives, by alkylating purines. Furthermore, hydrazine derivatives gave rise to 
chromosomal aberrations and other chromosomal or nuclear effects (Kimball, 1977).
Despite the evidence for mutagenic action and for carcinogenicity as a result of 
long-term bioassays, only few hydrazines have been successfully tested in rapid 
bacterial assays. Among them, methylhydrazine was found to be active in Salmonella 
typhimurium slvdim TA 1535 in the liquid assay and 1,1-dimethylhydrazine in several in 
vitro tests requiring microsomal activation (Brucick and Matheson, 1977). Tpsk and 
his group (Tosk et al., 1979) have employed the Salmonella typhimurium strain TA 
1530 in order to evaluate the mutagenicity of some hydrazines as possible direct-acting 
agents, and they proposed that while many of the hydrazines tested may have been 
direct-acting, it was possible that the bacteria themselves had performed an activating 
biotransformation. Moreover, a comparison of the mutagenic potential of hydrazine, 
monoacetylhydrazine (MAH) and sym-diacetylhydrazine (DAH) revealed that the 
unsubstituted compound was the most mutagenic and the disubstituted was non- 
mutagenic. Further studies on the mutagenicity/carcinogenicity of MAH and DAH in 
the Ames and the micronucleus tests indicated that only the former was positive in both 
tests (Bhide er al., 1984).
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1.3.2 Hydrazines in Agaricus bisporus
Although only few compounds containing the hydrazine nucleus are known to 
exist naturally (Liu et a i, 1982; La Rue 1977; Toth, 1988), substantial amounts of 
substituted hydrazines have been found in Agaricus bisporus.
L3.2.1 Agaritine
The first hydrazine from Agaricus bisporus, a phenolic derivative of glutamic 
acid, was isolated from the fruiting bodies of this mushroom in 1960 by Levenberg. 
This non-protein amino acid was obtained in a pure state from the press-juice of this 
fungus and was characterised as |3-N -[y-(L(+)glutam yl]-4-hydroxym ethyl- 
phenylhydrazine. Subsequently the trivial name of agaritine was adopted (Figure 1.5) 
(Levenberg 1960; 1961).
Figure 1.5: Structure of agaritine
1.3.2.1.1 Occurrence
Since the discovery of agaritine many investigators have synthesised (Daniels et 
al., 1961; Wallcave et al., 1979; Datta and Hoesch, 1987), isolated and/or quantified 
this compound both in the fruiting-bodies (Levenberg, 1960; 1964; Daniels etal., 1961; 
Kelly et al., 1962; Ross etal., 1982a, b; Liu et al., 1982; Speroni and Beelman, 1982; 
Fischer et a l,  1984; Stijve et a i, 1986; Sharman et al., 1990), as well as in the 
mycelium (Speroni et al., 1983) of this fungus. The concentrations of agaritine in 
Agaricus bisporus mnge from 008 to 1.17 g/kg fresh mushroom.
NH2
i
NH-NH-CO-(CH2)2-CH-COOH
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The presence of agaritine in Agaricus bisporus is not a unique feature for this 
mushroom, as 10 out of 15 different species belonging to the genus Agaricus 
(pattersonii, xanthodermus, argentatus, campestris, comptulis, crocodilinus, edulisy 
hortensia , micromegathus and perracus ) were found to contain agaritine in quantities 
comparable to those of Agaricus bisporus, whereas the remaining five species, all 
belonging to the sylvaticus subgroup were devoid of the compound (Levenberg, 1964). 
A subsequent study (Stijve et al., 1986) showed that 43 other types of edible 
mushrooms, including Shiitake (Lentinus edodes) and Oyster mushroom {Pleurotus 
ostreatus), none of which is a member of the genus Agaricus, did not contain agaritine. 
On the other hand, agaritine was present in 11 out of 16 members of the genus Agaricus.
1.3.2.1.2 Toxicity, carcinogenicity, mutagenicity
In view of the findings that (a) the hydrazide agaritine is present in Agaricus 
bisporus and other edible mushrooms at relatively high concentrations and (b) most 
hydrazines are hazardous (see 1.3.1), and bearing in mind the extensive consumption of 
this mushroom, especially in the western hemisphere, studies have been undertaken to 
evaluate any health risk resulting from the ingestion of agaritine.
The first of such studies (Toth et al., 1975a) indicated that a single subcutaneous 
injection of agaritine (100|ig/g body weight) to Swiss mice caused a decrease in survival 
rates and body weights, and resulted in congested lungs as well as slight fatty 
degeneration in the liver, the effects being more profound in males. In a second study 
(Toth et al., 1975b) agaritine was given at a dose range 25-400|ig/g body weight as a 
single injection to Swiss mice. The animals treated with the high doses exhibited a 
number of toxicity symptoms including hepatotoxicity and nephrotoxicity. 
Subsequently it was shown that the convulsive, toxic and lethal effects of this 
compound were successfully prevented by pyridoxine hydrochloride administration 
before and/or after injection of agaritine (Toth and Erickson, 1977).
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Although this hydrazide has never been shown to be carcinogenic in mice (Toth 
et al.y 1981b; Toth and Sornson, 1984; Clémençon, 1987), it was a weak, direct- 
acting mutagen in the Salmonella typhimurium strains TA 2637 (Sterner et al., 1982), 
TA 98, TA 100 (Ueijma etal., 1986), TA 1535 and TA 1537 (Rogan etal., 1982). In 
contrast, Friederich et al., (1986) were unable to detect any mutagenic activity 
towards TA 1535. Moreover, they reported that the weak mutagenicity of this toxin 
towards the bacterial strains TA 1537 and TA 97 decreased in the presence of an 
activation system (S9). It was, however, increased by either incubation at alkaline pH 
or preincubation with y-glutamyltransferase. In contrast to the latter finding, the group 
of Pool-Zobel (1990) failed to detect any increase in agaritine mutagenicity after 
preincubation with y-glutamyltransferase when TA 97 was employed.
1.3.2.1.3 Agaritine biosynthesis
The biosynthesis of agaritine in mushroom is illustrated in Figure 1.6. Since all 
intermediates between 4-aminobenzoic acid and agaritine contain the hydrazine nucleus 
they have been tested for toxicity, both in long- and short-term tests (Toth, 1986; 1988; 
Saccheta et al., 1990; Toth and Chauhan, 1985; Chauhan et al., 1985a, Roe et al., 
1967; Malca-Mor and Stark, 1982, Friederich et al., 1986). The compound 4- 
hydrazinobenzoic acid (HBA), present in the mushroom at levels 10.7±2|j.g/g fresh 
mushroom (Chauhan et al., 1984), was found to induce smooth muscle cell tumours of 
the aorta and large arteries (McManus et a l,  1987) and to be mutagenic in various 
Salmonella typhimurium strains in the Ames test (Friederich et al., 1986) while 
P-N-[y-L(+)-glutamyl]-4-carboxyphenylhydrazine (GCPH), isolated from this fungus 
at levels 42±3|ig/g fresh mushroom weight (Chauhan et al., 1985b), induced 
subcutaneous tumours in male mice after oral administration (Toth, 1986).
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Figure 1.6: Biosynthesis of agaritine in mushroom
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1.3.2.2 Agaritine degradation products
Agaritine is converted within the mushroom to 4-hydroxymethylbenzene 
diazonium ion (4-HMBD) via two routes. The first, a two-step reaction, involves 
cleavage of agaritine by the fungal enzyme y-glutamyltransferase to 4-hydroxymethyl- 
phenylhydrazine (4-HMPH) (Levenberg, 1961; 1964; Gigliotti and Levenberg, 1964) 
(Figure 1.7) and conversion of 4-HMPH by a fungal oxidative enzyme specific to 
hydrazines to 4-hydroxymethylbenzene diazonium ion (4-HMBD) (Figure 1.7). In the 
second pathway, agaritine is metabolised to 4-HMBD via a one-step mechanism, the 
reaction being catalysed by another enzyme system of Agaricus bisporus which is 
specific to hydrazides (Levenberg, 1964; Ross e ta l., 1981; 1982a) (Figure 1.7). 
Moreover, 4-HMPH can be converted to 4-methylphenylhydrazine (4-MPH) in vitro, 
but the significance of this in vivo has not been established (Levenberg, 1964) (Figure 
1.7).
Figure 1.7: Metabolism of agaritine
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1.3.2.2.1 Occurrence
4-HMPH has never been isolated due to its instability, whereas 4-HMBD was 
detected chiefly in the basal portion of the mushroom stalk but not in the cap 
(Levenberg, 1962) and was present in both acid and neutral extracts of Agaricus 
bisporus (Ross et a l, 1981) in quantities upto 0.6mg/kg fresh mushroom (Ross et a i,  
1982a). The group of Ross has also reported that a second diazonium compound was 
generated in acidic extracts from an unknown precursor in the mushroom. This 
compound was a substituted benzene diazonium ion and was found at levels 
corresponding to 20-30 ppm of the fresh mushroom (Ross et al., 1981; 1982a).
1.3.2.2.2 Carcinogenicity, mutagenicity
Though agaritine itself was reported not to be carcinogenic (Toth et al., 1981b; 
Toth and Sornson, 1984) all compounds derived from it, namely 4-HMPH, 4- 
HMBD and 4-MPH, can induce tumours in Swiss mice (Toth, 1977; 1979a, b; Toth et 
a l,  1978; 1981a; 1982; Toth and Nagel, 1981; Lawson era/., 1984; 1988; Shephard 
et a l, 1986). Moreover, these three agaritine breakdown products have been shown to 
be mutagenic in various Salmonella typhimurium strains in the Ames test (Toth, 1980; 
Rogan et <3/.,1982; Friederich et al., 1986). Furthermore, N-acetyl-4-HMPH was 
also reported to elicit positive DNA responses in the test on rayfriouse hepatocytes (Mori 
et al., 1988). In contrast, neither 4-HMPH nor 4-HMBD tetrafluoroborate displayed 
mutagenicity in a liver cell-mediated V79 mutagenesis system (Kuszynski, 1981).
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1 . 3 .3  Nitrosamines
In a study aiming to determine the potential threat to humans of carcinogenic 
nitroso compounds occurring in foodstuffs, it was reported that mushrooms contain N- 
nitrosamines. N-nitrosopiperidine was found in 62.2% of the various mushroom types 
examined. Moreover, N-nitrosodimethylamine and N-nitrosodiethylamine were also 
detected at maximum concentrations of 10.5 and 13.4|ig/kg, respectively (Tutelyan et 
a/., 1990).
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1.4 Other edible mushrooms
Although in ancient times mushrooms were regarded as "food for Gods", they 
are nowadays food for everyone. Therefore, a large variety of edible mushrooms, in 
addition to Agaricus bisporus, either wild or cultivated, is now commercially available. 
The most well-known wild types include cepes (French) or cep (English), chanterelles, 
morels and truffles, while Lentinus edodes (Shiitake), Pleurotus ostreatus (Oyster) 
and Volvaria volvacea (Padi Straw) are cultivated species.
\  A  .1 Lentinus edodes
Lentinus edodes belongs to the family of A garicaceae  and thus is a 
basidiomycete. It is commonly called Shiitake or Japanese mushroom because it is 
chiefly cultivated in Japan, where it is the country's second largest agricultural export, 
and exported mainly in dried or canned form, though some fresh supplies are available 
from U.K. and Dutch sources (Whitehall, 1990). Recently the production of Shiitake 
has been increased due to its excellent culinary properties and its long shelf-life; it can be 
stored as dried material and easily rehydrated without loss of the flavour.
Despite its popularity in the modern diet, consumption of this mushroom or 
exposure to Shiitake allergens can result in toxicity. During a period of 9 years, 30 
patients with toxicodermia, caused by eating Shiitake and which had a characteristic 
clinical picture, were observed (Nakamura and Kobayashi, 1985). Moreover, 
respiratory and immunological reactions among workers at Shiitake farms have also 
been reported (Sastre et al., 1990); the workers developed a hypersensitivity 
pneumonitis due to Shiitake spores, the latter being the aetiological agent of the 
mushroom workers' lung (Lockey, 1974). Indeed, Shiitake release tremendous 
numbers of spores into the atmosphere, mainly due to the fact that they have no veil and 
thus spores are released during cap growth prior to caps attaining the "marketable" size.
Furthermore, a fraction of Lentinus edodes obtained after extraction with 
ethanol, evaporation of the solvent and shaking the so-derived aqueous phase with
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ether, was found to contain some mutagenic material. When this fraction was tested in 
the Ames test using various Salmonella typhimurium strains it showed almost a 
doubling in the reversion rate in TA 100 but the mutagenic response was decreased 
upon addition of an activation system, though not altered after boiling of the mushrooms 
(von Wright et a i, 1982). The group of Griiter, however, argued against this finding 
by showing that this weak mutagenicity in the Ames test was actually an artefact, due to 
the presence of free histidine in the mushroom extracts, which apparently increased the 
reversion from histidine auxotrophy to prototrophy (Griiter et al., 1991). Finally, 
though it was reported that agaritine, a weak mutagen (see 1.3.2.1.2) occurred in 
Shiitake (Toth, 1979b), Stijve could not detect the hydrazide in Lentinus edodes 
extracts (Stijve et a i, 1986).
1 . 4 . 2  Pleurotus ostreatus
Pleurotus ostreatus is also known as "Oyster mushroom" because of its 
scallop-shape cap which has a blue-grey colour and a diameter of 5-15cm. It is a 
relatively delicate mushroom but with a shorter storage life than the common cultivated 
mushroom Agaricus Msponw (Whitehall, 1990). It is a very common naturally- 
occurring fungus, widely distributed in the U.K. It can also be cultivated and though 
there is some U.K. production, the major current source is Italy, Spain, Germany, 
Holland and Israel. Despite the presence of some claimed antitumourigenic compounds 
in this mushroom (Yoshioka et a i,  1975; 1985), a recent study in Iraq showed that 
aqueous extracts of this fungus, when administered orally or intraperitoneally to mice, 
gave rise to toxicity. The kidney, lung, liver, spleen, heart and small intestine were 
congested and displayed general cyanosis. Moreover, histopathological examination 
showed definite pathological changes in many organs and particularly in the liver of all 
treated mice (Al-Deen et ai, 1987).
Thus, when taken in large quantities in its fresh form, this edible mushroom can 
be potentially toxic. These toxic effects could be, at least partly, due to proteinaceous
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toxins already isolated from the fungus (Bernheimer and Avigad, 1979; Seeger, 1980). 
Fortunately, however, humans do not normally consume such large amounts of fresh 
and uncooked mushroom in a single meal and this could explain the absence of serious 
manifestations after eating smaller amounts of this edible species.
This fungus has also been reported to contain mutagenic material. A weak 
mutagenic response was observed when aqueous extracts of fresh or frozen Oyster 
mushrooms were tested in the Ames test employing the Salmonella typhimurium strain 
TA 98, the mutagenicity being dependent on metabolic activation only in the case of 
fresh mushrooms (Morales et ah, 1990a). A weak mutagenic activity was also seen in 
the CHO/HPRT assay in the presence of an activation system when an aqueous solution 
of canned Pleurotus ostreatus was tested (Morales et a i, 1990b).
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1.5 Aims of the study
Feeding raw Agaricus bisporus, the mushroom of commerce, to a strain of mice 
gave rise to a marked increase in the incidence of tumours in a number of sites. 
Moreover, many biological active compounds have been isolated from Agaricus 
bisporus, some with apparent toxicity. In particular, hydrazines, such as agaritine 
precursors and breakdown products have been demonstrated to be carcinogenic in mice. 
Extracts of Agaricus bisporus, as well as hydrazines isolated from this mushroom 
species, possess mutagenic activity in many strains of Salmonella typhimurium, 
indicating the presence of both frameshift and base-pair mutagens. Some of the 
identified hydrazines are direct-acting while others require metabolic activation to 
manifest their mutagenicity. However, most mutagenicity studies have generated 
contradictory data, possibly due to the fact that the content of the principal hydrazine, 
agaritine, is influenced by many factors such as mushroom strain spawned, compost, 
phase of cropping cycle, storage and cooking. Other compounds present in this fungus 
and which may also contribute to the mutagenicity are quinones, phenols and radical 
species generated by their metabolism. The evidence for toxicity, carcinogenicity and 
mutagenicity of Agaricus bisporus justify the need for further studies to evaluate any 
risk to humans due to the consumption of this mushroom. The objectives of this work 
are:
A. to confirm the mutagenic response of Agaricus bisporus in the Ames 
mutagenicity test, using mushrooms grown in the U.K., and to optimise the 
mutagenicity assay conditions of Agaricus bisporus extracts in this assay;
B. to determine how factors such as mushroom-strain, -type, -break, storage 
and cooking influence the levels of mutagenic materials in the mushroom;
C. using the Ames test, to assess the role of agaritine and its breakdown 
products in the mutagenicity of this fungus;
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D. to fractionate Agaricus bisporus extracts so as to identify the fraction in 
which mutagenicity resides and use this as a routine means for characterising mutagenic 
compound(s) in mushroom;
E. to investigate the role of metabolism in the production of mutagenic 
intermediates from Agaricus bisporus extracts;
F. to investigate the mutagenicity of Lentinus edodes (Shiitake) and Pleurotus 
ostreatus (Oyster mushroom) in the Ames test.
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CHAPTER 2
MATERIALS AND METHODS
2.1  Materials
Aroclor 1254 (Robens Institute of Health and Safety, Guildford, Surrey); 
9-aminoacridine, ampicillin, arachidonic acid from porcine liver, d-biotin, B-carotene, 
glucose-6-phosphate, glucose-6-phosphate dehydrogenase, y-glutamyl transpeptidase 
from bovine kidney, reduced and oxidised glutathione, L-histidine, isoniazid, 
menadione, N '-methyl-nitro-N-nitrosoguanidine, NADH, NADP, NADPH, 
nitroquinoline-N-oxide, N-nitrosopyrrolidine, norharman hydrochloride, superoxide 
dismutase from bovine liver, tetracycline hydrochloride, mushroom tyrosinase, 
tyrosine (Sigma Co., Poole, Dorset); 2-aminofluorene, dicoumarol, 2-nitrofluorene, 
phenylhydrazine hydrochloride (Aldrich Chemicals Co. Ltd, Gillingham, Dorset); 
benzidine (Koch-Light Laboratories Ltd, Colnbrook, Buckinghamshire); 
monoacetylhydrazine (K and K laboratories, ICN Biomedicals Inc., Cleveland, Ohio); 
prostaglandin H synthase from ram seminal vesicles (Cascade Biochem. Ltd, Reading, 
Berkshire); 2-aminoanthracene (Research Chemicals, Ralph N. Emanuel Ltd, 
Wembley); Glu-P-1 (2-amino-b-methyldipyrido [l,2-a:3\ 2'-d]-imidazole (Wako Fine 
Chemicals, 4040 Neuss 1, FRG) were all purchased.
Plastic disposable tubes (Sterilin, Teddington, Middlesex); Lab M agar (London 
Analytical & Bacteriological Media Ltd, Salford, Lancs); Vogel Bonner E plates (Becton 
and Dickinson, Oxford, Oxon); Oxoid No.2 nutrient broth (Oxoid Ltd, Basingstoke, 
Hants) were also purchased.
Agaricus bisporus mushrooms were either purchased locally or kindly donated 
by Chesswood Produce Ltd (Thakeham, Pulborough, West Sussex). The mushroom 
samples of known agaritine content were kindly provided by Mr. M. Sharman, Food 
Science Group, Ministry of Agriculture, Fisheries and Food, Norwich. Pure agaritine 
was a generous gift from.Professor B. Toth, Omaha, NE, U.S.A. Finally, the various 
Salmonella typhimurium strains were generously donated by Professor B.N. Ames, 
Berkeley, CA, U.S.A.
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2 .2  Methods
2 .2 .1  Animals and animal pretreatment
Male Wistar albino rats (about 200g) and adult male CD1 mice (20g) were 
obtained from the Experimental Biology Unit, University of Surrey. Male adult 
hamsters (about 90g) were obtained from Wrights of Essex, Essex.
All animals were housed at the University of Surrey, at 22°C, 50% humidity 
and under a 12 hours light-dark cycle (07.00 - 19.00 light). They were kept in cages 
with sawdust bedding and allowed food (Spratts Animal Diet No.l) and water ad  
libitum.
Induction of the hepatic cytochrome P450 1 and cytochrome P450 2B families 
in the rat was achieved by a single intraperitoneal injection of Aroclor 1254 (500mg/kg), 
dissolved in corn-oil (200 mg/ml), the animals being killed on the fifth day following 
dosing. Induction of the hepatic cytochrome P450 2E family in the rat was achieved by 
administration of 0.1% (w/v) isoniazid in the drinking water for 10 days prior to 
sacrifice.
2 . 2 . 2  Preparation of the various hepatic subcellular fractions
All equipment and solutions used during the preparation of the various hepatic 
subcellular fractions were previously sterilised in an autoclave at 120°C for 20 minutes.
2.2.2.1 Preparation of S9 fraction
The animals were killed by cervical dislocation, the livers were immediately 
excised, washed twice in sterile, ice-cold 1.15% (w/v) KC1 to remove excess of blood, 
placed in preweighed sterile universal tubes and weighed. The livers were then scissor- 
minced and homogenised in 2 volumes of sterile ice-cold 1.15% (w/v) KC1 using a
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homogeniser mortar which was immersed in ice during the homogenisation. The 
homogenate was subsequently adjusted to 25% (w/v) by further addition of sterile ice- 
cold 1.15% (w/v) KC1 and centrifuged at 9,000g for 20 minutes at 4°C in a Beckman 12 
21 centrifuge using a JA 17 rotor. With this procedure, cell debris, nuclei, 
mitochondria and lysosomes were removed and the resulting supernatant was carefully 
decanted off. This supernatant contained microsomes plus soluble (cell sap) fractions 
of the cell and it is termed the "S9 microsomal supernatant" (S9). Aliquots of S9 were 
stored at -20°C until required.
22.2.2 Preparation of the microsomal and cytosolic fractions
Aliquots of S9 were thawed over ice, transferred to polyethylene centrifuge 
tubes and centrifuged in a Beckman L7-65 Ultracentrifuge at 105,000g (45,000 rpm), 
for 60 minutes, at 4°G, using a Ti-70 head rotor. The resulting supernatant (105,000g 
supernatant), called the cytosolic fraction, was gently decanted off. The pellet was 
resuspended in sterile ice-cold 1.15% (w/v) KC1 using a hand homogeniser (105,000g 
pellet resuspended) and termed the microsomal fraction. Both cytosolic and microsomal 
fractions were used immediately.
2 . 2 . 3  Preparation of the mushroom extracts
Mushrooms (closed cups) were rinsed with water, drained and homogenised in 
96% (v/v) ethanol at a concentration of 100g/100ml for five minutes using a household 
Kenwood Food Blender. The homogenate was then filtered initially through muslin 
and subsequently through Whatman filter paper (Qualitative No.l). The solids were 
discarded while the filtrate was evaporated in a rotary evaporator under vacuum, at 
35°C. The final volume was about 10% of the original filtrate volume. Aliquots of 
the extract were kept at -20°C until required for use. Variations of the extraction 
procedure are described in the appropriate chapters.
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2 .2 .4  The Ames Salmonella  mutagenicity test
The mutagenic potential of the mushroom extracts was determined using the 
Ames mutagenicity test (Maron and Ames, 1983), employing various Salmonella 
typhimurium strains.
All equipment and heat-stable solutions were autoclaved at 120°C for 20 minutes 
prior to use and all experimental manipulations were performed in a class 2 flow cabinet 
under sterile conditions.
2.2.4.1 The bacterial tester strains
The histidine-requiring Salmonella typhimurium strains TA 97, TA 98, TA 
100, TA 102, TA 104, TA 1530, TA 1535, TA 1537 and TA 1538 were employed for 
this study.
Each of these strains contained a different mutation in the histidine operon, with 
the strains TA 97, TA 98, TA 1537 and TA 1538 able to detect frameshift mutagens 
and the strains TA 100, TA 102, TA 104 and TA 1535 able to detect base-pair 
substitutions. In addition to the histidine mutation, the tester strains contained other 
mutations that enhance their ability to detect mutagens such as the rfa mutation, which 
causes partial loss of the polysaccharide cell wall and thus increases the permeability to 
large molecules, and the uvrB mutation, which results in the loss of the DNA excision 
repair system, giving rise to an increased sensitivity in detecting many mutagens. 
Moreover, in the strains TA 97, TA 98, TA 100, TA 102 and TA 104, the sensitivity to 
mutagens has been further enhanced by the introduction of the R-factor plasmid, 
pKlOl, which confers both an error-prone repair system and ampicillin resistance to the 
bacteria. TA 102 also contains the multicopy plasmid pAQl which carries the histidine 
mutation and the tetracycline resistance gene.
The viability, the spontaneous reversion rate and the strain characteristics of the 
bacteria were routinely tested as described in 2.2.4A
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2.2A.2 Storage of the tester strains
The tester strains were stored either as frozen permanent cultures or as cultures 
on master plates.
2.2.4.2.1 Frozen permanent cultures
Frozen permanent copies of the tester strains were stored at -80°C in tightly 
capped cryotubes. They were prepared from fresh overnight cultures to which DMSO 
was added as a cryoprotective agent to give a final concentration of 9% (v/v).
2.2.4.2.2 Master plates
Master plates were prepared for bacterial strains which were used more 
frequently. For master plate preparation, a drop of thawed frozen permanent culture 
was applied to the surface of a Vogel Bonner E plate containing L-histidine (0.1M) and 
d-biotin (0.5mM) and streaked out for single colony isolation using a sterile platinum 
loop. The plate was then incubated for 48 hours at 37°C and subsequently stored at 
4°C.
2.2.4.3 Growing bacterial strains
Tester strain cultures were grown (a) in Oxoid nutrient broth (25mg/ml) for 
strains TA 1530, TA 1535, TA 1537 and TA 1538, (b) in Oxoid nutrient broth 
(25mg/ml) with ampicillin (25|ig/ml) for strains TA 97, TA 98 and TA 100 and (c) in 
Oxoid nutrient broth (25mg/ml) containing both ampicillin (25|ig/ml) and tetracycline 
(2jj.g/ml) for strains TA 102 and TA 104.
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For the preparation of fresh bacterial cultures, the appropriate nutrient broth 
solution (10ml) was inoculated with either the frozen permanent culture or a colony 
from the master plate using a sterile platinum loop. The inoculated broth was then 
incubated at 37°C in a shaking waterbath for 12 hours.
2.2.4.4 Testing for strain properties
As is advisable, the bacterial cultures were frequently tested for viability, 
spontaneous reversion rate and for the presence of the appropriate strain characteristics. 
All the tests were carried out in duplicate.
2.2.4.4.1 Test for histidine requirement
A volume of 0.1ml of the "high histidine/biotin solution" (0.1M L-histidine and 
0.5mM d-biotin) was spread over the surface of a Vogel Bonner E plate and allowed to 
dry. A fresh bacterial culture was then streaked onto the plate and in addition also onto 
a plate containing no histidine. The plates were incubated overnight at 37°C. The 
retention of the histidine mutation was shown if growth of bacteria was observed only 
on the histidine-supplemented plates.
2.2A4.2 Tests for the rfa mutation and the ampicillin resistance R factor
To 2.0ml of nutrient agar [agar: 0.6% (w/v), NaCl: 0.5% (w/v)] containing 
0.1M L-histidine and 0.5mM d-biotin solution, the fresh bacterial culture was added 
(0.1ml), the mixture was mixed and poured onto a Vogel Bonner E plate. The agar was 
allowed to solidify and a sterile filter paper disc (1cm in diameter) was then placed in the 
centre of the plate. A volume of 40}il of either crystal violet solution (1 mg/ml in water), 
for the rfa test, or ampicillin solution (8mg/ml in 0.02N NaOH), for the ampicillin 
resistance R factor test, was pipetted onto the disc and the plates were incubated
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overnight at 370C. A clear zone of inhibition around the disc indicated the presence of 
the rfa mutation and the absence of the ampicillin resistance R factor, respectively.
2.2.4A3 Test for bacterial viability
To 10ml of sterile nutrient broth, 0.1ml of an overnight culture was added and 
thoroughly mixed. An aliquot of this solution, (0.1ml), was transferred to 10ml of 
sterile nutrient broth and well mixed. The procedure was repeated once more. An 
aliquot of the final dilution, (0.1ml), was then added to 2ml nutrient agar which 
had been fortified with 0.1M L-histidine and 0.5mM d-biotin, mixed and poured onto a 
Vogel Bonner E plate. Following overnight incubation at 37°C, the number of colonies 
was counted and the viability (number of bacteria/ml) of the original culture calculated.
2.2.4.4.4 Test for spontaneous mutation rate
The spontaneous mutation rate, also known as spontaneous reversion rate, was 
tested during each Ames test by incorporating a blank into the test, i.e., by replacing 
the mutagen solution with the solvent alone.
Each tester strain reverts spontaneously at a characteristic frequency and typical 
spontaneous mutation rates are quoted in the literature (Ames et a l, 1975; Levin et ai, 
1984).
2.2.4.5 The plate incorporation assay
Into sterile 13mm x 100mm capped culture tubes, kept in a water bath at 45°C, 
2ml of top agar [agar: 0.6% (w/v), NaCl: 0.5% (w/v) containing 0.5mM L-histidine 
and 0.5mM d-biotin] ,0.1 ml of the fresh bacterial culture and the test compound at 
various concentrations and/or volumes were added and thoroughly mixed. 
Potassium phosphate buffer (0.2M, pH 7.4), (0.5ml), or the activation system, 
(0.5ml), prepared as described below (2.2.4.7), was added, mixed and poured onto
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Vogel Bonner E plates, ensuring uniform coverage of the mixture over the surface of 
the plate. The content of the plates was allowed to solidify for approximately 20 
minutes and the plates were then incubated for 48 hours at 37°C. The resulting revenant 
colonies were manually counted using a Gallenkamp colony counter.
In each test, which was carried out in triplicate, negative controls (i.e., blanks 
for detection of the spontaneous reversion rate) and positive controls (i.e., known 
mutagens specific of each tester strain, see Table 2.1) were included. In most cases, the 
positive control was dissolved in DMSO and applied at a volume of 0.1ml, except 
where otherwise stated.
Table 2.1: Positive controls for the various Salmonella typhimurium  
strains in the presence and absence of metabolic activation
Bacterial strain Positive control (Dose)
- Without activation With activation
TA 97 9-aminoacridine (50|ig/plate) 2-aminoanthracene (5jig/plate)
TA 98 2-nitrofluorene (2|ig/plate) 2-aminoanthracene (5pg/plate)
TA 100 MNNG* (2pg/plate) 2-aminoanthracene (5jig/plate)
TA 102 NQO** (2|ig/plate) 2-aminoanthracene (5|ig/plate)
TA 104 NQO** (2|ig/plate) 2-aminoanthracene (5pg/plate)
TA 1530 MNNG* (2p.g/plate) 2-aminoanthracene (5|ig/plate)
TA 1535 MNNG* (2pg/plate) 2-aminoanthracene (5pg/plate)
TA 1537 9-aminoacridine(50gg/plate) 2-aminoanthracene (5|ig/plate)
TA 1538 2-nitrofluorene(2jj.g/plate) 2-aminoanthracene (5pg/plate)
* : N'-methyl-nitro-N-nitrosoguanidine ** : nitroquinoline-N-oxide
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2.2A.6 The preincubation assay
Into sterile 13mm x 100mm capped culture tubes, which were kept at 4°C on 
ice, 0.5ml of the activation system (2.2.4.7), 0.1ml of the fresh overnight bacterial 
culture and the test mutagen at various concentration and/or volumes were added and 
mixed. The tubes were then incubated at 37°C in a shaking waterbath for various time 
intervals, as described in the appropriate chapters. On completion of the incubation, 
2ml of top agar (see 2.4.4.5) was added, the contents of the tubes were mixed, poured 
onto Vogel Bonner E plates and allowed to solidify. The plates were then incubated at 
37°C for 48 hours and the resulting revenant colonies were manually counted using a 
Gallenkamp colony counter.
As with the plate incorporation test method, each test was carried out in 
triplicate and negative / positive controls were included (see 2.2.4.5).
2.2.4.7 The activation system
The activation system usually contained 10% of the hepatic fraction and it is 
termed a 10% activation system. It comprises the following:
Liver fraction (25% w/v) 10%
Potassium chloride (0.33M) 10%
Magnesium chloride (0.08M) 10%
Potassium phosphate buffer (0.2M, pH 7.4) 50%
Cofactor solution (20 jimoles NADP/ml buffer and
25 pmoles glucose-6-phosphate/ml buffer) 20%
When the microsomal suspension was used as the hepatic fraction, the activation 
system was supplemented with glucose-6-phosphate dehydrogenase (1 unit/plate).
Where it was necessary to alter the % composition of the activation system, the 
amount of the hepatic fraction was changed and the amount of the buffer was adjusted 
accordingly so that the total volume of the activation system remained the same.
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2.2.5 Statistical analysis
The statistical analysis was carried out by using the Students' t-test.
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CHAPTER 3
ROLE OF VARIOUS 
ACTIVATION SYSTEMS IN 
THE MUTAGENICITY OF 
AGARICUS BISPORUS  
EXTRACTS
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3.1 Introduction
In a series of studies to determine which dietary constituents may play a role in 
the aetiology of human cancer, Agaricus bisporus was reported as a suspect food item. 
Uncooked mushrooms induced tumours in bone, forestomach, liver and lungs when 
orally administered to Swiss mice (Toth and Erickson, 1986) and hydrazines isolated 
from this fungus were carcinogenic to mice (Toth et a i, 1978; 1981a; 1982; Toth and 
Nagel, 1981; Toth, 1986; McManus et a i, 1987).
Extracts of Agaricus bisporus as well as mushroom constituents were positive in 
various short-term mutagenicity tests (Kellman and Berstein, 1978; De Flora et al., 
1979; Rogan et al., 1982; Sterner et al., 1982; von Wright et al., 1982; Friederich et 
a i, 1986; Ueijma et al., 1986; Mori et a i, 1988; Morales et a i, 1990a; Grüter et a i, 
1991). However, most of the mutagenicity studies generated contradictory results. 
The groups of De Flora and Pool-Zopel, for example, failed to detect any mutagenic 
activity in the Ames test (De Flora et a i, 1979; Pool-Zopel et al., 1990) whereas 
positive mutagenic response was reported by other researchers when the same assay 
was employed (Kellman and Berstein, 1974; Sterner et a i,  1982; von Wright et a i, 
1982). Furthermore, Agaricus bisporus extracts did not induce selective DNA 
amplification in Syrian hamster embryo cells or DNA single strand breaks in primary 
rat hepatocytes but, in contrast, increased sister chromatid exchange in Chinese hamster 
ovary cells (Santa Maria et a i, 1989; Pool-Zopel et a i, 1990). In a single in vivo 
study the same extract failed to induce genotoxicity in rat hepatocytes (Pool- 
Zopel et a i, 1990).
This discrepancy in the published studies prompted us to conduct further 
studies to clarify the eventual risk to humans resulting from the consumption of this 
worldwide and widespread used mushroom species. The purpose of the present study 
was therefore three-fold: (a) to confirm the mutagenicity of Agaricus bisporus using 
the Ames test, (b) to optimise the mutagenicity assay conditions of extracts of Agaricus
4.5
bisporus in this short-term mutagenicity assay and (c) to delineate the role of various 
activation systems in the mutagenicity of this mushroom species.
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3.2 Experimental design
3 .2 .1  Extraction procedures
The ethanolic extracts from Agaricus bisporus were prepared as described in 
Chapter 2. The extraction of Agaricus bisporus with chloroform and ethyl acetate is 
outlined in Tables 3.1 and 3.2, respectively.
Table 3.1: Extraction of Agaricus bisporus using chloroform
Extraction procedure I Fresh mushrooms (79g) were rinsed with water, chopped 
and extracted with 104ml chloroform under reflux conditions 
for 4 hours (temp.: 55°C). After filtration, the two phases of 
the filtrate were separated; the yellowish chloroform phase 
(73ml), designated as la, was evaporated to dryness in a 
rotary evaporator under vacuum (temp.: 376C). The residue 
(HOmg) was redissolved in 2.4ml sterile DMSO. The dark- 
brownish aqueous phase (27ml), designated as lb, was 
evaporated for 10 minutes in a rotary evaporator under 
vacuum (temp.: 37°C) to ensure the absence of any traces of 
chloroform. (The final volume following evaporation was 
26ml).
Extraction procedure II Fresh mushrooms (80g) were rinsed with water, chopped 
and extracted with 105ml ethanol 96% (v/v) under reflux 
conditions for 4 hours (temp.: 74°C). After filtration through 
Whatman filter (quantitative No.l), the filtrate (150ml) was 
vacuum-evaporated to dryness in a rotary evaporator (at 37°C) 
and the residue was redissolved, though not completely, in 
2.4ml sterile DMSO (DMSO-solution was designed as II).
Extraction procedure III Fresh mushrooms (80g) were rinsed with water and 
homogenised in a household blender (Kenwood) with 80ml 
ethanol 96% (v/v) for 10 minutes. After filtration (firstly 
through muslin and then through Whatman Quantitative No. 1 
filter), the filtrate was evaporated under vacuum to Vs of its 
volume using a rotary evaporator at 37°C. This concentrated 
solution was designated as III. A volume of 20ml of III were 
shaken in a separation funnel with 20ml chloroform and the 
two phases were separated; the aqueous phase was 
designated as I Va (22ml, brownish) whereas the chloroform 
phase (yellowish, 14ml) was evaporated to dryness (temp.: 
37°C). The residue was redissolved in 2.4ml distilled DMSO 
and designated as IVb.
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Table 3.2: Agaricus bisporus extraction using ethyl acetate
Extraction procedure I Fresh mushrooms (283g) were rinsed with water and then 
homogenised in a household blender (Kenwood) for 5 
minutes with 283ml ethanol 96% (v/v). The homogenate was 
filtered firstly through muslin and then through Whatman filter 
(Qualitative No.l). Finally, ethanol was evaporated off in a 
rotary evaporator. The final volume was about 20% of the 
original filtrate and this fraction, designated E, had a pH of 
6.5.
Extraction procedure II 15ml of fraction E were adjusted to pH 3.0 using 3M HC1 
and then shaken for 3 minutes in a separation funnel with 
45ml ethyl acetate. The aqueous phase was designated 3a 
(15ml) and the ethyl acetate phase was designated 3e 
(24.5ml). The latter was then evaporated to dryness using a 
rotary evaporator and the residue was redissolved in 2.4ml 
DMSO.
Extraction procedure HI 28.5ml of fraction E which had been adjusted to pH 7.0 using 
ION NaOH were shaken for 3 minutes in a separation funnel 
with 85.5ml ethyl acetate. The aqueous phase (25ml) was 
designated 7a and the ethyl acetate (87ml) 7e. The ethyl 
acetate from fraction 7e was evaporated off and the residue 
was redissolved in 8.7ml DMSO.
Extraction procedure IV 20.5ml of fraction E were adjusted to pH 10.0 with 10N 
NAOH and extracted with 61.5ml ethyl acetate in a separation 
funnel as above. The ethyl acetate phase (designated 10e, 
37ml) was evaporated to dryness and the residue was 
redissolved in 3.7ml DMSO. The aqueous phase (19ml) was 
designated 10a.
NB: To ensure that no ethyl acetate remained in the aqueous 
phases, 2ml aliquots from 3a, 7a and 10a were subjected to 
evaporation.
3.2.2 Activation systems
The activation systems were prepared as described in Chapter 2.
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3.3 Results
3 .3 .1  Mutagenicity of Agaricus bisporus extracts in various Salm onella  
typhimurium  strains and the role of S9 activation
Ethanolic extracts of Agaricus bisporus displayed a positive mutagenic 
response in the Salmonella typhimurium strains TA 1530, TA 1535, TA 1537, 
TA 1538, TA 97, TA 98, TA 100, TA 102 and TA 104, the last being consistently the 
most sensitive, showing a 4-fold increase over the spontaneous reversion rate (Table 
3.3). In all cases mutagenicity was evident in the absence of an activation system, and 
incorporation of such a system derived from the liver of Aroclor 1254-treated rats did 
not significantly influence mutagenicity (Table 3.3).
Table 3.3: Mutagenicity of Agaricus bisporus extracts in the Ames test
The activation system contained 25% (w/ v) hepatic postmitochondrial fraction (S9) from rats pretreated 
with Aroclor 1254, at a final concentration of 10% (v/v). The results are presented as Mean±SD for 
triplicates. All studies were repeated using hepatic samples from different but similarly treated animals, 
with the same results.
C om pound and M utagenic response(h is tid ine  revertan ts/p late )
concem raction________________________________ ______________________________________________________
TA VX TA MX) TA 102 TA KM
-S'J +S9 •S9 +S9 •S9 +S9 •S9 +S9
Spontaneous 
reversion rate 24i| 323 9(27 7212 298449 375420 39223 353433
Mushroom extracts (pi)
10
25
50
75
too
MNNG* (2pg) 
2-Aminoanthraeene (5|ig) 
9-Aminoacritlinc (50jig) 
2-NitroMuorene (2mg) 
Nitroquinolinc 
N-oxide (5pg)
24±2
2(25
47i|2
5(28
524
28210
5212
6(240
6(25
623
79-5
3379-22
9226
I24±2
15217
192-17
I93±5
108250
93410
96417
96410
10749
12449
18324190
42 272 
536457 
642435 
699412 
722420
38824232
555446
616414
71247
76223
785428
21174112
880452
915466
979449
12044108
15214110
794445
856479
9094185
1171494
15014127
2604431
Com pound and M utagenic response(histidine revertants/plate)
TA 1530 TA 1535 TA 1537 TA 1538 TA97
-S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9
Spontaneous 
reversion rate 2(23 1944 7—1 224» 642 942 745 1042 11647 9346
Mushroom extracts fotl)
10 3212 2944 642 223 742 1443 542 1443 14742 6148
25 3747 3(22 74 2 2245 1243 122 642 125 15149 7941 1
50 42412 323 94 2 1 2246 123 1342 1045 1949 192426 147426
75 4243 3645 1042 325 1445 1843 1045 227 20347 199431
100 5214 425 144 4 4147 1545 1945 122 229 2925 207413
MNNG* (2pg) 989486 - 336413 - - - - • - 22194132-Aminoanthraeene (5t*g) . 54259 242415 - 129410 - . 282422
161141929-Aminoacridinc (50pg) - - - 14054304 •
2-Nitronuorene (2mg) - - • • - * 26219
Nitroquinolinc 
N-oxidc (5pg) - - - - - - -
•N’-mcthyl-nitro-N-nitrosogunnklinc
49
Incorporation of an activation system containing hepatic postmitochondrial 
fraction (S9) derived from rats pretreated with isoniazid, a known inducer of the 
cytochrome P450 2E family, did not influence the mutagenicity of the ethanolic extracts 
oi Agaricus bisporus but, as expected, increased the mutagenic response of the 
nitrosamine N-nitrosopyrrolidine, when TA 1530, a bacterial strain particularly 
sensitive to nitrosamines, was used as the indicator strain (Table 3.4). Moreover, 
addition of an activation system containing hepatic cytosolic fraction from isoniazid- 
induced rats also failed to change the mushroom mutagenicity when the Salmonella 
typhimurium strain TA 1530 was employed (Table 3.4).
Table 3.4: The contribution of the cytochrome P450 2E family to the
mutagenicity of Agaricus bisporus ethanolic extracts
The activation systems contained either postmitochondrial fraction (S9) or cytosolic fraction (cyt) from 
isoniazid-treated male rats [25% (v/v)l and were incubated with the bacteria (TA 1530 or TA 104) and 
various concentrations o f ethanolic mushroom extracts for 1 hour at 37°C in a shaking waterbath. N- 
nitrosopyrrolidine (10m g/m l) was used as positive control with TA 1530 as an indicator strain. 
Results are expressed as Mean±SD for triplicates.
Compound Mutagenicity (Histidine revertants/plate)
TA 1530 TA 104
-S9 +S9 +cyt -S9 +S9
Spontaneous reversion rate 12±1 13± 3 10±2 281± 15 312±10
N-Nitrosopyrrolidine (100p.l) 12±2 56±15 - - -
Mushroom extract (pi)
25 15±2 16± 3 15±1 644± 45 529±15
50 21±0 18± 1 16±2 798± 62 781±48
75 22±3 23± 1 20±2 969±119 864±53
100 29±5 24± 3 24±2 1121± 79 940±22
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As Figure 3.1 illustrates, an activation system derived from hog's liver, which 
is characterised by high FAD-containing monooxygenase activity but low cytochrome 
P450 activity, failed to enhance the mutagenic activity of the mushroom mutagens, 
even when the activation system contained 30% of the porcine S9 preparation.
Figure 3.1: Activation of mushroom mutagens by hog hepatic S9 
preparations
The activation system contained various concentrations o f hepatic postmitochondrial fractions derived 
from pig. The bacterial strain TA 104 and various concentrations o f  ethanolic extracts o f  A garicu s  
b isporus  were employed. The spontaneous reversion rate o f 341±20 has already been subtracted. 
Results are expressed as Mean for triplicates.The SD did not exceed 11% o f  the mean values.
2000  -i
C L
>  1000 -
no activation  
10% S9  
20% S9  
30% S9
40 80 100 12020 600
Concentration of mushroom extracts fyjl /  plate)
5:1
3 .3 .2  Species differences in the activation of mushroom mutagens
Activation systems derived from the livers of untreated mice, hamsters or rats 
also failed to enhance the mutagenic activity of the ethanolic mushroom extracts even 
when the activation systems contained 30% of the hepatic S9 preparations (Table 3.5).
Table 3.5: Mutagenicity of Agaricus bisporus ethanolic extracts 
in the presence of activation systems derived from mouse, 
hamster and rat
The activation system contained hepatic postmitochondrial fractions derived from untreated m ice, 
hamsters and rats. A volume o f IOOjj.1 o f mushroom extracts was used and the assay was carried out in 
the presence o f Salmonella typhimurim  strains TA 104 and TA 98. The spontaneous reversion rates o f  
420^:53 and 54±6 for TA 104 and TA 98 respectively, have already been subtracted. The results are 
expressed as Mean±SD for triplicates.
(I) TA 104
Concentration 
of the S9 
fraction in the
Mutagenic response 
(Histidine revertants/plate)
activation system (%) Mouse Hamster Rat
0 422± 95 422± 95 422± 95
5 374± 78 282+136 440± 58
10 360± 62 383± 95 359±102
20 398± 78 223± 93 262± 55
30 378±110 339± 42 434± 22
(II) TA 98
Concentration Mutagenic response
of the S9 (Histidine revertants/plate)
fraction in the
activation system (%) Mouse Hamster Rat
0 53±17 57±17 53±17
5 50±19 79± 4 51±14
10 53± 6 53± 8 56± 7
20 67± 7 48±15 61±13
30 48±16 78±11 50± 9
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3.3.3 Activation of mushroom mutagens by rat hepatic microsomal 
and cytosolic fractions
Use of an activation system which contained cytosolic fraction, instead of 
microsomes, derived from Aroclor 1254-treated rats markedly enhanced the 
mutagenicity of the ethanolic mushroom extracts. However, addition of an activation 
system containing isolated microsomes from Aroclor 1254-induced rats did not 
influence the mushroom mutagenicity (Figure 3.2).
Figure 3.2: The role of hepatic cytosolic and microsomal activation 
systems in the mutagenicity of Agaricus bisporus ethanolic 
extracts in the Ames test
The Salmonella typhimurium  strain TA 104 was employed. The activation systems contained 10% 
(v/ v) cytosolic or microsomal fractions derived from Aroclor 1254-treated rats. The spontaneous 
reversion rate o f  501—94 has already been subtracted. Each point represents the M ean^SD for 
triplicates.
3 0 0 0  -i
2000 -
I03
1000 -Q)Ç~o
no activation  
cytosolic activation  
microsomal activation
.£2T
1.00.0 0.2 0.4 0.6 0.8
Mushroom extracts (g of fresh mushroom/plate)
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3 . 3 . 4  Possible interference in the metabolic capacity of the activation 
system s
In order to ensure that the mushroom extracts themselves did not influence the 
metabolic capacity of the activation system, the mutagenicity of phenylhydrazine, 
benzo(a)pyrene and Glu-P-1 (2-amino-6-methyldipyrido-[l,2-a:3 ,2 -d]-imidazole) 
was determined in the presence and absence of the mutagenic extracts. Clearly the 
mushroom extracts did not affect the mutagenicity of these known mutagens and are 
unlikely to influence the metabolic viability of the activation system (Tables 3.6 - 3.8). 
The increase in the mutagenic responce observed in the simultaneous presence of the 
mushroom extracts and benzo(a)pyrene or Glu-P-1 is attributable to the mutagenic 
activity of the fungal extracts per se.
Table 3.6: Modulation of the mutagenicity of phenylhydrazine in the
Ames test by ethanolic extracts from Agaricus bisporus
The activation system contained 10% (v/v) postmitochondrial fraction from Aroclor 1245-induced  
rats and was preincubated with the bacteria (TA 1537), the mushroom extracts and phenylhydrazine 
hydrochloride, for 20 minutes at 37'C in a shaking waterbath. Results are presented as M ean±SD for 
triplicates.
Phenylhydrazine
(pg/plate)
Mushroom extracts 
(pl/plate)
Mutagenic response 
(Histidine revertants/plate)
17±3
- 100 43±6
200 - 142±7
200 10 137±5
200 25 129±12
200 50 147±16
200 75 132±5
200 100 132+6
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Table 3.7: Modulation of the mutagenicity of benzo(a)pyrene in the 
Ames test by Agaricus bisporus ethanolic extracts
The activation system contained 10% (v/v) postmitochondrial fraction from Aroclor 1254-treated rats. 
The Salm onella typhim urium  strain TA 100 and lOOjil o f  benzo(a)pyrene, dissolved in DMSO  
(0.4mg/ml), were used. Results are expressed as Mean±SD for triplicates.
Benzo(a)pyrene Mushroom extracts Mutagenic response
(jig/plate) (pi/plate) (Histidine revertants/plate)
126 ± 8
100 197 ±20
40 - 431 ±22
40 10 438 ±75
40 25 415 ±66
40 50 518 ±63
40 75 647 ±65
40 100 693 ±53
Table 3.8: Influence of ethanolic extracts from Agaricus bisporus on 
the mutagenicity of Glu-P-1 in the Ames test
The activation system contained 10% (v/v) microsomal fraction derived from Aroclor 1254-induced  
male rats and was incubated with the bacteria (TA 104) and 2jig o f Glu-P-1, dissolved in DM SO  
(20pg/m l), for 1 hour at 37°C in a shaking waterbath. The spontaneous reversion rate o f  390±32 has 
already been subtracted. Number o f histidine revenants are presented as Mean±SD.
Glu-P-1
(gg/plate)
Ethanolic mushroom extracts 
(p,l/plate)
Mutagenic response 
(Histidine revertants/plate)
25 449 ±48
- 50 605 ±84
- 75 869±86
- 100 1084 ±14
2 - 374 ±24
2 25 647 ±80
2 50 906 ±38
2 75 1173 ±79
2 100 1153 ±70
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3 .3 .5  The cytosolic activation of mushroom mutagens
The cytosolic activation of the mushroom mutagens (Figure 3.2) was evident 
even when the concentration of the cytosolic fraction in the activation system was as 
low as 2.5% (v/v) and increase in the concentration of the cytosolic fraction in the 
activation system did not enhance further the mutagenicity (Figure 3.3). Moreover, 
preincubation of mushroom extracts for various time intervals with 10% cytosolic 
activation system did not influence the cytosol-potentiated mushroom mutagenicity 
(Figure 3.4).
As shown in Figure 3.5, the cytosol-mediated potentiation of the mutagenicity 
of the mushroom extracts was not inducible by previous treatment of rats with Aroclor 
1254. It was, however, abolished with prior boiling of the activation system at 60°C 
for 15 minutes.
Figure 3.3: Cytosol-m ediated activation  of the ethanolic ex trac ts  of 
Agaricus bisporus
The activation systems contained hepatic cytosolic (105,000g supernatant) fractions derived from 
Aroclor 1254-treated rats. An aliquot o f  lOOpl mushroom extract and the strain TA 104 were used: 
The spontaneous reversion rate o f 447±35 has already been subtracted. The results are expressed as
H  A: no activation
■  B: 2.5%  cytoso lic  activation  H C: 5.0%  cytoso lic  activation
■  D: 10 % cytosolic activation
■  E: 20  % cytosolic activation
■ ,  F: 30  % cytosolic activation
F
Mean±SD for triplicates.
2000 i
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Figure 3.4: Effect of preincubation of the m ushroom  ex tracts with 
cytosolic  ac tiv a tio n  system  on A g a r ic u s  b isp o ru s  
m utagenicity
The activation system contained 10% (v/v) cytosolic (105,000g supernatant) fraction derived from the 
liver o f male rats pretreated with Aroclor 1254 and was incubated with the bacteria (TA 104) and various 
concentrations o f mushroom extracts for 0, 20, 40  and 60 minutes at 37°C in a shaking waterbath. 
The spontaneous reversion rate of 399—24 has already been subtracted. The results are presented as 
Mean for triplicate. The SD did not exceed 11% o f the mean values.
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Figure 3.5: Influence of (a) animal pretreatm ent and (b) heating on the 
cytosol-mediated activation of Agaricus bisporus m utagens
The activation systems contained 2.5% (v/v) hepatic cytosolic (105,000g supernatant) fractions 
derived from untreated and Aroclor 1254-treated male rats. Dénaturation o f  the activation systems was 
achieved by heating the activation systems at 60°C for 15 minutes. Mushroom extracts corresponding 
to 0.8g o f  fresh mushroom and the Salm onella  typhim urium  strain TA 104 were used. The 
spontaneous reversion rate o f 510^28 has already been subtracted. Results are expressed as Mean±SD  
for triplicates.
4000 -,
A B C D E
A: no activation
B: cytosol from Aroclor 1254-treated rats 
C: cytosol from Aroclor 1254-treated rats, denatured  
D: cytosol from untreated rats 
E: cytosol from untreated rats, denatured
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Table 3.9 shows that the cytosolic activation of the mushroom mutagens was 
dependent on an NADPH generation system since no such activation was evident in the 
absence of cofactors. Supplementation of the complete cytosol activation system with 
NADH inhibited the fungal mutagenicity, but the effect was not concentration- 
dependent. However, NADH did not influence the mutagenic response obtained either 
in the absence of an activation system or in the presence of a cytosolic activation system 
devoid cofactors.
Table 3.9: The role of (a) an NADPH-generation system and (b) NADH
in the cytosolic activation  of the ethanolic m ushroom  
extracts
The Salmonella typhimurium  strain TA 104 and a mushroom extract corresponding to 0.6g o f fresh 
mushroom were used. The cytosolic fraction [10% (v/ v) in the activation system] was derived from 
liver o f male Aroclor 1254-induced rats. The spontaneous reversion rate of 417—27 has already been 
subtracted. Results are expressed as Mean±SD for triplicates.
Histidine revertants/plate
extract extract extract extract
+NADH +NADH +NADH
(1.5mM) (3.0mM) (4.5mM)
no activation 947±152 953±101 909±92 919±121
cytosolic activation system
+ NADPH gen. system 1223± 41 787± 53 829±67 859± 62
cytosolic activation system
-NADPH gen. system 764± 75 755± 25 766±67 707± 53
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3.3.6 The effect of acétylation on mushroom mutagenicity
Supplementation of the activation system with acetyl CoA did not influence the 
mutagenicity of the mushroom extracts in the presence of hamster S9 but, as expected, 
increased the mutagenicity of the aromatic amine, benzidine (Table 3.10).
Table 3.10: M utagenicity of Agaricus bisporus ethanolic ex tracts  
using h am ste r S9 supp lem ented  with acetyl CoA as 
activation system
Ethanolic extracts from Agaricus bisporus  were incubated with 20% (v/v) hamster S9 in the presence 
and absence o f  acetyl C oA , (200nm ol/plate), for 20  minutes at 37°C in a shaking waterbath. 
Benzidine, dissolved in DM SO, was used as positive control with TA 98 as the indicator strain. 
Results are presented as Mean±SD for triplicates.
Compound Mutagenicity (Histidine revertants/plate)
TA 98 TA 104
-acetyl CoA 4-acetyl CoA -acetyl CoA 4-acetyl CoA
Spontaneous reversion rate 25±2 21±4 320±7 350±3
Benzidine (300nmol) 124±22 451±49 - -
Mushroom extract (pi)
25 27±3 30±2 432±17 481±59
100 37±6 42±5 705±45 671+90
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3.3.7 Effect of norharm an on the mutagenic activity of mushroom 
ethanolic extracts
In order to investigate whether norharman has a synergistic role in the activation 
of the mushroom mutagens, the mutagenicity of the ethanolic extracts of Agaricus 
bisporus was tested in the presence and absence of norharman. Clearly norharman 
had no significant effect on the mutagenic activity of the fungal mutagens and is, 
therefore, unlikely to have a synergistic effect on the activation of the mushroom 
extracts (Table 3.11). As expected, an increase in the number of histidine revenants 
was observed with diphenylnitrosamine (DPhN) which served as positive control.
Table 3.11: M utagenicity  of A g a ricu s  b isporus  ex trac ts  using S9 
supplemented with norharm an as activation system
The activation system contained postmitochondrial fraction from the liver o f Aroclor 1254-treated rats 
[20% (v/v)] and was prcincubated with the bacteria (TA 98 or TA 104) and ethanolic mushroom extracts 
in the presence or absence o f 3mM norharman (Nh), dissolved in water, for 20 minutes at 37°C in a 
shaking waterbath. Diphenylnitrosamine (DPhN) served as positive control in TA 98 which was used 
as the indicator strain. Results are presented as Mcan±SD for three plates.
Compound Mutagenicity (Histidine revertants/plate)
TA 98 TA 104
-Nh +Nh -Nh +Nh
Spontaneous reversion rate 22+ 7 21± 6
30± 8 785±13
434± 5 458+ 7
DPhN (lOOfig)
Mushroom extract (jj.1)
50
75
100
37+ÎO 57+ 9
48± 6 64± 8
54±10 65± 4
911+ 21 973+143
1269+ 74 1352± 61 
1416± 134 1500± 60
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3 .3 .8  Activation of mushroom mutagens by purified prostaglandin H 
syn thase
Since some xenobiotics are oxidised and thus activated in a reaction catalysed by 
prostaglandin H synthase (PGS), it was considered desirable to study the possible 
participation of PGS in the activation of the mushroom mutagens. As Table 3.12 
shows, addition of purified PGS to the ethanolic mushroom extracts did not 
significantly affect the fungal mutagenicity, though a marginal increase in the mutagenic 
response was seen when the Salmonella typhimurium strain TA 98 was employed. 
However, the enzyme enhanced the mutagenicity of 2-aminofluorene (2-AF), a 
compound known to be activated by this enzyme system.
Table 3.12: Participation  of purified prostaglandin H synthase in the 
activation of Agaricus bisporus m utagens
A mixture (total volume: 1.0ml) containing ethanolic mushroom extracts, potassium phosphate buffer 
(0.2M , pH 7.4), lOOp.1 o f PGS (200 units) and lOOpl o f the bacteria (TA 98 or TA 104) was incubated 
for 3 minutes at 37°C in a shaking waterbath. A volume o f 10pl arachidonic acid, dissolved in 95% 
(v/v )  ethanol to give a final concentration o f IOOjiM, was then added and the mixture was further 
incubated for 30 minutes. 2-AF was served as the positive control with TA 98 as the indicator strain. 
Results are expressed as Mean±SD for triplicates.
Compound Mutagenicity (Histidine revertants/plate)
TA 98 TA 104
-PGS +PGS -PGS +PGS
Spontaneous reversion rate 17± 4 13± 2 378± 24 365±29
2 - A F ( l# g ) 18± 5 43± 8 - -
Mushroom extract (pi)
25 21+ 1 31± 2 - -
50 30±11 37± 7 - -
75 31±10 43±13 - -
100 38± 9 51 + 10 1365+127 1404+77
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3 . 3 . 9  Evaluation of various mushroom extraction procedures
To establish the most efficient extraction procedure for the mushroom 
mutagens, fresh Agaricus bisporus fruit bodies were extracted using methanol, water, 
chloroform or ethyl acetate, and the mutagenicity of these extracts was compared with 
the mutagenic activity of ethanolic mushroom extracts. From Tables 3.13 and 3.14 it is 
evident that both chloroform and ethyl acetate failed to extract the mushroom mutagens, 
and that the mutagenic material always remained in the aqueous and/or ethanolic 
fractions. In contrast, Agaricus bisporus mutagens could be extracted with either 
water or methanol and, as is illustrated in Table 3.15, the mutagenicity of the 
methanolic and water extracts was of the same magnitude as that induced by the 
ethanolic extracts.
Table 3.13: Mutagenicity of Agaricus bisporus fractions obtained after 
extraction with chloroform
The mushroom fractions were prepared as described in Table 3.1. The Salmonella typhimurium  strain 
TA 104 and the.six fractions were employed. Results are presented as Mean±SD for triplicates.
Fractions Mutagenicity (Histidine revertants/plate)
Spontaneous reversion Mushroom extracts (p.1)
rate ______________________________
50 100 200
581±21
la 707± 83 719±46 729± 32
lb 1153±125 1242±99 1266± 31
II 2528±121 toxic toxic
III 1150± 82 1399±53 1572± 42
IVa 1296±125 1491±67 1955±204
IVb 791± 95 717±76 711± 34
la: organic extract obtained when mushrooms were extracted with chloroform under reflux conditions 
lb: aqueous extract obtained when mushrooms were extracted with chloroform under reflux conditions 
II: extract obtained when mushrooms were extracted with ethanol under reflux conditions 
III: ethanolic extract (standard procedure)
IVa: aqueous phase following chloroform extraction o f III 
IVb: organic phase following chloroform extraction o f III
62
Table 3.14: Mutagenic activity of the m ushroom  fractions derived from
ethyl acetate extraction in the bacterial strains TA 104 and 
TA 97
The preparation o f the mushroom extracts was described in Table 3.2. Aliquots (100p.l) o f  each 
fraction were used. Numbers of histidine revenants are presented as Mean±SD for three plates.
I. Salmonella typhimurium strain TA 104
Fractions Histidine revertants/plate
Spontaneous 
reversion rate 
304+43
Mushroom extract (p.1)
25 50 75 100
E 629± 38 795± 38 918± 56 1109± 43
3a 495± 51 582± 35 919±145 1139±102
3e 478± 20 478± 46 462+ 24 460± 46
7a 720± 90 983± 57 1230±121 1236± 42
7e 561±131 542± 31 497± 62 457± 30
10a 584±158 799±100 1013±142 1064+ 23
10e 491± 66 588± 28 613±122 695± 97
II. Salmonella typhimurium strain TA 97
Fractions Histidine revertants/plate
Spontaneous
reversion rate Mushroom extract (|ll)
135±22
25 50 75 100
E 207± 21 231±13 278±30 289±49
3a 161±21 188±30 204+17 265± 3
3e 124±11 122± 5 120± 8 178± 6
7a 176±18 201±19 259±27 299±38
7e 107± 6 132±17 107± 2 133± 1
10a 128±15 181±12 210± 3 258±27
10e 141+22 165± 1 151+11 148+13
E: Ethanolic extract (standard procedure). 3a, 7a, 10a: Aqueous extracts following extraction o f  
fraction E with ethyl acetate at pH3, pH7 and pH 10 respectively. 3e, 7e, 10e: Organic extracts 
following extraction with ethyl acetate at pH3, pH7 and pH 10 respectively.
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Table 3.15: Mutagenicity of Agaricus bisporus extracted with polar 
solvents
Agaricus bisporus fruit bodies were homogenised for 5 minutes in methanol or 96% (v/v) ethanol at a 
concentration o f  Ig/m l, and in water at a concentration o f 1.5g/ml using a household food blender. 
The homogenates were filtered and the filtrates were vacuum-evaporated. Extracts corresponding to 
0.6g o f  fresh mushrooms and the bacterial strain TA 104 were employed in the A m es test. The 
spontaneous reversion rate o f 344±5 has already been subtracted. Results are presented as Mean±SD for 
triplicates.
Solvent Mutagenic response 
(Histidine reverants/plate)
Ethanol 1037+101
Methanol l l 37+79
Water 1085±84
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3.3.10 "Localisation” of mutagens in Agaricus bisporus
An investigation was undertaken to study the distribution of the mutagens in the 
various parts of the mushroom. Clearly the skin had the highest mutagenic activity, 
followed by the cap, while the gills displayed the lowest mutagenic response (Figure 
3.6).
F igure 3.6: Distribution of mutagenic activity in Agaricus bisporus
The various parts o f  Agaricus bisporus were extracted with ethanol and the extracts were tested in the 
bacterial strain TA 104. The spontaneous reversion rate o f 398±23 has already been subtracted. Results 
are expressed as Mean for triplicates. The SD did not exceed 11% o f the mean values.
2000 n
skin
cap
stipe
gills
Q.
•o
100 1208 0604 020
Concentration of mushroom extracts (pl/plate)
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3.4 Discussion
3 .4 .1  M u tag en ic ity  of A g a r ic u s  b isp o ru s  e x tra c ts  in v a rio u s
Salmonella typhimurium  strains
Ethanolic extracts of Agaricus bisporus displayed clear, but weak mutagenicity 
in Salmonella typhimurium strains detecting frameshift and base-pair substitution 
mutagens. This may suggest that the two types of mutation are caused by different 
mushroom constituents, although the possibility that the same compound is responsible 
for both mutation types cannot be excluded. By far the most sensitive strain for these 
mushroom extracts was TA 104, a strain particularly sensitive to oxidative mutagens 
such as aldehydes, quinones, hydroperoxides and reactive oxygen species (Levin et a i, 
1982; Marnett et a i, 1985), thus raising the possibility that such chemicals, rather than 
hydrazines, may be important contributors to mushroom mutagenicity.
3.4.2 The role of cytochrome P450-dependent m ixed-function oxidases
in the activation of mushroom mutagens
In agreement with previous studies (Sterner et al., 1982; von Wright et aL, 
1982; Morales et a l, 1990a), the presence of an activation system containing S9 
fractions derived from untreated mice, rats and hamsters or Aroclor 1254-induced rats 
did not influence significantly the mutagenic response exerted by the mushroom 
extracts. Murine hepatic fractions were used since (i) the carcinogenicity of Agaricus 
bisporus was established in mice (Toth and Erickson, 1986) and (ii) mouse liver or 
lung cytochrome P450 mediated mixed-function oxidases were capable of metabolising 
the mushroom hydrazines agaritine and 4-hydroxymethylphenylhydrazine to the 
diazonium ion which is the postulated ultimate mutagen (Lawson and Toth, 1983; 
Lawson et al., 1984; Lawson and Chauhan, 1985; Lawson, 1987). Rats were 
employed as, in contrast to mice, feeding of mushrooms to this animal species failed to 
induce tumours (Matsumoto et al., 1991). Hamsters were used since further testing of 
a suspect carcinogenic agent in a third rodent is always recommended when this agent
66
provokes tumours in mice but not in rats (Parke and loannides, 1981). Incorporation of 
an activation system containing isolated microsomal fractions instead of S9 fractions, 
also failed to enhance the mutagenicity.
The failure of the various activation systems to affect the fungal mutagenicity 
may therefore imply that (i) Agaricus bisporus contains direct-acting genotoxins and (ii) 
the Aroclor 1254-induced families of cytochrome P450, namely P450 1 and 2B, have 
no major effect on the metabolism of mushroom mutagens, whether activation or 
deactivation. Bearing in mind the chief role of the P450 1 isoenzymes in the metabolic 
activation of polycyclic aromatic hydrocarbons, aromatic and heterocyclic amines, 
azobenzenes etc. (loannides and Parke, 1990), it may be concluded that mutagenic 
compounds belonging to these chemical groups are unlikely to be present in Agaricus 
bisporus at significant levels. However, a further possibility merits consideration. 
Mushroom extracts are likely to contain a plethora of chemicals, having different 
structures, one or more of which could interact with cytochrome P450, inhibiting their 
activity and, thus leading to a gross underestimation of the contribution of the enzyme 
system to the activation/deactivation of mushroom mutagens. Indeed, certain classes of 
hydrazine derivatives, chemicals known to be present at substantial amounts in Agaricus 
bisporus, have been shown to have the ability to modify the function of cytochromes 
P450 as terminal oxidases (Moloney et a i, 1984). This, however, was not the case, 
as mushroom extracts did not influence the mutagenicity of phenylhydrazine, 
benzo(a)pyrene and Glu-P-1, mutagens that rely on cytochrome P450-mediated 
metabolic activation in order to express their mutagenic activity, thus demonstrating the 
viability of the activation systems.
Since Russian researchers demonstrated the presence of nitrosamines in 
Agaricus bisporus (Tutelyan et al., 1990), the contribution of such chemicals to the 
mutagenicity of the fungal extracts was also investigated. For this, mushroom extracts 
were tested in TA 104, the most sensitive strain for the fungal mutagens, and in 
TA 1530, a strain particularly sensitive to nitrosamines, in the presence of an activation 
system containing 89 fractions derived from the liver of rats pretreated with isoniazid.
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This activation system is rich in cytochrome P450 2E isoenzymes which are known to 
activate various nitrosamines (Yang ef a i, 1985), including N-nitrosopyrrolidine 
(McCoy et al., 1979) which served as positive control. Consequently, the failure of 
this activation system to enhance the mutagenic response of the extracts, coupled with 
the fact that hepatic fractions from Aroclor 1254-treated rats (P450 2B) also failed to 
promote activation, indicates that nitrosamines are unlikely to be involved in the 
observed mushroom mutagenicity.
3 .4 .3  Contribution of FAD-containing monooxygenases to the
activation of mushroom mutagens
Some hydrazine derivatives and in particular 1,1-disubstituted hydrazines, are 
metabolised by the microsomal FAD-containing monooxygenase enzymes (Prough et 
al., 1981). It is therefore possible that the phenylhydrazines present in Agaricus 
bisporus are activated by this enzyme system. This possibility was, however, ruled 
out when incorporation of an activation system derived from hog’s liver, which is rich 
in FAD-dependent monoxygenases but low in cytochromes P450 (Ziegler and Mitchell, 
1972), failed to enhance the mutagenic response. In support of this finding were also 
other studies which demonstrated that FAD-containing monoxygenases were not 
involved in the microsomal metabolism of the mushroom hydrazines (Lawson, 1987).
3 .4 .4  Cytosolic activation of Agaricus bisporus extracts
Though activation systems containing hepatic S9 fractions or isolated 
microsomes did not influence the mutagenicity of Agaricus bisporus, incorporation of 
an activation system containing cytosolic fractions from livers of rats markedly 
enhanced the mutagenic response. It may therefore be inferred that an activity present in 
cytosol is capable of activating the mushroom mutagens and that microsomal enzymes 
may deactivate the generated electrophiles from Agaricus bisporus thus masking the 
cytosol-mediated mutagenicity. This cytosolic activity is not influenced by
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preincubation or previous treatment of the animals with Aroclor 1254 but, as all 
enzymes, is denatured by heating. Moreover, its catalytic activity is dependent on 
NADPH. NADH, on the contrary, inhibited the cytosolic activation of the fungal 
mutagens, though not in a concentration-dependent manner. This inhibition was not 
evident in the absence of the cytosolic activation system or in the absence of NADPH. 
These findings indicate that NADH does not interfere with the direct-acting mutagenicity 
of the mushroom extracts nor interact with the cytosolic enzyme itself. Rather its role 
may be to divert the electron flow in the cytosol-catalysed reaction which results in the 
generation of the mushroom mutagens.
3.4.5 The effect of acétylation on the mushroom mutagenicity
Hydrazines, putative mushroom mutagens, are readily acetylated, producing 
hydrazides (Prough and Moloney, 1985). Acétylation of this group of chemicals is 
generally considered as a detoxication mechanism (Colvin, 1969) and mutagenicity 
studies have substantiated this since hydrazine was shown to be more mutagenic than its 
monoacetyl derivative while diacetylhydrazine was negative in the Ames test (Tosk et 
al., 1979). In the present study, however, incorporation of acetyl CoA into the hamster 
S9 mix, characterised by high N-acetylase activity (Light et al., 1987), failed to alter the 
mutagenic response of the mushroom extracts, but gave the expected increase in number 
of revenants with benzidine, an amine activated by N-acetylation followed by N- 
hydroxylation (Kennedy et al., 1983).
3.4.6 Role of norharman in the mutagenicity of mushroom extracts
Supplementation of the activation system with norharman did not influence the 
mutagenicity of the mushroom extracts in the presence of Aroclor 1254-treated rat S9, 
but enhanced the mutagenicity of the positive control diphenylnitrosamine.
Norharman [9H-pyrido(3,4-6)indole] is present in tobacco smoke and in 
DL-tryptophan pyrolysates and a role as a "co-mutagen" has been ascribed to it (Nagao
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et a l, 1977b). Although norharman is not mutagenic itself, it can either enhance the 
mutagenicity of many compounds such as Trp-P-1 (3-amino-l,4-dimethyl-5H- 
pyrido[4,3-b]indole), Trp-P-2 (3-amino-l-methyl-5H-pyrido[4,3-b]indole) (Nagao et 
al.y 1977c), 4-dimethylaminobenzene and related compounds (Nagao ef <2/., 1977b) or 
induce a mutagenic response with chemicals which are otherwise negative in the Ames 
mutagenicity test, examples being aniline, o-toluidine (Nagao et al., 1978) and 
nitrosamines (Wakabayashi et al., 1981). On the other hand, norharman has been 
reported to have both co-mutagenic and antagonistic effects on benzo(a)pyrene 
mutagenicity (Riebe et a i, 1982) and to inhibit the mutagenicity of other chemicals, 
exemplified by kaempferol (Nagao et a i, 1978). Though the mode of its action is not 
yet clearly understood, the following mechanisms were put forward:
(a) it facilitates the metabolic conversion of chemicals to proximate or ultimate 
mutagens or inhibits the inactivation of proximate and ultimate mutagens;
(b) intercalation of norharman into double-stranded DNA has been reported 
(Hayashi et a i, 1977) and such interactions may increase the susceptibility of 
DNA to damage by mutagens. Moreover, DNA modified by norharman 
intercalation may be subject to error-prone repair;
(c) it can react with the chemical itself forming a new metabolite which is then 
activated to a mutagen by the activation system;
(d) it inhibits activating enzymes such as aryl-hydrocarbon hydroxylase (Levitt et 
a i, 1977) or inactivating enzymes.
3.4.7 Contribution of prostaglandin H synthase in the activation of
mushroom mutagens
A marginal, though not statistically significant, increase in the mutagenic 
response was observed when purified prostaglandin H synthase (PGS) was 
preincubated with ethanolic mushroom extracts. This enzyme is known to catalyse the
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first two steps in the biosynthesis of prostaglandins from arachidonic acid (Josephy, 
1989) but also to play a critical role in the extrahepatic activation of many carcinogens, 
as it occurs in most mammalian tissues, with relatively high activities in certain 
pulmonary cells, the gastrointestinal tract, the renal medulla and accessory sex organs 
(Christ and van Dorp, 1972). With its peroxidase activity, prostaglandin H synthase 
can co-oxidise various xenobiotics to reactive intermediates capable of binding to 
cellular macromolecules (Krauss and Eling, 1984). Some of its substrates include 
polycyclic aromatic hydrocarbons and their dihydrodiols (Marnett, 1981; Guthrie et al, 
1982), aromatic amines (Robertson er <2/., 1983; Boyd and Eling, 1987; Josephy,
1989), heterocyclic aromatic amines (Wild and Degen, 1987) and arylhydrazines 
(Sinha, 1983). The possibility was, therefore, examined that mushroom components 
may be co-oxidised and thus activated by this enzyme. However, these PGS-activated 
compounds are likely to belong to a different class of chemicals than the direct-acting 
and cytosol-activated fungal mutagens since their mutagenicity is detected in TA 98 but 
not in TA 104. Suspect PGS-activated compounds include the fungal phenylhydrazines 
since both agaritine and the acetyl form of 4-hydroxymethylphenylhydrazine were 
found to be metabolised by this enzyme to the diazonium ion (Lawson, 1987). Lending 
support to this hypothesis is the finding that another hydrazine, namely hydralazine, 
was mutagenic in the Ames test in the presence of PGS as the sole activation system 
(Lawson, 1987). Whether the present observations have any implications in vivo is 
not clear but it seems unlikely since the activation of the mushroom mutagens by this 
enzyme was poor.
3 .4 .8  Extraction of mutagens from Agaricus bisporus
As mushrooms constitute a diverse mixture of chemicals, and since the chemical 
nature of the fungal mutagens is at present unknown, various extraction procedures 
must be exploited; in order to isolate particular mutagenic agents. Indeed, previous 
studies indicated that both mutagenic and antimutagenic fractions can be isolated from
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the same food item when different extraction procedures are used (Hannan et al.y 1989) 
and that incorrect choice of the extraction solvent in mutagenicity screening studies 
can lead to false negative results in the Ames test (Kellman and Berstein, 1978; Hannan 
et aL, 1989) and consequently to underestimation of the risk to humans resulting from 
the consumption of this food.
In the present study, solvents with different polarities were used. It was evident 
that non-polar solvents such as chloroform and ethyl acetate failed to extract the 
mushroom mutagens but, the mutagenic material was readily extracted by polar 
solvents. This is in agreement with studies undertaken by the group of von Wright 
which reported that the Agaricus bisporus extracts remained in the aqueous phase 
following fractionation with ether (von Wright et aL, 1982). Moreover, when the 
mutagenicity of the polar-derived extracts were tested in the Ames test, no significant 
differences in the mutagenic response were observed.
Mutagenicity of the extracts was not modulated by a change in pH. This is 
surprising since the presence of 4-hydroxymethylbenzene diazonium ion, the postulated 
ultimate mushroom mutagen, and of a second diazonium ion, also a suspect mutagen, 
was demonstrated in acidic Agaricus bisporus extracts (Ross et a i, 1981; 1982a). It 
may be therefore inferred that (i) the Agaricus bisporus mutagens are hydrophilic and 
consequently their absorption through the gastrointestinal tract may be limited, (ii) the 
diazonium ions are unlikely to contribute significantly to the mutagenicity of the 
mushroom extracts and (iii) any of the three polar solvents employed are suitable for 
extracting the mushroom mutagens. The random choice of ethanol as the solvent for 
routine-based extraction was therefore maintained.
3 .4 .9  D istribution of mutagens in Agaricus bisporus
Studies undertaken to localise the mutagenic material in Agaricus bisporus fruit 
bodies showed that the skin contained the highest content of mutagens, whereas lower 
levels were present in the cap, stipe and gills. These findings further rule
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out the possibility of a contribution of the diazonium ion in the mutagenicity of Agaricus 
bisporus extracts, since this chemical species was reported to be confined chiefly to the 
basal portion of the stipe and to be absent from the caps (Levenberg, 1962). The 
observation that the skin possesses the highest mutagenic potential is of interest but this 
may only reflect to the higher content of solids in this mushroom part compared with the 
cap which contains about 90% water. On the other hand, it is a custom of many 
consumers to peel the mushroom skin and thus their exposure to mutagens is likely to 
be lower.
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CHAPTER 4
FACTORS INFLUENCING THE 
MUTAGENICITY OF 
AGARICUS BISPORUS  
EXTRACTS
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4.1 Introduction
A number of studies revealed that Agaricus bisporus extracts display a weak 
but reproducible mutagenicity in the Ames test (von Wright et a i, 1982; Sterner et a i, 
1982; Morales et a i, 1990a; Grüter et al., 1991). As this fungus is consumed in large 
amounts by the human population in many parts of the world, factors which enhance or 
reduce the mutagenicity of the mushroom will have self-evident implications, and are 
therefore of great concern. The few studies addressing this problem focused entirely 
on the mushroom hydrazide agaritine.
Agaritine is an established weak genotoxin which is present at relatively high 
amounts in Agaricus bisporus (Levenberg, 1960; 1964; Daniels et al., 1961; Kelly et 
a/., 1962; Ross et al., 1982b; Liu et a i, 1982; Fischer et a l , 1984; Stijve et aL, 
1986; Sharman et a i, 1990). It occurs predominantly in young mushrooms (buttons) 
and its concentration diminishes with age (Kelly et a/., 1962; Chiarloer aL, 1979; 
Fischer et aL, 1984; Stijve et aL, 1986). Other factors causing a decrease in agaritine 
content include post-harvest storage (Ross et aL, 1982b; Liu et aL, 1982), cooking or 
other thermal processing (Ross et aL, 1982b; Liu et aL, 1982; Speroni et aL, 1985; 
Sastry et aL, 1985), canning (Ross et aL, 1982b; Liu et aL, 1982), blanching (Liu et 
aL, 1982), and freezing with subsequent thawing (Liu et aL, 1982). However, 
freezing itself, or bisulphite treatment prior to freezing, and freeze-drying do not 
influence its levels (Liu et aL, 1982). Moreover, some steps in the cultivation of 
Agaricus bisporus, such as composting, spawning and cropping also modulate 
agaritine amounts (Speroni et aL, 1983). Agaritine content, however, is not influenced 
by the mushroom strain or by the season of cropping (Liu et aL, 1982; Fischer et aL, 
1984; Stijve et aL, 1986).
In light of these data, it was considered appropriate to extend the above studies 
in order to determine whether factors such as mushroom strain, age, break, time of 
harvest, storage and cooking can influence the mutagenic potential of Agaricus bisporus
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extracts. Such studies will enable the understanding of the formation and stability of 
these mutagens, so that the conditions leading to the lowest mutagenicity will be 
employed in their cultivation, storage and cooking.
7-6
4 .2  Experimental design
In order to determine whether the mushroom strain influences the mutagenic 
response of Agaricus bisporus, a brown variety (Brown 856) and two white varieties 
(Somy 609 and A93) were assessed for mutagenicity in the Ames test, following 
extraction with ethanol as described in Chapter 2.
The effect of the age of the fruit body on the mutagenic potential of Agaricus 
bisporus was studied by extracting button, closed cup, open cup and flat mushrooms 
(extraction procedure as in Chapter 2) and assessing the extracts in the Ames test.
The influence of the break on the mutagenic activity of Agaricus bisporus was 
tested by using ethanolic extracts (see Chapter 2) from Agaricus bisporus mushroom, 
harvested from the first, second and third flush.
The possibility that seasonal variation in mutagenicity may exist was 
investigated. Agaricus bisporus obtained in Autumn, Winter, Spring and Summer 
were extracted and tested in the Ames test within 24 hours of purchase.
The stability of the fungal mutagens during storage was also examined. 
Freshly-picked Agaricus bisporus were randomly divided into three groups. The first 
group was extracted within six hours of harvest. The second group was extracted after 
being kept in the refrigerator (4°C) for 9 days. Finally, the third group was extracted 
after being stored in the refrigerator (4°C) for 15 days. The mutagenic activity of the 
extracts was tested 24 hours after the last extraction.
To evaluate the effect of cooking on the mushroom mutagenicity, mushrooms 
were extracted (a) raw, (b) following boiling in water (90-100°C) for various time 
intervals and (c) following microwave cooking for three minutes at full power (600W). 
The ethanolic extracts (see Chapter 2) were assessed for mutagenicity in the Ames test 
within two hours of preparation.
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4.3 Results
4 .3 .1  Effect of the mushroom strain on mutagenicity
Figures 4.1 and 4.2 show the mutagenicity of extracts from three different 
strains of Agaricus bisporus, namely of the brown variety "856 Brown", and of two 
white varieties "Somy 609" and "A93", in the Salmonella typhimurium strains TA 104 
and TA 100, respectively. Each of the mushroom strains was tested using fruit bodies 
from the three developmental stages i.e., buttons, close cups and open cups. All 
samples exhibited positive mutagenicity, the response being similar and clearly not 
dependent on the mushroom strain.
Figure 4.1: Mutagenicity of ethanolic extracts from various Agaricus
bisporus  strains in the Salmonella  typhimurium  strain 
TA 104
The ethanolic extracts were prepared from button, closed cup and open cup mushrooms o f  three 
Agaricus bisporus strains, namely the brown variety "856 Brown" and the white varieties "Somy 609" 
and "A93", all o f  which were harvested from the second break. A volume o f 50|il o f each extract and 
the Salmonella typhimurium  strain TA 104 were employed. The spontaneous reversion rate o f 571±15 
has already been subtracted. Results are presented as Mean±SD for triplicates.
1: buttons 
2: closed  cups 
3: open cups
□  Som y 609  
0 A93 
E3 856  Brown
2000
J L
1000
0
321
78
Fipure 4.2: Mutagenic activity of ethanolic extracts from three 
Agaricus bisporus strains in the bacterial strain TA 100
The ethanolic extracts were prepared from button, closed cup and open cup fruit bodies o f  three 
Agaricus bisporus strains, namely the brown variety "856 Brown" and the white varieties "Somy 609" 
and "A93", all o f  which were picked up from the second break. A volume of 100p.l o f each extract and 
the bacterial strain TA 100 were used. The spontaneous reversion rate o f 127±11 has already been 
subtracted. Numbers o f histidine revenants are presented as Mean±SD for three plates.
1: buttons
2: closed  cup s
3: o p e n  cups
□  Som y 609  
0 A93 
EB 856  Brown
4 . 3 . 2  Influence of the mushroom age on mutagenic response
In order to determine whether the age of the mushroom influences the mutagenic 
activity of this fungus, button, closed cup, open cup and flat fruit bodies of Agaricus 
bisporus were investigated in the Ames test employing the Salmonella typhimurium 
strain TA 104. As shown in Figures 4.3 - 4.5, the mutagenicity decreased with the age 
of the fruit body in all three Agaricus bisporus strains, the youngest mushrooms (i.e., 
the buttons) exhibiting significantly higher mutagenicity than the open or flat fruit 
bodies. To test whether this difference in mutagenic activity was due to the different 
water content of the mushrooms, the percentage of dry mass and/or water content in 
"A93" mushroom samples was determined. Since the water content did not correlate 
with the developmental stage of the mushroom, it is unlikely to be responsible for the 
observed difference in mutagenic response (Table 4.1).
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Figure 4.3: The effect of mushroom age on the mutagenicity of the
Agaricus bisporus strain “Somy 609”
The ethanolic extracts were prepared from button, closed cup and open cup fruit bodies collected from 
the second break. The bacterial strain TA 104 was used. The spontaneous reversion rate o f 457+15  
has already been subtracted. Numbers o f histidine revenants are presented as Mean±SD for triplicates.
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Figure 4.4: The influence of mushroom age on the mutagenic activity 
of extracts from the Agaricus bisporus strain  "856 Brown"
The ethanolic extracts were prepared from button, closed cup and open cup mushrooms collected from 
the second break. The bacterial strain TA 104 was used. The spontaneous reversion rate o f 457±15  
has already been subtracted. Results are expressed as Mean±SD for three plates.
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Figure 4.5: The role of mushroom age in the mutagenic potential of 
extracts from the Agaiicus bisporus strain "A93"
The ethanolic extracts were prepared from buttons, closed cups, open cups and flats collected from the 
second break. The bacterial strain TA 104 was used. The spontaneous reversion rate o f 562±50 has 
already been subtracted. Results are expressed as Mean±SD for three Petri dishes.
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Table 4.1: W ater content in Agaricus bisporus mushrooms
Agaricus bisporus (A93) from the second break were dried under vacuum to determine the dry mass of 
the sample's
Mushroom Type Dried Mass (%) Water (%)
Buttons 8±1 92±1
Closed cups 7±1 93±1
Open cup 1Q±2 90±1
Flat 8±1 92±2
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4.3.3 Role of the mushroom break on mutagenic potential
Figure 4.6 illustrates- the-mutagenic response of ethanolic extracts of 
mushrooms harvested from the 1st, 2nd and 3rd break (or flush). Though a tendency 
for higher mutagenicity in the later breaks exists, the mutagenic activity of the three 
mushroom samples was not significantly different, indicating that the mushroom break 
is unlikely to modulate the mutagenic potential of Agaricus bisporus.
Figure 4.6: Mutagenicity of extracts from Agaricus bisporus collected 
from the 1st, 2nd or 3rd break
Fresh, closed cup "A93" mushrooms were extracted with ethanol and tested in the Ames test using the 
Salmonella typhimurium  strain TA 104. The spontaneous reversion rate o f 375+30 has already been 
subtracted. Results are expressed as Mean±SD for triplicates.
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4.3.4 Seasonal variation in Agaricus bisporus mutagenicity
To investigate whether mushrooms harvested in different seasons display 
variable mutagenic activity, extracts of Agaricus bisporus obtained in Autumn, Winter, 
Spring and Summer were assessed in the Ames test within 24 hours of purchase. As 
Table 4.2 shows, a seasonal trend is not evident since the mutagenic response was 
similar in all cases.
Table 4.2: M utagenicity of extracts of Agaricus bisporus harvested in
different seasons
Closed cup Agaricus bisporus were picked up in different seasons, extracted and tested within 
24 hours after cropping. Aliquots o f ethanolic extracts corresponding to 0.65g fresh mushrooms and 
the bacterial strain TA 104 were used. The mean spontaneous reversion rate o f  365±23 for 12 
plates, three o f each experiment, has already been subtracted. Results are presented as Mean±SD for 
triplicates.
Season Histidine revertants/plate
Autumn 1202+51
Winter 1123+8
Spring 1365±127
Summer 1248+120
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4.3.5 Effect of storage time on the mutagenicity of mushroom extracts
Storage of mushrooms for 9 days at 4°C gave rise to a modest increase in the 
mutagenic activity of "SomyJ)09"jmd ''856 Brown''strains. Storage for additional 6 
days further enhanced the mutagenic response, the effect being more pronounced in the 
brown variety of Agaricus bisporus (Figure 4.7).
F igure 4.7: Effect of storage on Agaricus bisporus m utagenicity  
using the bacterial strain TA 104
Mushrooms ("Somy 609", "856 Brown" and "A93") were extracted with ethanol (i) within 6 hours o f  
collection, (ii) after being stored for 9 days at 4°C  and (iii) after 15 days storage at 4°C . The 
spontaneous reversion rate o f 562±5 has already been subtracted. Results are presented as Mean±SD  
for three plates.
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4 .3 .6  Mutagenicity of cooked mushrooms
Microwaving of mushrooms on full power for 3 minutes resulted in a 
significant loss of the mutagenic activity, the decrease being 32% when IOOjj.1 aliquots 
of the extracts were used in the Ames test. Some of the lost mutagenicity was, 
however, recovered in the juice produced by microwaving. Boiling of mushrooms at 
100°C for 40 minutes also markedly diminished the mutagenic response, the reduction 
being 44% when 100p.l aliquots of the mushroom extracts were tested for mutagenicity 
(Figure 4.8). Loss of mushroom mutagenicity of about 25% was evident within the 
first minute of boiling, the mutagenic activity being reduced to about 44% within the 
first 5 minutes and remaining at that level until the end of the 40-minute boiling period 
(Figure 4.9).
Figure 4.8: Mutagenicity of microwaved and boiled mushrooms in 
the Salmonella typhimurium  strain TA 104
Raw mushrooms, mushrooms microwaved at full power (600W) for 3 minutes and mushrooms boiled 
at 100°C for 40 minutes were extracted with 96% (v/v) ethanol at a concentration o f  Ig/m l. The 
spontaneous reversion rate o f 302±14 has already been subtracted. Numbers o f  histidine revertants are 
presented as Mean±SD for three plates.
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Figure 4.9: Effect of boiling on the mutagenic activity of A garicus
bisporus extracts
An aliquot o f lOOjil o f  ethanolic extract and the bacterial strain TA 104 were used. Each point 
represents the Mean^SD o f three plates.
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4.4 Discussion
In view of the findings that extracts of Agaricus bisporus possess mutagenic 
activity and because of the enormous, worldwide use of this species by humans, 
attempts were made to identify some factors which could modulate the mutagenic 
potential of this fungus.
4 . 4 . 1  Factors affecting the mutagenic response of mushrooms
4.4.1.1 Mushroom strain
The first factor to be investigated was the strain of mushroom. Nowadays 
many cultivated varieties of Agaricus bisporus are available, each with different 
phenotype, texture or taste and possibly variable content in primary and/or secondary 
metabolites. Consequently, the levels of the fungal genotoxic compounds may also be 
strain-dependent. The results in Figures 4.1 and 4.2 demonstrate that the mushroom 
strains investigated did not markedly modulate the mutagenic activity. It is worth 
pointing out that the amounts of the genotoxin agaritine in the cultivated mushrooms 
seem to be strain-independent (Liu et al., 1982; Speroni et al., 1983; Fischer et al., 
1984; Stijveera/., 1986).
4.4.1.2 Mushroom age
Several mushroom constituents undergo drastic quantitative changes with the 
development of the carpophore. There are striking differences between the levels of 
sugars, urea and free amino acids, including the non-protein amino acid agaritine, in 
young and old mushrooms (Stijve et al., 1986). Agaritine content, for example, 
decreases significantly with the age of the fungus and this has been attributed to its 
breakdown by the enzyme y-glutamyltransferase (Kelly et al., 1962; Chiarlo et al., 
1979; Fischer era/., 1984; Stijve etal., 1986). Changes in the amounts of the fungal
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mutagen(s) with the age were also demonstrated in the present study. Button 
mushrooms were found to contain significantly more; mutagenic material than fully 
developed ones with expanded caps (flats), indicative of the decomposition of the 
mutagen(s) during the life cycle of the mushroom. It may be argued that this difference 
in the mutagenic response was due to the fact that young mushrooms are more 
"compact," i.e., they have higher solids contents and lower water levels than the older 
ones. However, this was shown not to be the case, since the water content and dried 
mass were similar in all four developmental stages of the mushroom and thus not 
dependent on the fungal age.
4.4.1.3 Mushroom break
During the cropping or harvesting period of Agaricus bisporus, a very 
interesting and agriculturally unique event occurs. Rhythmic 3-5 days of harvests, 
which constitute a single "flush" or "break", are followed by periods of 7-10 days 
when few or no mushrooms are available for collection. Usually growers harvest from 
the first three or four breaks and thus it was considered desirable to test whether there is 
a variable incidence in the mutagenic response of mushrooms harvested from different 
flushes. The results showed a slight increase in the mutagenic potential in the later 
breaks which was, however, statistically not significant. This was rather unexpected as 
evidence exists that mushroom composition varies considerably among flushes of the 
crop cycle. Mannitol levels, for example, were highest in mushrooms harvested from 
the peak day of a given flush and lowest in mushrooms cropped between flushes 
(Hammond and Nichols, 1979). Moreover, significant decreases in lysine, ornithine, 
aspartic acid and glutamic acid were observed in fourth flush mushrooms, compared to 
initial-break mushrooms. The opposite was true for phenylalanine, proline, total amino 
acid nitrogen and agaritine whose levels considerably increase in the later flushes 
(Speroni et a i, 1983). Of interest was also the observation that third flush mushrooms 
had bigger caps and larger stipe diameters. These findings and observations suggest
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that the metabolic interaction between compost and mushrooms is changing during the 
latter stages of the cropping cycle, resulting either in stimulation or inhibition of 
production of individual mushroom components. The possibility that this occurs with 
the fungal mutagen(s) cannot be excluded, though the effect is not very clear.
4.4.1.4 Harvest in different seasons
With the advances in the commercial mushroom exploitation, Agaricus bisporus 
crop production continues throughout the year. It was therefore of interest to assess the 
mutagenicity of mushrooms harvested in different seasons. From the results in Table
4.2 no seasonal trend was evident, suggesting that the time of crop production, and 
consequently harvesting, does not influence the mutagenicity of this species. The same 
holds true for the levels of agaritine, one of the candidates responsible for the 
mutagenic potential of Agancws bisporus (Liu er ti/., 1982). These findings are, 
perhaps, not surprising since the conditions of a crop production are computer- 
controlled and the same throughout the year.
4.4.1.5 Storage
Because it is normal for mushrooms to be stored for some days at 4°C in fresh- 
markets or domestic refrigerators, and since evidence exists that the levels of some 
mushroom components are dramatically decreased with post-harvest storage, an 
example being the direct-acting mutagen agaritine (Ross et a i,  1982b; Liu et a i,  
1982), the effect of storage on the mushroom mutagenicity was investigated. An 
increase in the mutagenic response which was dependent on the duration of storage was 
seen in two of the mushroom strains assessed. This effect of storage was more 
pronounced in the case of the brown variety. It is also worth pointing out that 
brownish spots appeared on the cap of all fruit bodies which were stored, being more 
abundant after the 15 days storage period. It is possible that chemicals present in the
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mushrooms, particularly in the brown variety, were metabolised during storage, for 
example through oxidation, to more active substances with mutagenic potential. The 
possibility though that mutagens were produced by the action of microorganisms is not 
excluded. This is not uncommon and is best exemplified by aflatoxin B i, produced by 
Aspergillus flavus. Despite these findings, it seems premature to make specific 
recommendations about eventual health risks. It should be borne in mind, however, 
that extended storage of mushrooms is not common as deterioration in quality and 
appearance occurs, thus mushrooms are often used shortly after purchase.
4.4.1.6 Cooking of mushrooms
Although the consumption of raw mushrooms is now increasing (e.g., in fresh 
salads), cooked mushrooms are generally more widely used. There have been many 
reports concerning the production of mutagens during cooking (Lijinski and Shubik, 
1964; Matsumoto et al., 1978; Nagao et al., 1977a; Commoner et al., 1978; 
Bjeldanes et al., 1982a,b) and there are strong indications that mutagens/carcinogens in 
heated food are of considerable importance in the aetiology of cancer. Mutagenic 
heterocyclic aromatic amines have been, for example, identified in fish and beef cooked 
under moderate conditions (Sugimura and Sato, 1983), some of which were 
demonstrated to be rodent carcinogens (Matsukura et a i, 1981). The possibility 
therefore exists that cooked mushrooms may be more mutagenic than raw ones. This 
has been studied employing two ways of cooking, microwaving and boiling, though 
other cooking methods, e.g., frying, remain to be investigated.
The results in Figure 4.8 indicate, however, a significant reduction rather than 
potentiation of the mushroom mutagenic activity by both cooking methods. Also, a 
greater effectiveness of boiling, compared with microwaving, to destroy the mutagenic 
material was observed. These findings suggest that (a) Agaricus bisporus contains 
thermolabile as well as heat-stable mutagens since 68% and 56% of the mutagenicity 
remained after microwaving or boiling, respectively and (b) long time r  i slow heating
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treatment (i.e., boiling) favours the destruction of mutagens more than short time-rapid^ 
heating (/.e., microwaving).
In contrast to these results, Pool-Zobel et a i, (1990) failed to demonstrate any 
effect of cooking (boiling and frying) on the mutagenicity of Agaricus bisporus 
extracts. In contrast, studies undertaken by the group of Ross (Ross et al., 1982b) to 
investigate the influence of boiling on mushroom mutagenicity generated similar results 
to the ones presented in Figure 4.9. Moreover, a Spanish study indicated the absence 
of any mutagenic activity in canned Agaricus bisporus mushrooms and this was 
attributed to the presence of thermolabile mutagens in this fungus species which were 
destroyed by the heating applied during canning (Morales et a i, 1990b). Furthermore, 
the levels of agaritine, one of the most likely contributors to mushroom mutagenicity, 
were found to have dropped by as much as 87% by canning, 66% having been 
removed by blanching in boiling water and the rest by the subsequent thermal 
processing used, while a 32% loss of this genotoxin was reported when fresh 
mushrooms were sauteed in olive oil at 300°C for 7 minutes (Ross et al., 1982b). In 
support of these observations were also the results of a long-term study which 
demonstrated that feeding of rats with cooked, y-irradiated Agaricus bisporus did not 
provoke any harmful effect on the animals (van Logten et al., 1971).
Even though cooking appears to be a practical method of reducing the levels of 
mutagenic agents in Agaricus bisporus, this cannot be generalised since the effect of 
other cooking methods, probably more widely used in the case of mushrooms, such as 
frying, have not yet been studied.
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CHAPTER 5
CONTRIBUTION OF 
AGARITINE 
TO THE MUTAGENICITY OF 
AGARICUS BISPORUS  
EXTRACTS
93
5.1  Introduction
Though hydrazines, an important group of chemical carcinogens, occur rarely 
in nature (Liu et a i, 1974; La Rue 1977; Toth, 1988), a series of phenylhydrazine 
derivatives are present in substantial amounts in Agaricus bisporus, and are believed to 
contribute to the toxic, mutagenic and carcinogenic properties of this mushroom. At 
least five of these compounds have been isolated (Levenberg, 1960; 1961; 1964; 
Daniels et a i, 1961; Kelly et al., 1962; Ch au h an et al., 1984; 1985a, b; Chulia et al., 
1988), the most important being agaritine (Table 5.1).
Agaritine is a colourless, water soluble solid and its presence seems to be 
limited to basidiomycetes of the genus Agaricus (Levenberg, 1964; Anonymous, 1983; 
Stijve et al., 1986). In Agaricus bisporus this hydrazide is mainly present in the 
fruiting bodies at concentrations which range from ,008 to 1,73 g/kg fresh 
mushroom (Levenberg, 1960; 1964; Daniels et a i, 1961; Kelly etal., 1962; Ross et 
al., 1982b; Liu et al., 1982; Fischer et al., 1984; Stijve et a/., 1986; Sharman et al.,
1990), though these levels are known to be influenced by many factors (Ross et al., 
1982b; Liu et al., 1982; Speroni et al., 1983).
The fruit bodies of this mushroom also displayed a y-glutamyltransferase 
activity. This enzyme catalyses the removal of the glutamyl moiety from agaritine, 
leading to the formation of 4-hydroxymethylphenylhydrazine which may be further 
converted to the highly reactive 4-hydroxymethylbenzene diazonium ion. The latter 
may be also formed directly from agaritine in a one step mechanism catalysed by an 
oxidative enzyme (Levenberg, 1961; 1964; Gigliotti and Levenberg, 1964) (Figure 
5.1).
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Table 5 .1: O ccurrence and biological effects of phenylhydrazine
derivatives in the genus of A garicus
Phenylhydrazines
HOOC- i h -n h 2
4-carboxyphenylhydrazine
O ccurrence Toxicity Carcinogenicity Mutagenicity
(%  in fresh
mushroom)
U x lO '3 + + +
A.bisporus rabbit po: smooth muscle 
guinea pig of aorta/arteries
HOOC
COOHI
NH-NH-CO-(CH2)2-CH
n h 2
4.2x10
A.bisporus
P-N-[Y-L-(+)glutamyl]-4-carboxyphenylhydrazine
COOH
H -N H -O M C H ^-C H  4.0xl0*3
NH2 A.cam pes tris
P-N-[Y-L-(+)glutamyl]-4-formylphenylhydrazine
H,C
COOH
NH-NH-CO-(CH2)2-CH
I
NH2 .
P-N-[Y-L-(+)glutamyl]-4-hydroxymethylphenylhydrazine 
(AGARITINE)
H,C
Y-glutamyltransferase
NH-NH,
Voxidative
icnzyme
+
mouse
8-117x10 3 +
AM sporus mouse
4-hydroxymcthylphenylhydrazine
oxidative enzyme 
specific for hydrazines
(unstable to + 
be isolated) mouse 
A.bisporus
OH
H2C /  ^ =  N 0.06x1 O'3 
A.bisporus
+
mouse
+
po: subcutis
po: lung, 
blood vessel
4-hydroxymethylbenzene diazonium ion
sc: skin^ubculis 
ig: stomach
From Gry and Kirsten, 1991
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In support of the hypothesis that phenylhydrazines of this fungus are the most 
likely contributors to the mushroom carcinogenicity and mutagenicity, agaritine has 
been shown to be a direct-acting mutagen towards various Salmonella typhimurium 
strains in the Ames test (Sterner et a i, 1982; Rogan et a i, 1982; Ueijma et al., 1986; 
Friederich et al., 1986). In addition, its mutagenicity was enhanced by incubation at 
alkaline pH and in the presence of y-glutamyl transpeptidase (Friederich etal., 1986). 
Moreover, the enzymic breakdown product of agaritine, i.e., 4-hydroxy- 
methylphenylhydrazine, is also a direct-acting mutagen in the Ames test (Rogan et al., 
1982; Friederich et al., 1986), being more potent than the parent compound (Friederich 
et al., 1986); it also elicited positive DNA repair responses in rat and mouse liver cells 
when the hepatocyte/DNA repair test was employed (Mori et a i, 1988). Furthermore, 
4-hydroxymethylbenzene diazonium ion, the putative ultimate mutagen, exhibited the 
most potent mutagenicity in the Ames test when compared with agaritine or 4-hydroxy­
methylphenylhydrazine (Rogan ef a/., 1982; Friederich ef ti/., 1986).
In contrast to its mutagenicity, agaritine failed to elicit a carcinogenic response 
after oral or subcutaneous administration to mice (Toth et al., 1981b; Toth and 
Sornson, 1984; Clémencon, 1987). In addition, it failed to damage the DNA of 
pancreatic acinar cells when administered intraperitoneally to rats and hamsters 
(Curphey et a i, 1987). Furthemore, it did not induce positive DNA repair synthesis in 
rat or mouse hepatocytes (Mori et al., 1988), thus casting doubts as to the role of 
agaritine in the carcinogenicity of Agaricus bisporus. Surprising, however, its 
degradation products, 4-hydroxymethylphenylhydrazine and 4-hydroxymethyl- 
phenylbenzene diazonium ion, were tumourigenic in mice. The former, when 
administered orally in its stabilised acetyl form, gave rise to lung and blood vessel 
tumours (Toth et a i, 1978), while the sulphate or tetrafluoroborate salt of the latter, the 
postulated ultimate carcinogen, induced glandular stomach tumours after a single 
intragastric instillation to mice (Toth et al., 1982). When the compound was 
administered subcutaneously to mice, tumours were localised in the subcutis and skin
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(Toth gf a/., 1981a; Lawson et a i, 1984). Moreover, exposure of V79 cells to the 
diazonium ion followed by y-irradiation resulted in single strand breaks and DNA- 
DNA crosslinks (Lawson et a/., 1988). Furthermore, the compound bound to murine 
stomach DNA and produced, to a small extent, DNA adducts in the liver of mice 
(Shephard et a l,  1986).
It may be argued that mice are unable to hydrolyse the glutamyl substituent of 
agaritine to release the ultimate carcinogens. However, mammalian y-glutamyl 
transpeptidase was more effective than the mushroom enzyme in catalysing this reaction 
(Ross et a l, 1982b). Moreover, other mammalian enzymes such as the murine hepatic 
cytochrome P450-dependent mixed-function oxidases and mouse lung or ram seminal 
vesicle prostaglandin H synthase can also convert agaritine or 4-hydroxymethyl­
phenylhydrazine to the diazonium ion (Lawson and Chauhan, 1985; Lawson, 1987). 
It is also noteworthy that feeding of uncooked mushrooms to mice gave rise to tumours 
in the lungs, liver, bone and forestomach, i.e., at different sites from the tumours 
induced by the above compounds. Thus the role of agaritine or its natural metabolites 
in the mutagenicity and carcinogenicity of Agaricus bisporus remains unclear. This 
study was therefore undertaken to evaluate the contribution of these fungal hydrazines 
to the mutagenicity of the ethanolic mushroom extracts.
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5 .2  Results
As expected, ethanolic extracts from Agaricus bisporus displayed a positive 
mutagenic response towards tht Salmonella typhimurium strains TA 1535, TA 1537, 
TA 1538, TA 97, TA 98, TA 100, TA 102 and TA 104, the last being the most 
sensitive. In contrast, agaritine, when tested at a concentration corresponding to the 
level in lOOfil of ethanolic extract, exhibited mutagenicity only in the bacterial strains 
TA 97 and TA 1537 (Table 5.2). Incorporation of an activation system containing 
hepatic cytosolic fractions derived from Aroclor 1254-treated rats failed to enhance the 
mutagenicity of agaritine but, as expected (see 3.3.5), increased the mutagenicity of the 
ethanolic mushroom extracts in TA 104 (Table 5.3). Addition of y-glutamyl 
transpeptidase, the enzyme which converts agaritine to more mutagenic agents, did not 
influence mutagenicity of the ethanolic mushroom extracts (Table 5.4).
Table 5.2: A comparison of the mutagenicity of agaritine and A g a ricu s  
bisporus extracts in the Ames test
The mutagenicity o f  mushroom extracts was compared to that o f agaritine (286fig). The agaritine 
concentration was calculated as that being present in a lOOjil aliquot o f ethanolic extracts assume a 
mushroom content o f  0 .05g/kg fresh mushrooms (Stijve el a i ,  1986). Numbers o f  histidine 
revenants arc presented as M can-SD for triplicates.
Compound Histidine revertants/plate
TA 1535 TA1537 TA 1538 TA97 TA98 TA 100 TA 102 TA104
Spontaneous 
reversion rate 20±3 11±1 7-1 113±7 1211 8 1 1 9 259117 337116
Agaritine (286pg) 22±1 30±2 8±1 241134 1612 9 6 1 5 329129 562164
Mushroom 
extract (lOOjil) 
corresponding to 
286pg o f agaritine
39±4 22±1 14±1 22612 29H 194H 7 519135 11931206
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Table 5.3: Effect of cytosolic activation on the mutagenicity of agaritine
and mushroom extracts
The activation system contained 10% (v/v) hepatic cytosolic (105,000g supernatant) fractions from 
Aroclor 1254-treated rats. Mushroom extracts corresponding to an agaritine level o f  2 8 6 |ig ,  
synthesised agaritine (286|jg), and the bacterial strain TA 104 were employed. Results are presented 
as M ean±SD for three plates.
Compound Histidine revertants/plate
No activation With cytosolic activation
Spontaneous reversion rate 344+19 325±11
Agaritine (286pg) 713±20 733±38
Mushroom extract (lOOpl)
corresponding to 286pg 
of agaritine
1268±69 1568±42
Table 5.4: Effect of y-glutamyl transpeptidase on the m utagenicity  of
Agaricus bisporus extracts in the Ames test
Ethanolic mushroom extracts (IOOjj.1) were preincubated with 2  units o f  y-glutamyl transpeptidase 
(y-G T ) in 0.2M  potassium phosphate buffer, pH 8.2, for 14 hours at 37°C in a shaking waterbath. 
Results are expressed as Mean±SD for triplicates.
Compound Histidine revertants/plate
TA 97 TA 102 TA 104 TA 1537
Spontaneous reversion rate 98± 7 252±36 323±12 7±1
Mushroom extract 290+37 681±73 1143+91 13±3
Mushroom extract + y-GT 250±28 621±41 992±52 14+3
Table 5.5 shows the mutagenicity of ethanolic extracts of various mushroom 
types, containing markedly different agaritine content, in the Salmonella typhimurium 
strain TA 104. All the samples displayed mutagenicity in the absence of an activation 
system but the response was not correlated to the agaritine content. While the 
mutagenicity of the mushroom types, whose agaritine levels ranged from 0.3 to 1.7 
g/kg fresh mushroom weight, was similar, the mushroom with the highest agaritine 
content exhibited significantly lower mutagenic activity (Table 5.5). Similar 
observations were made with the bacterial strains TA 98 and TA 100 (Table 5.5). In 
order to examine whether the low mutagenic activity of the extracts from the mushroom 
type D was due to a toxic effect exerted by the high levels of agaritine, lower 
concentrations of the extracts were tested in the Arnes test. The observed 
concentration-dependent increase in the mutagenicity precluded the possibility that 
agaritine was toxic to the bacteria and thus responsible for the low mutagenic response 
of this mushroom sample (Table 5.6). Lending support to this is also the observation 
that the background lawn was normal. Moreover, use of y-glutamyl transpeptidase as 
an activation system with the mushroom containing the highest agaritine content did not 
alter the mutagenic response (Table 5.5), supporting the previous findings (Table 5.4).
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Table 5.5: M utagenic potency of Agaricus bisporus types containing
different levels of agaritine
Freeze-dried mushrooms were ground to a fine powder and extracted with 96% (v/ v) ethanol (0.1 
mg/ml) by overnight incubation in a shaking water bath at 37°C. The extracts were then filtered 
(Whatman filter paper. Qualitative N o .l)  and evaporated to dryness under N2- Finally the residues 
were redissolved in 1.12ml DMSO and lOOpl o f these solutions were employed in the Ames test with 
the bacterial strains TA 104, TA 98 and TA 100. The spontaneous reversion rates (414±23,21± 3 and 
89± 12 for TA 104, TA 98 and TA 100 respectively) have already been subtracted. Results are 
presented as Mean±SD for three plates.
Mushroom Type Agaritine content 
(g/kg fresh weight)
Histidine revertants/plate
TA 104 TA 98 TA 100
A 0.30 1199±165 10±4 68±11
B 0.86 1216±65 16±2 59±7
C 1.70 1590±82 14±1 35±14
D 6.50 446±93* 6+2**
443±126# 2±1# 2± 1#
#: with 5 units of y-glutamyl transpeptidase *
**
***
: P<0.01 
: P<0.02 
: P<0.05
Table 5.6: Mutagenicitv of ethanolic extracts from mushroom tvpe D
The extracts were prepared as described in Table 5.5. The Salmonella typhimurium  strain TA 104 was 
used. The spontaneous reversion rate o f 4 9 1 -5 3  has already been subtracted. Numbers o f  histidine 
revertants are presented as Mean±SD for triplicates.
Mushroom extract (pl/plate) Histidine revertants/plate
25 452+29
50 566±50
100 635±42
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The possible contribution of agaritine to the mutagenicity of the mushroom 
extracts was further investigated by (a) incubating the ethanolic extracts, whose pH 
value was either 8.2 or 9.0, for various time intervals at 25°C and (b) (frozen - 
storage of the fungal extracts for 30 days at -20°C and subsequent thawing. The 
former treatment was previously reported to enhance the mutagenicity of agartitine 
(Friederich et a i, 1986), while the latter treatment resulted in a 74% loss of agaritine 
when fresh mushrooms were employed (Liu et a i, 1982). In the present study, 
incubation of the mushroom extracts did not significantly affect the mutagenicity 
(Figure 5.7). Nor was the mutagenic response of the extracts altered after freezing and 
thawing as compared with the mutagenic activity of freshly prepared extracts (Table 
5.8).
Table 5.7: Role of incubation in the m utagenicity of alkaline ethanolic
extracts from Agaricus bisporus
Ethanolic mushroom extracts were adjusted to pH 8.2 or 9.0 by addition o f  Tris-HCl buffer and the 
extracts were incubated at 25°C in a shaking waterbath. Aliquots were collected after different 
incubation times and frozen immediately at -20°C. A volume o f lOOjil o f each sample was tested in 
the bacterial strains TA 104 and TA 1537. The spontaneous reversion rates were 308^45 and 8 -1 ,  
respectively. Results arc presented as Mean±SD for three plates.
_____________ Histidine revertants/plate
Incubation time (hours) TA 104  TA 1537
pH 8.2 pH 9.0 pH 8.2 pH 9.0
0 857±100 798±21 17±3 15±1
3 781± 17 735±66 12±2 14+2
6 772±109 647±19 16±2 10±1
9 726± 84 707±50 11±4 12±2
12 731±114 694±23 11±3 14±3
23 737± 36 733±16 10±3 13±1
27 708± 58 708±53 12±1 9±2
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Table 5.8: Influence of freezing-storage with subsequent thawing on
the mutagenicity of Agaricus bisporus extracts
Ethanolic extracts were stored at -20°C and thawed 30 days later. The bacterial strain TA 104 and 75jil 
o f extracts were used. The results are presented as Mean±SD for triplicates.
Compound Histidine revertants/plate
Spontaneous reversion rate 425± 26
Fresh extracts 1517±101
Stored extracts 1417± 47
In order to examine whether 4-hydroxymethylbenzene diazonium ion was
involved in the mutagenicity of the fungal extracts, the pH of the extracts was varied
(pH: 4-10), with a view of stabilising the ion. Such variation in pH did not influence
the mutagenic response of the extracts in Salmonella typhimurium strain TA 104 (Table
5.9).
Table 5.9: Effect of dH on the mutagenicity of ethanolic m ushroom
extracts in the Ames test
A volum e o f IOOjj.1 o f the mushroom extracts and the Salm onella typhimurium  strain TA 104 were
employed. The spontaneous reversion rate o f 535—58 has already been subtracted. The results are
presented as Mean^SD.
pH Histidine revertants/plate
4 960± 88
5 997±127
6 1123± 77
7 776±145
8 919± 80
9 847± 26
10 941+164
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5.3  Discussion
5.3.1 Contribution of agaritine to the mutagenicity of mushroom extracts
Feeding of Agaricus bisporus to Swiss mice caused an increased incidence of 
tumours at various sites (Toth and Erickson, 1986) and suspect compounds which may 
be responsible for this carcinogenic effect include the phenylhydrazines present in this 
mushroom.
Agaritine was the first of such chemicals to be isolated. Because of its 
hydrazine structure, concern has been voiced that agaritine may be one of the 
contributors to the mushroom carcinogenicity despite, the fact that carcinogenicity 
studies failed to substantiate this (Toth et aL, 1981b; Toth and Sornson, 1984). In 
agreement with previous publications (Rogan et aL, 1982; Friederich etal., 1986) the 
present study showed that synthesised agaritine was mutagenic in the Salmonella 
typhimurium strains TA 97 and TA 1537 but, in contrast to other studies ( Rogan et 
a/., 1982; Ueijma et aL, 1986), the compound failed to elicit a mutagenic response in 
TA 100 and TA 1535 . On the other hand, ethanolic mushroom extracts, containing a 
concentration of agaritine similar to that employed in the mutagenicity studies, have 
been found to be positive in all the Salmonella typhimurium strains used indicating that 
agaritine may play, at best, a very limited role in the mutagenicity of ethanolic 
mushroom extracts and/or that this mushroom type contains additional, possibly more 
potent mutagens. This was also suggested by Sterner et aL (1982) who showed that 
agaritine was mutagenic towards one of the three bacterial strains assessed, while 
Agaricus bisporus extracts were positive in all three. Moreover, it is also possible that 
the presence of other compounds in the test sample inhibited or masked the mutagenic 
effect of agaritine.
When Lawson and Chauhan (1985) investigated the ability of murine liver 
cytochrome P450-dependent mixed-function oxidases to metabolise various 
arylhydrazines, they demonstrated that agaritine was better metabolised to the
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diazonium ion by S9 fraction than by the microsomal fraction. These findings led 
them to the conclusion that this was due to the presence in the cytosol of an enzyme that 
could remove the glutamyl moiety from agaritine, making the subsequent molecule 
more amenable to the mixed-function oxidases. However, incorporation of a cytosolic 
fraction derived from the liver of rat did not enhance the mutagenicity of agaritine but, 
as expected (see 3.3.5), markedly potentiated the mutagenic response of the ethanolic 
extracts. This suggests that even if agaritine is metabolised by cytosolic enzyme(s), 
this metabolite is unlikely to play a major role in the cytosol-mediated activation of the 
ethanolic extracts.
Since the group of Friederich reported that the mutagenicity of agaritine 
significantly increased by incubation at alkaline pH (Friederich et aL, 1986) it was 
considered desirable to test the mutagenic potential of the ethanolic extracts under the 
same conditions employed by these authors. The results from Table 5.7 clearly 
showed that this treatment did not influence the mutagenic activity of the extracts, 
neither in TA 1537, the strain used by Friederich et aL, nor in TA 104, the most 
sensitive strain in detecting the mutagens in Agaricus bisporus ethanolic extracts, 
indicating once more that agaritine is unlikely to be involved in the mutagenicity of the 
mushroom extracts.
Further published data indicate that the agaritine content in the mushroom 
decreased to as much as 74% after freezing-storage at -25°C for 30 days and 
subsequent thawing at room temperature (Liu et aL, 1982). However, extracts of 
mushrooms which were kept frozen for 30 days and subsequently thawed displayed a 
mutagenic response similar to that of the freshly prepared extracts (Table 5.8), 
indirectly indicative again that agaritine makes a limited contribution to the observed 
mutagenic activity of the ethanolic mushroom extracts.
Unequivocal experimental evidence that agaritine does not mediate the 
mutagenicity of the ethanolic extracts from Agaricus bisporus was obtained in studies 
where the mutagenic potency of various mushroom types, containing markedly
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different agaritine content, was investigated. The agaritine levels of these samples were 
determined by high-performance liquid chromatography (Sharman er aL, 1990) prior to 
their use in the Ames test. If agaritine was a major candidate responsible for the 
Agaricus bisporus extracts mutagenicity, then it would be expected that the mutagenic 
response of the samples would correlate with their agaritine content. However, strains 
of mushrooms whose agaritine content ranged from 0.3 to 1.7 g/kg fresh mushrooms 
showed a similar degree of mutagenic potency. More interestingly though, was the 
observation that the mushroom type with the highest agaritine levels had the lowest 
mutagenicity. It may be argued that this very low mutagenic activity was due to a toxic 
effect exerted by the high agaritine content of this extract. However, the concentration- 
dependent increase in the mutagenicity of this extract implied that the concentration of 
agaritine was not bacteriocidal.
5.3.2 Participation of agaritine breakdown products in the mushroom
m utagenicity
Though the results discussed above precluded the involvement of agaritine in 
the mutagenic potency of Agaricus bisporus ethanolic extracts, the possibility that not 
agaritine per se but rather its breakdown products are possible candidates for the 
observed mutagenic response should also merit consideration. As is well established 
(Friederich et aL, 1986), 4-hydroxymethylphenylhydrazine (4-HMPH), the first 
enzymic metabolite of agaritine, was more mutagenic in the Ames test than the parent 
compound, and 4-hydroxymethylbenzene diazonium ion (4-HMBD), the putative 
ultimate carcinogen and mutagen, was the most potent mutagenic agent of the three. 
Moreover, both compounds are established carcinogens in mice (Toth et aL, 1978; 
Toth and Nagel, 1981; Toth etal., 1981a; 1982; McManus etal., 1987) and the latter 
was shown, to form DNA adducts in various murine organs (Shephard et aL, 1986). 
Furthermore, use of y-glutamyl transpeptidase as an activation system, the enzyme 
which removes the glutamyl moiety to form eventually the benzene diazonium ion
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(Levenberg, 1961; 1964; Gigliotti and Levenberg, 1964), enhanced the mutagenic 
potential of agaritine (Friederich et al., 1986). However, in the present study the 
enzyme failed to increase the mutagenicity of the ethanolic extracts (Table 5.4), even 
when extracts of the mushroom type containing the highest agaritine amounts were 
used (Table 5.5), pointing out that agaritine metabolites are unlikely to participate in 
the mutagenicity of the ethanolic extracts.
The involvement of the diazonium ion in the mushroom mutagenicity was 
further investigated by changing the pH of the extracts. If the diazonium cation played 
a significant role in the fungal mutagenicity, then it would be expected that the 
mutagenic response would be higher at the pH where the ion is stabilised. The finding 
that changes in pH of the extracts did not alter their mutagenicity provides further 
evidence that even this postulated ultimate mutagen is not a major contributor to the 
mutagenic potency of Agaricus bisporus ethanolic extracts.
5 .3 .3  G eneral considerations
Conclusively, the results of this study demonstrated that neither agaritine per se 
nor its breakdown products mediate the mutagenicity of ethanolic extracts from 
Agaricus bisporus and that other mushroom constituents are the principal contributors 
to the observed mutagenic response. However, these fungal phenylhydrazine 
derivatives are established mutagens, and only with the exception of agaritine, 
genotoxic carcinogens in their purified form.
Although data concerning the fate of these mushroom chemicals in the body are 
very limited, a single study undertaken by Ross et al. (1982b) demonstrated that in 
mice, agaritine is absorbed through the gastrointestinal tract. Though the compound 
was not detected in the blood at any time, it was present in five sections of the stomach 
and gut at 0.25 - 2 hours after administration, but not 3 hours after treatment. The 
disappearance of agaritine after the 3 hour-period can be explained by (a) its rapid 
excretion since it is water soluble or (b) its conversion in situ to its known metabolites
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or (c) by its distribution throughout the body, being transformed to the diazonium ion 
by the oxidative enzymes present in the various cells. Mammalian enzymes capable of 
metabolising agaritine or its first breakdown product are known to exist. For example, 
the murine liver cytochromes P450 and mouse lung or ram seminal vesicle 
prostaglandin H synthase were shown to metabolise both agaritine and 4-HMPH to the 
highly reactive diazonium ion (Lawson and Chauhan, 1985; Lawson, 1987), and since 
the latter induces tumour at the sites of application, the implications of this hypothesis 
are self-evident. Metabolism of agaritine by cytochrome P450 enzymes was also 
proposed by the group of Friederich (Friederich et aL, 1986) who showed that addition 
of S9 led to a reduction of its mutagenicity, suggestive of a detoxication of the 
compound. Furthermore, the fungal y-glutamyltransferase, which catalyses the 
formation of 4-HMBD within the mushroom, has very similar properties to the 
mammalian y-glutamyl transpeptidase. The latter is an ubiquitous membrane-bound 
enzyme, primarily found in cells that have a secretory or absorptive function, with high 
concentrations in the kidney and pancreas (Hanigan and Pilot, 1985). Pig's renal y- 
glutamyl transpeptidase was demonstrated to be capable in vitro of hydrolysing 
agaritine to 4-HMPH and was shown to be 7-9 times more active than its mushroom 
counterpart (Ross et a i,  1982b). However, genotoxicity or tumour induction was not 
observed in any of these organs after administration of agaritine to mice (Curphey et 
a i, 1987), thus casting doubts as to the effectiveness of this enzyme in vivo and to the 
activation of agaritine in mammals.
Also noteworthy is the fact that 4-HMPH induced tumours in lungs and blood 
vessels after oral administration (Toth et al., 1978). The organotropy of these 
carcinogenicity studies suggests that tissue-specific enzymes may be necessary for its 
activation to genotoxic species but whether these enzymes are present in man and/or 
whether 4-HMPH is a good substrate for them is not clear.
The diazonium ion is a direct-acting genotoxic species since it binds covalently 
to DNA and produces DNA damage at the sites of application (Shephard et a i,  1986).
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This was also expected in light of the organotropy found in carcinogenicity studies 
(Toth et a l,  1981a; 1982; Lawson et al., 1984). In the units of covalent binding 
index (CBI), this chemical has a potency of 13 in murine stomach and can therefore be 
classified as a weak genotoxic carcinogen which is about 100 times less effective than 
the standard mutagen and stomach carcinogen N'-methyl-nitro-N-nitrosoguanidine 
which has a CBI of 1500 in rat stomach (Shephard et al., 1986). It may be argued 
that since the diazonium ion is inherently; unstable - it decomposes at cellular pH in 
vitro - and because of its charged nature, it will not have the ability to cross membrane, 
barriers, to penetrate the cell and to react with DNA. However, its half-life in the body 
is sufficiently long and, unexpectedly, it does cross the cell membrane, findings which 
explain its established genotoxicity.
5 .3 .4  Role of agaritine and/or its metabolites in the aetiology of human
cancer
According to a Swiss estimation (Shephard et al., 1986), a daily consumption 
of 4g of Agaricus bisporus by a 60kg person will result in an "exogenous" exposure to 
the diazonium ion of 40ng/kg/day. However, the "endogenous" exposure, that is the 
exposure resulting from the conversion of agaritine to 4-HMBD, will possibly be more 
important, since agaritine is much more abundant in the mushroom and a sizeable 
portion of it might be metabolised to the diazonium in situ.
According to a second estimation (Friederich et al., 1986), 10 to 60mg of 
agaritine may possibly be consumed during a meal consisting of 100g of mushrooms. 
These levels would give rise to IxlO4 to 2xl05 histidine revenants in the Ames test, if 
the whole amount of agaritine were to be converted into the diazonium cation. This 
mutagenic response is more or less equivalent to the revenants induced in TA 100 by 
lp.g of the activated form of aflatoxin B]. If, however, mammals convert agaritine to 
its diazonium derivative in vivo and if the diazonium could succeed in reaching the 
DNA of potentially dividing cells is as yet unknown.
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Admittedly, the contribution of this group of chemicals to the mushroom 
carcinogenicity and consequently their role in the aetiology of human cancer is difficult 
to evaluate. Clearly further studies m vivo using the radiolabelled compounds and a 
number of animal species are needed to give more insight into the absorption, organ 
distribution, metabolism and possible DNA binding of these mushroom 
phenylhydrazines. On the other hand, even in the unlikely case of agaritine or its 
metabolites being demonstrated to be hazardous agents for the human health, one 
would bear in mind that factors such as processing and storage diminish agaritine 
content significantly (see 4.1). Consequently the consumer is exposed normally to 
much lower levels of these toxins than in freshly collected mushrooms.
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CHAPTER 6
CONTRIBUTION OF 
PHENOLS, QUINONES AND 
REACTIVE OXYGEN SPECIES 
TO THE MUTAGENICITY OF 
AGARICUS BISPORUS  
EXTRACTS
6.1 Introduction
Phenolic and quinoid compounds, an important group of chemicals with 
mutagenic, carcinogenic and cytotoxic properties, are widely distributed in nature 
(Brunmark and Cadenas, 1989). Agaricus bisporus is one of the many natural 
products which contain such agents, the metabolism of which, within the mushroom, is 
illustrated in Figure 6.1 (Boekelheide et a i,  1980a). These fungal phenols and 
quinones are associated with the pink-to-brown pigmentation change in the gill tissue; 
they appear in this tissue during the prodromal period of sporulation and they are 
inhibitors of respiratory and other sulphhydryl-dependent enzymes, of DNA synthesis 
and replication, and of protein synthesis (Weaver et al., 1970; 1971b; 1972; McCarty 
eta l., 1973; Vogel et al., 1974; 1975; Graham et al., 1977; Tiffany et al., 1978; 
FitzGerald et al., 1984). Their principal role within the mushroom is to initiate and 
maintain the dormant and cryptobiotic state of the spore, though a role as inhibitors of 
mushroom viruses and bacteria has also been ascribed to them (Weaver et al., 1972; 
Vogel and Weaver, 1972; Tavantzis and Smith, 1982).
The compound y-L-glutaminyl-4-hydroxybenzene (GHB) was the first of these 
fungal phenols/quinones to be identified (Jadot et al., 1960). It is considered as one of 
the most predominant non-protein amino acids in Agaricus bisporus (Oka et a l, 1981), 
it occurs as an off-white crystalline solid primarily in the gills at levels Img/g gill tissue 
(Weaver et al., 1970; 1971b) but it was also detected in other mushroom parts 
(Sasaoka et al., 1980; Oka et al., 1981). The cresolase activity of tyrosinase, an 
enzyme present in the mushroom, catalyses the ohydroxylation of GHB to form the 
catechol y-L-glutaminyl-3,4-dihydroxybenzene (GDHB) which has been isolated from 
Agaricus bisporus and its wild type Agaricus campestris and trivially named 
agaridoxin (Szent-Gyorgyi et a i, 1976; Tsuji et a/.,1981). This is further metabolised 
by the catecholase activity of tyrosinase to the o-benzoquinone, y-L-glutaminyl-3,4- 
benzoquinone (GBQ) which subsequently takes part in a base-catalysed reaction to 
yield 2-hydroxy-4-iminoquinone (HIQ). This compound, also known as 490 quinone
1 1 2
due to its visible absorption maximum at 490 nm, is the pink-red pigment of the gill 
tissue which with aging is converted to a second, as yet unidentified brown quinone 
with an absorption maximum at 360 nm. The latter, termed 360 quinone, is in turn 
polymerised to form an inert black melanin-like material (Vogel et al., 1974). Both 
HIQ and 360 quinone were reported to be recovered in purified form from the gill 
tissue (Weaver et a/., 1970).
Figure 6.1: Formation of quinones in Agaricus bisporus
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Many studies demonstrated the potential use of these Agaricus bisporus 
products as chemotherapeutic agents in the treatment of cancer (Vogel et a l, 1975; 
1977; 1979; Graham et al., 1977; Tiffany et al., 1978; Rosowsky et al., 1979; 
Burger et al., 1979; Al Obeide et al., 1990) but, in contrast, other studies showed that 
these compounds are toxic to bacteria and mammalian cells (Vogel et al., 1974; Calder 
et a/.,1975; Burger et al., 1979; Boekelheide et al., 1980c), some of their toxic effects 
being mediated by radicals and reactive oxygen species (Boekelheide et al., 1980c). 
However, none of these mushroom metabolites have been so far tested for mutagenicity 
or carcinogenicity.
Phenols and/or quinones are known to be involved in the generation of radical 
species. Briefly, quinoid agents (Q) can be reduced enzymically by flavoproteins in 
either one-electron or two-electron transfer processes to yield the semiquinone radical 
(Q -) or hydroquinone (QH2), respectively (Figure 6.2) (lyanaki and Yamasaki, 1970; 
lyanaki, 1987; Brunmark and Cadenas, 1989). The semiquinone radicals usually 
have high affinity for molecular oxygen (O2) and reduce it to the superoxide anion 
(02-"). The quinone is regenerated in this process and a redox cycle can be initiated 
forming large amounts of O2 ". The latter can subsequently dismutate to form 
hydrogen peroxide (H2O2) and O2 in a reaction catalysed by the superoxide 
dismutases. However O2 " and H2O2 may also take part in metal-catalysed reactions to 
form more toxic species of active oxygen such as the hydroxyl radical (OH ) and the 
singlet oxygen (102) (Totter, 1980; Thor e ta l.,1982; Brunmark and Cadenas, 1989). 
Both O2 ' and the other more active forms of oxygen have been implicated in a number 
of toxic manifestations including mutagenicity and carcinogenicity (Bruyninckx et al., 
1978; Totter, 1980; Ames, 1983; Harman, 1984; Hirota and Yokohama, 1981; 
Cerutti et al., 1990), damage to DNA and other nuclear structures, exemplified by sister 
chromatid exchanges and DNA strand breaks (Totter, 1980; Brawn and Fridovich, 
1981; Floyd, 1981; Speit et al., 1982), as well as enzyme inhibition, lipid 
peroxidation and oxidation of thiol groups of proteins (Kappus and Sies, 1981; Thor et
al., 1982; Osawa et al., 1990) (Figure 6.3). Thus, quinones which undergo one- 
electron reduction can be cytotoxic or genotoxic by a process mediated by any of these 
active radical species (Bachur et al., 1978; Begleiter, 1983; Brunmark and Cadenas, 
1989). On the other hand, two-electron reduction of quinones, mainly catalysed by 
DT-diaphorase, is generally accepted as a detoxication mechanism. That is, it protects 
against the toxic effects of quinones since it competes with the one-electron reduction 
pathway and converts the quinones to the hydroquinone which can be subsequently 
conjugated with glucuronic acid and sulphate, thus facilitating their excretion (Thor et 
al., 1982; Lind et al., 1982; Brunmark and Cadenas, 1989). There are, however, 
exceptions e.g., some quinones can be activated by DT-diaphorase to cytoxic and 
genotoxic agents (Talcott et al., 1983; De Flora et al., 1987; Siegel et al., 1990a, b; 
Lee et al., 1992).
Figure 6.2: Enzymic reduction of quinones
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Figure 6.3: Consequences of the one-electron reduction of quinones
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Consequently, the question arises whether the fungal phenols and/or quinones 
contribute to the mushroom mutagenicity/carcinogenicity and whether they can generate 
reactive oxygen species that may be responsible, at least partly, for the mutagenicity of 
this fungus. The scope of this study was, therefore, to investigate the possible 
involvement of such chemicals in the mutagenic potential of ethanolic extracts from 
Agaricus bisporus.
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6.2  Results
As Table 6.1 shows, both the direct-acting and the cytosol-mediated mushroom 
mutagenicity (see sections 3.3.1 and 3.3.5) were more evident in the bacterial strain 
TA 104. This strain is particularly sensitive to quinones, reactive oxygen species and 
hydroperoxides, thus raising the possibility of such chemicals to be responsible for the 
mutagenic activity of the ethanolic extracts from Agaricus bisporus. This assumption 
was investigated by assessing the effects (i) of enzymes known to metabolise these 
agents and (ii) of selective scavengers of the reactive oxygen species, on the mutagenic 
potential of the fungal extracts.
Tables 6.1: Mutagenic activity of ethanolic extracts from A g a r i c u s  
b isporus  in the presence of hepatic cytosolic activation 
system
The activation system contained 10% (v/ v) cytosolic fraction (105,000g supernatant) (cyl) derived from 
the liver o f Aroclor 1254-treated male rats. Results are expressed as Mcan±SD for triplicates.
Compound Histidine revenants/plate
TA 97
rcvl 4-CVl
TA 98
-CVt +CVI
TA 100
T-CVt +CVI
TA 102
-i-cvt 4-CVt
TA 104
•+CVI -f-cvt
TA 1537
*cvt -f-CVl
Spontaneous 
reversion rate 98+24 90+8 17+4 18+1 95+1 108±1 259+17 289+29 337+16 394+41 11+1 15+2
Mushroom 
extracts 
(1 OOjxl )
184+8 190+4 44+9 44+12 201+24 202+9 419+35 457+2 1193+96 1506+91 16+1 18+2
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6.2.1 Participation of phenols and/or quinones in the mutagenicity of
Agaricus bisporus
6.2.1.1 Tyrosinase-mediated activation
Incubation of ethanolic mushroom extracts with purified mushroom tyrosinase, 
the enzyme which catalyses the conversion of phenols to quinones within the 
mushroom, markedly enhanced the mutagenic response (Figure 6.4). This tyrosinase- 
mediated activation was dependent on the concentration of the enzyme (Figure 6.5) and 
was further enhanced when the pH of the extracts was increased from pH 7.4 to 
pH 8. It was, however, unaffected by supplementation of this enzyme system with 
y-glutamyl transpeptidase, the enzyme which was shown to convert agaridoxin to 490 
quinone in vitro (Table 6.2).
Figure 6.4: Activation of Agaricus  bisporus  ethanolic extracts by 
tyrosinase
Mushroom extracts were preincubated with tyrosinase (8000 units), d issolved in 0.2M  potassium  
phosphate buffer, pH 7.4, and the bacteria (TA 104) for 25 minutes at 3 T C  in a shaking waterbath. 
The spontaneous reversion rate o f 353^9 has already been subtracted. Each point represents the 
Mean±SD for three plates.
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Figure 6.5: M utagenicity of mushroom  extracts in the Ames test with 
tyrosinase as activation system
Ethanolic mushroom extracts (75|J.l) were preincubated with the bacteria (TA 104) and various 
concentrations o f  tyrosinase , dissolved in potassium phosphate buffer, 0.2M , pH 7.4, for 25 minutes 
at 37'C in a shaking waterbath. Results are presented as Mean±SD o f triplicates.
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Table 6.2: Effect of pH on the tyrosinase-m ediated  activa tion  of
Agaricus bisporus extracts
Ethanolic mushroom extracts (lOOpl) were preincubated with the bacteria (TA 104) in (i) the absence 
o f  tyrosinase, (ii) the presence o f  tyrosinase (8000 units), and (iii) the presence o f  tyrosinase (8000  
units) and y-glutamyl transpeptidase (y-GT, 5 units), for 25 minutes at 37'C in a shaking waterbath. 
The spontaneous reversion rate o f  272±4 has already been subtracted. Numbers o f  histidine revenants 
are presented as Mean±SD for triplicates.
pH Histidine revertants/plate
-tyrosinase +tyrosinase +tyrosinase/y-GT
7.4 1037±51 1323±40 1463±83
8.0 1024±44 1768±164 1793±23
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6.2.1.2 Role of DT-diaphorase
Supplementation of the cytosolic activation system with dicoumarol, an 
inhibitor of DT-diaphorase, abolished the cytosol-mediated activation of the mushroom 
extracts, though 12% of the decrease was attributable to DMSO, the solvent used. 
This inhibitory effect of dicoumarol was, however, not demonstrated in the absence of 
the cytosolic activation system (Figure 6.6). Similarly, menadione, a good substrate 
for DT-diaphorase, significantly reduced the mutagenic response of Agaricus bisporus 
extracts, the inhibition being evident only in the presence of a cytosolic activation 
system (Table 6.3). It may, therefore, be inferred that (i) DT-diaphorase plays, at least 
partly, a role in the activation of the mushroom mutagens and (ii) since this enzyme is 
known to metabolise a variety of quinones, that such chemicals are involved in the 
potentiation of the mutagenic response of the extracts.
Figure 6.6: Inhibition of the cytosol-m ediated activation of A g a r ic u s  
bisporus extracts by dicoumarol
The activation system contained 2.5% (v/v) hepatic cytosolic fractions (105,000g supernatant) derived 
from Aroclor 1254-treated rats. Ethanolic mushroom extracts (lOOpl), dicoumarol, dissolved in 
DMSO to a final concentration o f  30pM , and the Salm onella  typhim urium  strain TA 104 were 
employed. The spontaneous reversion rate o f 506*38 has already been subtracted. Results are 
presented as Mean±SD for triplicates.
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Table 6.3: Modulation of the mutagenicity of ethanolic extracts from
Agaricus bisporus by menadione
The activation system contained 2.5% (v/v) hepatic cytosolic fractions (105,000g supernatant) from 
Aroclor 1254-induced rats. Ethanolic mushroom extracts (lOOjil), 9mM menadione, dissolved in 
DMSO , and the bacterial strain TA 104 were used. The spontaneous reversion rate o f  418±28 has 
already been subtracted. Numbers o f  histidine revenants are presented as Mean±SD of triplicates.
Compound Histidine revertants/plate
no activation with activation
Mushroom extracts 1462±97 1938^23
Mushroom extracts and menadione 1363±45 1172±149
6.2.1.3 Participation of tyrosinase in the cytosolic activation of the mushroom extracts
In order to test whether, apart from DT-diaphorase, mammalian tyrosinase is 
also involved in the cytosol-mediated activation of Agaricus bisporus extracts, 
tyrosine, at a concentration known to inhibit the catalytic activity of tyrosinase, was 
added in the mushroom extracts and the mixture was assessed in the Ames test, in the 
presence of a cytosolic activation system. As Table 6.4 shows, tyrosine failed to 
inhibit the mutagenic response, indicating that mammalian tyrosinase is unlikely to 
participate in the cytosolic activation of the fungal extracts.
Table 6.4: Effect of tyrosine on the cytosolic activation of  A g a r i c u s
bisporus  extracts
The activation system contained 10% (v/v ) cytosolic fractions (105,000g supernatant) derived from the 
liver o f  male Aroclor 1254-treated rats. Tyrosine (Im M ), dissolved in water, lOOpl o f  ethanolic 
mushroom extracts and the S alm onella  typhimurium  strain TA 104 were used. The spontaneous 
reversion rate o f  341±43 has already been subtracted. Numbers o f histidine revenants are presented as 
Mean±SD for three plates.
Compound Histidine revertants/plate
Mushroom extract 777±61
Mushroom extract + tyrosine 798±14
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6 .2 .2  Involvement of reactive oxygen species in the mutagenicity of
Agaricus bisporus
Since the metabolism of quinones is often related to the generation of reactive 
oxygen species, studies were undertaken to investigate the role of such chemicals in the 
mutagenicity of Agaricus bisporus extracts.
6.2.2.1 Contribution of superoxide anion and hydrogen peroxide
Use of superoxide dismutase, the enzyme that detoxicates superoxide anions, 
caused a significant decrease in the mutagenic response of the ethanolic mushroom 
extracts, both in the presence (24-43% inhibition), and to a lesser extent, in the 
absence (19-24% inhibition) of an activation system, though the effect was not always 
concentration-dependent (Figure 6.7). Similarly, catalase, the enzyme which converts 
hydrogen peroxide to water, significantly inhibited the direct-acting and cytosol- 
mediated mushroom mutagenicity (16-35% and 27-45% inhibition, respectively), again 
the response being concentration-independent (Figure 6.7). In order to test whether 
the inhibitory effects of these two enzymes were additive, catalase and superoxide 
dismutase were incorporated together in the mushroom extracts. An additive effect 
was observed in the absence of an activation system, but this was not always evident 
in the presence of such system (Figure 6.7).
The possible participation of hydrogen peroxide in the mutagenicity of Agaricus 
bisporus was further investigated by using reduced and/or oxidised glutathione. 
Reduced glutathione (GSH) caused 64% and 81% inhibition of the mushroom 
mutagenic activity in the absence and presence of cytosolic activation system, 
respectively, while the oxidised form of glutathione (GSSG) exerted an inhibitory 
effect, which was of the magnitude of 65%, only in the cytosol-mediated mutagenicity 
of the ethanolic extracts (Figure 6.8).
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F igure 6.7: The inh ib ito ry  effects of (a) ca ta lase , (b) superox ide 
dism utase and (c) catalase+superoxide dism utase on the 
direct-acting (I) or cytosol-m ediated (II) m utagenicity  of
Agaricus bisporus
The activation system contained 10% (v/v) hepatic cytosolic (105,000g supernatant) fractions derived 
from Aroclor 1254-induced rats. The bacterial strain TA 104, ethanolic mushroom extracts (lOOpM), 
catalase and/or superoxide dismutase (SOD), both dissolved in water, were employed. In the case of 
the simultaneous presence of the enzymes, 25, 50, 100 and 200 units o f each enzym e were used. The 
spontaneous reversion rate o f  390±17 has already been subtracted. Each point represents the 
Mean±SD for three plates.
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Fipure 6.8: G lu ta th io n e-m ed ia ted  m o d u la t io n  o f  m ushroom
mutagenicity
The activation system contained 10% (v/v) cytosolic (105,000g supernatant) fraction derived from the 
livers o f Aroclor 1254-treated rats. Ethanolic extracts o f A garicus bisporus  (lOOjil), the bacterial 
strain TA 104 and reduced or oxidised glutathione (GSH or GSSG respectively), dissolved in 0.2M  
potassium phosphate buffer, pH 7.4, to give a final concentration o f  5m M , were em ployed. The 
spontaneous reversion rate o f 401426 has already been subtracted. Results are presented as Mean±SD  
for triplicates.
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6.2.2.2 Inhibition bv DMSO
The radical scavenger DMSO decreased the mutagenicity of mushroom extracts 
in a concentration-dependent manner, in the presence and absence of a cytosolic 
activation system. In both cases, an inhibition of 53% was observed by the highest 
DMSO volume employed in the assay (Figure 6.9).
Figure 6.9: Inhibition of the mushroom mutagenicity by DMSO
The activation system contained 10% (v/v) hepatic cytosolic (105,000g supernatant) fraction derived 
from Aroclor 1254-induced male rats. Ethanolic extracts o f  A garicus b isporus  (IOOjj.1) and the 
Salm onella typhimurium  strain TA 104 were employed. The spontaneous reversion rate o f  394±36  
has already been subtracted. Each point represents the Mean±SD for the three plates.
2000  -  
1800 -î :
1600 -.j 
1400 
1200 -
S
I0)
>
£
1000 -
8 0 0 -
6 0 0 -
no activation
with cytosolic activation
400
200
0 200 300100 400 500
Concentration of DMSO (pl/plate)
125
6.2.2.3 Effect of (3-carotene
In order to assess whether singlet oxygen ( ^ 2) is also a candidate responsible 
for the Agaricus bisporus mutagenicity, the mutagenic potential of ethanolic mushroom 
extracts was tested in the presence and absence of (3-carotene, a known 102-quencher. 
As Table 6.5 shows, (3-carotene did not affect the mutagenicity, indicating that ^02 is 
unlikely to contribute to the mutagenic activity of this fungus.
Table 6.5: M utagenicity of Agaricus bisporus extracts in the presence
of (3-carotene
Ethanolic mushroom extracts (lOOjil), (3-carotene, dissolved in DMSO at a concentration range o f 10'^ 
to 10"3 M, and the bacterial strain TA 104 were employed.
Compound Histidine revertants/plate
Spontaneous reversion rate 455± 28
Mushroom extract 1854±62
Mushroom extract + (3-carotene, 10"7M 1789±102
Mushroom extract + (3-carotene, lO^M 1844±78
Mushroom extract + (3-carotene, lO'^M 1963± 53
Mushroom extract + [3-carotene, 10"4M 1780±96
Mushroom extract + (3-carotene, lO'^M 1821+84
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6.3 Discussion
6 .3 .1  Contribution of phenols and/or quinones to the mushroom
mutagenicity
By far the most sensitive bacterial strain for detecting the direct-acting and the 
cytosol-activated Agaricus bisporus mutagens was TA 104. This strain contains A : T 
base pairs at the critical mutated sites and is reverted particularly by oxidative mutagenic 
agents such as quinones, hydroperoxides and other reactive oxygen species (Levin et 
a l 1982). It was, therefore, inferred that (i) such chemicals are likely to be involved 
in the mushroom mutagenicity and (ii) cytosolic enzyme(s) activate(s) the pathway(s) 
which generate(s) such substances.
As a consequence of these observations and in view of previous reports which 
indicated (i) the cytotoxic and genotoxic nature of phenolic/quinoid compounds (Chests 
et al., 1984; Siegel et al., 1990a, b; Lee et al., 1991) and (ii) the ability of some 
quinones to induce DNA damage by acting selectively at A : T sequences (Lee et a l, 
1991), the hypothesis was put forward that the phenols and quinones present in this 
fungus may contribute to the mutagenic response of the mushroom extracts.
Support to this assumption was provided by the findings that DT-diaphorase, 
the enzyme which catalyses the two-electron reduction of many quinones, mediates, at 
least partly, the activation of mushroom metabolite(s). The most likely reaction 
implicated in the potentiation of the mutagens of Agaricus bisporus extracts by this 
enzyme seems to be the conversion of the fungal quinone GBQ, probably via a 
semiquinone intermediate, to the hydroquinone agaridoxin. Both dicoumarol, the, most 
potent inhibitor of this enzyme, and menadione, an excellent substrate of DT- 
diaphorase, inhibited this reaction and thus the formation of the reactive intermediate.
Bioactivation of quinones by DT-diaphorase is rather rare. Most in vitro and 
in vivo studies demonstrated that this enzyme, which occurs in multiple forms in 
several organs (Ernster, 1967; Prochaska and Talalay, 1986) is part of a cellular
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defence mechanism against quinone toxicity. That is, it reduces its substrates to 
hydroquinones thus facilitating their terminal conjugation with UDP-glucuronate or 
sulphate and cell disposition as water-soluble products (Ernster, 1967; Lind et al., 
1982; Thor etal., 1982; Brunmark and Cadenas, 1989). However, in agreement with 
the results of the present study, other investigators showed that the enzyme is also 
capable of activating some chemicals to mutagens, e.g., 3-bromomethylmenadione 
(Talcott et al., 1983) and 4-nitroquinoline-N-oxide (De Flora et al., 1987). Moreover, 
it has the ability to activate chemicals to species which can induce DNA interstrand 
cross-linking, DNA alkylation and cytotoxicity to the HT-29 human colon carcinoma 
cell line, examples being the quinones diaziquone, mitomycin C and a series of 
aziridinylbenzoquinones (Siegel etal., 1990a, b; Lee etal., 1991).
The possible involvement of fungal phenols and quinoid compounds in the 
mutagenicity of Agaricus bisporus was further investigated by incubating the extracts 
with mushroom tyrosinase, the enzyme which catalyses the first two steps in the 
metabolism of these chemicals in the fungus (Figure 6.1). The increase in the 
mutagenic response of the extracts, which was dependent on enzyme concentration and 
on the pH of the samples, provides unequivocal experimental evidence that mushroom 
phenols and quinones mediate, at least partly, the mutagenicity of Agaricus bisporus 
extracts. It is reasonable to assume that the ethanolic extracts contain phenols and 
quinones, some or all of which are direct-acting mutagens. The level of tyrosinase in 
the extracts is likely to be low, probably because of enzyme dénaturation during the 
extraction procedure, and thus addition of exogenous tyrosinase was necessary for the 
tyrosinase-catalysed pathway to be triggered. Activation of this pathway could have 
subsequently led to the formation of new mutagens or to an increase in the amounts of 
genotoxins already present in the extracts but in low concentrations. Moreover, when 
the pH of the sample was raised from neutrality to an alkaline value, the mutagenic 
response was potentiated, as this pathway operates maximal by basic pH; the first 
step, i.e., the hydroxylation of GHB to agaridoxin is optimal at pH 8, the second step
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is relatively pH-insensitive and the non-enzymic generation of HIQ from GBQ is base- 
catalysed. However, the possibility that some of these mushroom components were 
activated to genotoxins by endogenous tyrosinase during the extraction procedure 
cannot be excluded. That is, while tyrosinase is physically membrane bound and 
segregated from the substrate in the gill tissue (Weaver et al., 1970; 1971a), the 
likelihood of cell-membrane disruption during the homogenisation exists, which might 
have resulted in the liberation of the enzyme. By this mechanism, therefore, the 
enzyme might have been brought into contact with the substrate and activation 
initiated.
In order to ascertain whether the iminoquinone plays a role in the mutagenicity 
of this mushroom species, the mutagenic response was determined in the presence of 
both y-glutamyl transpeptidase and tyrosinase. y-Glutamyl transpeptidase from 
porcine kidney was shown to metabolise agaridoxin to the iminoquinone (Boekelheide 
et al., 1980c). Failure of y-glutamyl transpeptidase, in the present study, to alter the 
mutagenic response could imply that the 490 quinone is not a major contributor to the 
mushroom mutagenicity. This is quite surprising though, as HIQ is an established 
cytoxic agent (Vogel et al., 1974) and as a group, iminoquinones have been implicated 
in many toxic effects (Albano et al., 1985; Moore et al., 1985). The possibility, 
therefore, exists that (i) the amounts of y-glutamyl transpeptidase applied were 
inadequate for the reaction to be initiated, (ii) 490 quinone already present in the extracts 
or formed by addition of tyrosinase could contribute to the direct-acting mushroom 
mutagenicity and (iii) the iminoquinone is deactivated prior to entering the bacteria.
Moreover, agaridoxin itself could also be considered as a candidate responsible 
for the mutagenicity of the extracts. This biphenol was previously isolated from 
methanolic mushroom extracts (Szent-Gyorgyi, 1976) and it is likely to be extracted by 
ethanol. Consequently, low levels of the compound already present in the mushroom 
extracts, could explain the observed direct-acting mutagenic response. The newly 
synthesised agaridoxin, formed when tyrosinase was added by the hydroxylation of
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GHB, a stable monophenol present at high levels in ethanolic mushroom extracts (Oka 
et aL, 1981), could result in the potentiation of the mutagenic activity of the extracts. 
Further support for the involvement of agaridoxin in the mushroom mutagenicity is 
provided by the superoxide dismutase-mediated inhibition of the fungal extracts. This 
enzyme, apart from scavenging O2 ', has also the ability to inhibit the autooxidation of 
hydroquinones (Cadenas et al., 1988). Indeed, agaridoxin which is actually the 
hydroquinone of GBQ, is a strong autooxidisable substance (Szent-Gyorgyi et al.,
1976).
Though no carcinogenicity or mutagenicity data are available for this 
catecholamine, the compound was reported to be cytotoxic to B16 murine melanoma 
cells in culture (Rosowsky et al., 1979) and to inhibit DNA synthesis in intact and 
isolated L1210 cells (FitzGerald et al., 1984). Moreover, this mushroom metabolite 
has a LD50 of 100-200mg/kg in neonatal C57B1/6J mice and induces proximal 
convoluted tubular injury as early as 2 hours after injection to adult mice, which 
progresses by 24 hours to profound acute tubular necrosis. Focal acinar epithelial 
necrosis in the pancreas was also observed after administration of agaridoxin to mice 
(Boekelheide et al., 1980c). Furthermore, this chemical behaves as a potent ai-type 
adrenergic agonist of mammalian adenylate cyclase (Wheeler et al., 1982). Whether, 
however, these biological activities of agaridoxin have any relevance to human health is 
presently unknown and this compound merits further investigation.
The possibility that mammalian tyrosinase is involved in the cytosolic 
activation of the mushroom extracts was also considered. Use of tyrosine, at 
concentrations known to competitively inhibit the enzyme (Hearing and Ekel, 1976), 
failed to alter the mutagenic response. It may be, therefore, inferred that (i) tyrosinase 
was not present in the cytosolic fraction and (ii) mammalian tyrosinase is not capable of 
metabolising the mushroom phenols. Previous studies, however, preclude the latter 
possibility since the mammalian enzyme was shown to catalyse the conversion of 
GHB to agaridoxin (Boekelheide et al., 1980a, c) and give support to the former.
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Indeed this enzyme was earlier reported to be present in mitochondria (White and Hu,
1977).
These findings lend support to a role of fungal phenols/quinones in the 
mutagenicity of Agaricus bisporus extracts. Since, however, most quinones exert their 
biological effects via semiquinone or reactive oxygen species formation (Bachur et al., 
1978; Powis et a i, 1981; Thor et al., 1982; Begleiter, 1983; Brunmark and 
Cadenas, 1989), the possibility of the contribution of such agents to the mushroom 
mutagenicity was also investigated.
6 .3 .2  Participation of free radicals and reactive oxygen species in
mushroom mutagenicity
Semiquinones and reactive oxygen species are involved in the initiation and 
progression of various types of tissue injury and disease, including aging, 
inflammation, phagocytosis, immunotoxicity, lipid peroxidation and genotoxic injury. 
Consequently, they are linked to mutagenesis and carcinogenesis (Bruyninckx et al., 
1978; Kameda et al., 1979; Totter, 1980; Kappus and Sies, 1981; Packer et al., 
1981; Bovs etal., 1981; Ames, 1983; Harman, 1984; Osawa. et al., 1990).
A common means of assessing the participation of such substances in toxic 
processes involves the use of selective scavengers, i.e., agents with strong preferential 
reactivity towards one reactive oxygen species. This method was selected in the 
present study to determine whether such chemicals are contributors to the mutagenicity 
of ethanolic extracts from Agaricus bisporus.
6.3.2.1 Role of superoxide anion
It is well-established that reduction of quinones leads to the formation of 
semiquinones, which have high reactivity with molecular oxygen, resulting in the 
production of the superoxide anion and the regeneration of the quinone. O2 ' is 
implicated in inflammatory processes, haemolysis of erythrocytes (Packer et al., 1981;
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Hochstein and Jain, 1981), augmentation of DNA strand breaks (Brawn and Fridovich, 
1981), mutagenesis and carcinogenesis (Totter, 1980). Protection of the body against 
the O2 " toxicity is provided by a family of metalloenzymes, the superoxide dismutases, 
which catalyse the conversion of O2 " to H2O2 (McCord and Fridovich, 1969).
In the present study, a decrease in the direct-acting and particularly the cytosol- 
mediated mutagenic responses of the fungal extracts by superoxide dismutase, 
suggests that (i) superoxide anions are involved in the mushroom mutagenicity and (ii) 
formation of such agents is triggered by cytosolic enzyme(s). Moreover, it may be 
inferred that Agaricus bisporus extracts contain a semiquinone which was formed
(1) as an intermediate in the tyrosinase-catalysed oxidation of agaridoxin to GBQ, or
(2) during the non-enzymic oxidation of agaridoxin by O2 or O2 ', or (3) during the 
non-enzymic reduction of HBQ by O2""' or (4) as an intermediate in the DT-mediated 
reduction of GBQ to agaridoxin (Brunmark and Cadenas, 1989). The first possibility 
is supported by the previous finding that tyrosinase catalyses the oxidation of catechol 
to o-benzoquinone via an a-benzosemiquinone (Mason, 1965)
6.3.2.2 Contribution of hydrogen peroxide
Dismutation of O2 ' yields H2O2 which, if present in the mushroom extracts, 
could play a role in Agaricus bisporus mutagenicity. Indeed, the inhibition of the 
mutagenic response by catalase and reduced glutathione (GSH) substantiate this 
expectation. Both catalase and GSH were more effective in the presence of a cytosolic 
activation system, indicative of cytosolic-mediated production of H2O2. The finding 
that oxidised glutathione (GSSG) was effective in decreasing the cytosol-mediated but 
not the direct-acting mutagenicity of the extracts implies the cytosolic conversion of 
GSSG to GSH by glutathione reductase. Further support for the involvement of H2O2 
in the mushroom mutagenicity is provided by the finding that TA 102 was less 
sensitive than TA 104 in detecting the fungal mutagens. TA 102 has the same histidine 
mutation as TA 104 but this is present in a multicopy plasmid. The group of Levin,
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however, showed that TA 102 is reverted less effectively than TA 104 by peroxides, 
including H2O2 (Levin gf a/., 1982).
Hydrogen peroxide has previously been reported to be implicated in many toxic 
processes, including involvement in peroxidation processes (Kameda et a i, 1979). In 
addition, H9O2 gives rise to aldehyde formation, augmentation of DNA strand breaks 
(Brawn and Fridovich, 1981; Floyd, 1981), induction of sister chromatid exchange in 
normal and BrdUrd-substituted DNA of V79 Chinese hamster cells. Moreover, it 
causes base changes and chromosomal aberrations in murine ascites tumours and 
Chinese hamster cells.(Speit et al., 1982).
In order to test whether the inhibitory effects of catalase and superoxide 
dismutase were additive, the mutagenicity of the extracts was tested in the presence of 
both enzymes. Evidence for an additive effect was more clear in the absence than in 
the presence of an activation system. A possible explanation for this is the existence in 
cytosol of a plethora of enzymic activities, one or more of which could interact with the 
"scavenging" enzymes.
In conclusion, these studies implicate O2 ' and H2O2 in the mechanisms of 
mushroom mutagenicity.
6.B.2.3 Involvement of hvdroxvl radicals
Addition of DMSO , an established OH- scavenger, to the ethanolic mushroom 
extracts caused a marked concentration-dependent decrease in the mutagenicity of the 
extracts. The inhibition was of the magnitude of 53%, regardless of the presence or 
absence of an activation system, when 4()0fil of DMSO, the highest volume tested, was 
applied. These results indicate that (i) OH- are also implicated in the mutagenicity of 
Agaricus bisporus extracts and (ii) cytosolic enzymes are not involved in the formation 
of OH .
The genotoxic and cytotoxic nature of OH- is well documented. This oxygen 
species is much more reactive than O ' and H2O2 and is known to be involved in
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radiation-induced tissue injury and lipid peroxidation (Packer et aL, 1981). 
Moreover, it gives rise to aldehyde formation in DNA (Floyd, 1981), and formation of 
8-hydroxydeoxyguanosine in human lymphocytes and polymorphonuclear leucocytes 
(Bashir et aL, 1991), it induces single and double strand breaks, base modifications 
and rearrangements in DNA, thus resulting in mutagenesis (Totter et aL, 1980; Hsie et 
aL, 1986).
6.3.2.4 IQ? as a candidate responsible for mushroom mutagenicity
The possible involvement of ]02  in Agaricus bisporus mutagenicity was 
investigated by using p-carotene, the most potent 102-quencher. The mutagenic 
activity of the tested samples was unaffected by p-carotene, possibly because of the 
absence of '0 2  from the extracts. This is not surprising, since the formation of 102 is 
favoured by lipids, and Agaricus bisporus is almost fat-free and contains no 
cholesterol (Whitehall, 1990).
6.3.3 C onclusions
The present study demonstrated that phenols and quinones present in Agaricus 
bisporus, as well as O2 ", H2O2 and OH- formed by their metabolism, are involved in 
the mutagenic activity of the ethanolic mushroom extracts. It is presently unknown 
which of the fungal phenolic and quinoid compounds are responsible for the observed 
mutagenicity. The unavailability of the pure compounds precludes an identification, 
agaridoxin, however, is the most likely ultimate mutagen.
These findings are a cause for concern because the involvement of oxidants in 
pathogenesis and particularly in the induction of cancer is well established. Recent 
advances in the mechanisms of oxidant carcinogenesis suggest that, besides being 
genotoxic and mutagenic, oxidant-induced DNA breakage, stimulates poly ADP- 
ribosylation of chromosomal proteins, including histones, thereby modulating local
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chromatin conformation. In addition, oxidants activate signal transduction pathways 
and transiently alter gene expression, in particular of the c-fos, c-myc and [3-actin 
genes. The induction of these genes appears to be required for the stimulation of cell 
proliferation in tumour promotion (Cerutti et aL, 1990; Cerutti and Amstad, 1991).
These findings carry, therefore self-evident implications. On the other hand, 
one should bear in mind that the direct-acting mutagenic response is weak and 
potentiation in mutagenicity occurs after activation by tyrosinase, DT-diaphorase and/or 
other cytosolic enzymes. The possibility, however, exists that mushroom metabolites 
are not effective substrates for the human tyrosinase and cytosolic enzymes. For 
example, though mushroom and mammalian tyrosinases have several properties in 
common (Harrison et aL, 1967; Mason, 1976; Hearing and Ekel, 1976; Winkler et 
aL, 1981), they also exhibit striking differences, exemplified by substrate selectivity 
(Pomerantz, 1964; 1966; Hearing and Jimenez, 1987). Indeed, the group of 
Boekelheide demonstrated that mammalian tyrosinase could hydroxylateGHB to 
agaridoxin only at 25% of the rate found for tyrosine and was not able to oxidise 
agaridoxin to GBQ (Boekelheide et aL, 1980a).
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CHAPTER 7
MUTAGENICITY 
OF OTHER EDIBLE 
MUSHROOMS
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7.1 Introduction
Several commercially cultivated mushrooms have become popular food items in 
the modern diet owing to a continuous supply throughout the year and to the fact that 
they are valuable sources of nourishment; they are high in minerals, rich in soluble B 
group vitamins and in addition, they contain more proteins than most other vegetables. 
On the other hand, they are low in calories, containing only traces of sugar, no 
cholesterol and are almost fat-free. They also have a significant fibre content 
(Whitehall, 1990). Though Agaricus bisporus is the most extensively cultivated 
mushroom, the cultivation of Shiitake (Lentinus edodes) and Oyster mushrooms 
{Pleurotus ostreatus) is also substantial due to their good culinary properties.
Shiitake, also known as the Japanese mushroom because it is mainly cultivated 
in Japan, has been grown in Asian forests for centuries. Since the ancient years it was 
known that possessed medicinal properties and it is said to contribute to longevity 
(Claydon, 1985), facts which are not entirely without foundation. Antitumour, 
antiviral, antibiotic and hypolipidaemic compounds have been isolated from this 
mushroom (Chihara et a i, 1969; 1970 a,b; Suzuki et aL, 1979; 1989; Togami et aL, 
1982; Sugano et al., 1982; 1985; Takehara et aL, 1979; Chibata et aL, 1969; Fujii et 
aL, 1978). Moreover, Lentinus edodes extracts have been reported to prevent blood 
pressure to increase in spontaneously hypertensive rats (Kabir et al., 1987), to possess 
antiatherosclerotic properties in man (Li-Khva-Ren et a/., 1989) and to have strong 
antitumour activity against various tumours implanted subcutaneously in mice (Nanba 
and Kuroda, 1987; Nanba et al., 1987). Antitumorigenic activity has also been shown 
for the Oyster mushroom (Yoshioka et al., 1975; 1985).
Despite the "beneficial" properties of Shiitake or Oyster mushrooms, both 
fungi have been shown to cause allergies to humans (Sastre et al., 1990; Lopez et al., 
1985; Liengswangwong et al., 1987). Moreover, consumption of Shiitake can cause
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toxicodermia in man (Nakamura and Kobayashi, 1985) while Oyster mushrooms were 
toxic to mice (Al-Deen et al., 1987).
Only very few studies concerning the mutagenicity of these two mushroom 
species have been undertaken. The group of von Wright observed that Lentinus edodes 
extracts were direct-acting, weak mutagens in the Ames test but later this was shown 
to be an artefact (Grüter et a i, 1991). Using the same mutagenicity test, a positive 
mutagenic response in the Salmonella typhimurlum strain TA 98 was observed with 
aqueous extracts of fresh or frozen Oyster mushroom but a negative with canned 
mushroom extracts. However, canned extracts gave positive mutagenicity when tested 
in the CHO/HPRT assay in the presence of an activation system (Morales et a i, 1990 
a, b). Due to the relatively limited mutagenicity data for these two edible mushrooms, 
the present study was undertaken to evaluate the mutagenicity of these mushroom 
species and compare it to that of Agaricus bisporus.
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7 .2  Materials and Methods
7 . 2 . 1  Materials
Shiitake mushrooms, produced in Holland, Oyster mushrooms and white, 
closed cup Agaricus bisporus, both produced in U.K., were bought locally and 
extracted immediately after purchase. Millipore filters (0.45jj. pore size) were 
purchased from Millipore (Millipore, Ireland). The Salmonella typhimurium strains, 
all other chemicals, reagents and cofactors were obtained from the sources cited in 
Chapter 2.
7 . 2 . 2  Methods
7.2.2.1 Mushroom extraction
Mushrooms were washed with water, drained and homogenised in 96% (v/v) 
ethanol , at a concentration of Ig/ml, for five minutes using a household Kenwood 
Food Blender. The homogenate was subsequently filtered initially through muslin and 
then through Whatman filter paper (Qualitative No.l). The solids were discarded and 
the filtrate was vacuum-evaporated in a rotary evaporator, at 35°C. The final volume 
was 10% (v/v) of the original filtrate volume. The extract was then stérile filtered 
through a millipore filter (0.45ji pore) and kept at-20°C until use.
1 .2 2 2  Shiitake extract bacterial inhibition test
Since in preliminary studies the Shiitake extracts displayed toxicity towards the 
Salmonella typhimurium bacteria, a toxicity study was undertaken in order to 
determine concentrations of the extracts suitable for mutagenicity testing. The 
following procedure was employed: molten top agar (2ml) containing O.IM 
L-histidine and 0.5mM d-biotin was mixed with lOOjil of TA 100 bacterial culture and
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poured onto Vogel Bonner E plates. The agar was left to solidify and then a sterile filter 
paper disc was placed in the centre of each plate. The Shiitake extract was diluted to 
1/5, 1/10, 1/20, 1/30 and 1/50 of the original extract and 5Op.l of each dilution was 
pipetted onto the filter paper discs. The plates were incubated overnight at 37°C. A 
zone of inhibition around the filter paper was evident with the 1/5 and 1/10 dilutions 
whereas normal bacterial growth over the whole plate was observed with all other 
dilutions. Consequently, the 1/20 dilution was used in the Ames tests.
1 2 2 3  Mutagenicity of mushroom extracts in the Ames test
For testing the mutagenicity of the mushroom extracts in the Salmonella 
typhimurium strains TA 98, TA 100 and TA 104, the standard plate incorporation 
method (section 2.2.4.5) and 10% (v/v )  activation system derived from the livers of 
Aroclor 1254-treated rats (AS9) (sections 2.2.1, 2.2.2 and 2.2.4.7) were employed. 
In order to investigate whether nitrosamines are involved in the mutagenicity of the 
mushroom extracts, the preincubation version of the Ames test (section 2.2.4.6) 
(preincubation time: 60 minutes; temperature: 37°C) and a 25% (v/v )  activation system 
prepared from hepatic S9 of isoniazid-treated rats (IS9) (sections 2.2.1, 2.2.2 and 
2.2.4.7) were used with the tester bacterial strain TA 1530. Isoniazid is an inducer of 
the cytochrome P450 2E subfamily which is one of the P450 subfamilies involved in 
the metabolism of many nitrosamines and TA 1530 is the most sensitive strain for 
detecting nitrosamines.
The extracts of Agaricus bisporus and Pleurotus ostreatus were tested in a 
concentration range corresponding to 0-0.8g of fresh mushrooms while a range 
corresponding to 0-132mg of fresh mushrooms was used for Shiitake extracts owing to 
the toxicity of this mushroom species to the bacteria.
140
7.3 Results
7.3.1 Mutagenicity of Oyster mushroom extracts
Ethanolic extracts of Oyster mushrooms displayed direct-acting, weak 
mutagenicity in the Salmonella typhimurium strains TA 1530 (Table 7.1), TA 98 
(Figure 7.1), TA 100 (Figure 7.2) and TA 104 (Figure 7.3), the last being the most 
sensitive showing a 4-fold increase over the spontaneous reversion rate. The 
mutagenic activity was of the same magnitude as that induced by the ethanolic extracts 
of Agaricus bisporus, though the mutagenicity of the latter mushroom species was 
slightly higher in the strain TA 104. Incorporation of an activation system derived from 
the liver of Aroclor 1254-induced rats (AS9) did not significantly influence the 
mutagenicity in any of the strains used (Figure 7.1 - 7.3). Addition of an activation 
system derived from the liver of isoniazid-treated rats (IS9) abolished the mutagenicity 
of Oyster mushroom extracts in the strain TA 1530. Dénaturation of the activation 
system by heating the S9 mix at 60°C for 12 minutes prevented the loss of the 
mutagenic activity (Table 7.1).
Figure 7.1: Mutagenicity of Agaricus bisporus and P le u r o tu s  
ostreatus ethanolic extracts in the Salm onella typhim urium  
strain TA 98.
The activation system contained 10% ( 7 V) hepatic postmitochondrial fraction from Aroclor 1254- 
treated male rats (AS9). The spontaneous reversion rate o f 20±4 has already been subtracted. Results 
are presented as Mean for triplicates. The SD did not exceed 10% o f the mean values.
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Figure 7.2: Mutagenicity of Agaricus bisporus and Pleurotus ostreatus 
ethanolic extracts in the Salmonella typhimurium  strain 
TA 100
The activation system contained 10% (v/ v) hepatic postmitochondrial fraction from Aroclor 1254- 
treated male rats (A59). The spontaneous reversion rate o f  120*15 has already been subtracted. Results 
are presented as Mean for three plates. The SD did not exceed 16% of the mean values.
3 0 0 - i
£
51
Cl
2  200 -  cCti
o
>
2
■o—  A. bisporus-S9  
—  P .ostreatus-S9  
-a—  A .bisporus+S9  
^ — P .ostreatus+S9
0)Ç
" O
1 0 0 -
.£2
I
0<F
0.0 0.2 0 .4 0.6 0.8 1.0
Mushroom extracts (g of fresh mushrooms/plate)
Figure 7.3: Mutagenicity of Agaricus bisporus and P leu ro tu s  
ostreatus ethanolic extracts in the Salmonella typhimurium  
strain TA 104
The activation system contained 10% (v/ v) hepatic postmitochondrial fraction from Aroclor 1254- 
treated male rats (AS9). The spontaneous reversion rate o f  520*32 has already been subtracted. Results 
are presented as Mean for three Petri dishes. The SD did not exceed 9% of the mean values.
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Table 7.1: M utagenicity of Agaricus bisporus and Pleurotus ostreatus
ethanolic extracts in the Salm onella  typhim urium  strain 
TA 1530
The activation system contained 25% (v/ v) hepatic postmitochondrial fraction from isoniazid-treated 
male rats (IS9). Dénaturation o f the system was achieved by heating the IS9 mix at 60°C for 12 
minutes. The results arc expressed as Mcan±SD for three plates.
Concentration 
of mushroom
extracts (g of Histidine revertants/plate
fresh mushrooms 
per plate)
-IS9 +IS9 +denatured IS9
A.bisporus P.ostreatus A.bisporus P.ostreatus A.bisporus P.ostreatus
0 14±3 14±3 11 + 1 11±1 4±1 4±1
0.1 22+3 20±5 18+2 8±1 23+5 21+3
0.2 21+4 27±2 18±1 9±2 18+1 23+3
0.4 23±1 34±7 20±3 11±2 2l±l 27±3
0.8 28±4 33±11 22+3 7±2 26±3 25+5
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7 .3 .2  Mutagenicity of Shiitake mushroom extracts
Ethanolic extracts of Shiitake were toxic to the bacteria when applied at 
concentrations higher than 132mg fresh mushroom/plate (no colonies on the Vogel 
Bonner E plates). At lower, non-toxic concentrations the extracts were not mutagenic 
in anys of the four bacterial strains used regardless of the presence or absence of an
activation system (Table 7.2).
Table 7.2: M utagenicity of Shiitake ethanolic extracts in the 
Salmonella typhim urium  strains TA 98, TA 100, TA104 and 
TA 1530
The activation system contained either 10% OVv) hepatic postmitochondrial fraction (S9) from Aroclor 
1254-treated rats (AS9) or 25% (v/v) S9 from isoniazid-treated rats (IS9). The results are expressed as 
M eantSD for three plates.
Concentration 
of mushroom 
extracts (mg of 
fresh mushroom 
per plate)
Histidine revertants/plate
TA 98 TA 100 TA 104 TA1530
-AS9 +AS9 -AS9 +AS9 -AS9 +AS9 -IS9 +IS9
0 20±2 17±1 107±25 97+6 335+25 581+50 14±3 14±3
22 14±1 8±1
44 24±3 25±4 89±4 9 7-3 337-9  607±70 15±1 14±1
66 14±1 18-3 128±41 94±8 305±10 499±77 16±2 15±3
88 15±4 29±4 119±5 100±6 229±9 561±107
110 16±5 31±5 73±1 76±5 toxic toxic
132 toxic toxic toxic toxic toxic toxic
144
7.4 Discussion
The use of mushrooms and in particular of the cultivated species Agaricus 
bisporus, Pleurotus ostreatus and Lentinus edodes as human food is relatively large. 
Despite their extensive use, little is known about the chemistry of these fungi and even 
less about their toxic potential.
To date only few studies have been undertaken to evaluate the mutagenicity of 
edible mushrooms (von Wright et al., 1982; Sterner et al., 1982; Morales et al., 1990 
a,b; Grüter et al., 1991) and albeit the variable incidence of positive results, the data of 
all studies indicated that mutagenic compounds occur among basidiomycetes and other 
advanced fungi. In view of these findings it was considered desirable to test the 
possible mutagenic effect of two cultivated mushroom species popular in the U.K., 
namely Oyster mushrooms {Pleurotus ostreatus) and Shiitake {Lentinus edodes), and 
to compare their mutagenic activity with that of Agaricus bisporus (Chapter 3). For 
this comparative study ethanolic extracts of the three mushroom species were prepared 
and tested in the Ames mutagenicity test in the presence and absence of an activation 
system using the Salmonella typhimurium strains TA 98 , TA 100 , TA 104 and 
TA 1530.
7.4.1 Mutagenicity of exracts from Lentinus edodes
Extracts of Lentinus edodes were found to be toxic towards all four bacterial 
strains when applied at concentrations higher than 132mg of fresh mushroom. This 
bacteriocidal effect may well be attributed to lenthionine, the odour-giving compound of 
Shiitake, which is known to possess antibiotic properties against many fungi and 
bacteria (Morita and Kobayashi; 1966; 1967; Claydon, 1985). Toxicity to bacteria was 
also demonstrated in TA 1538 by the group of von Wright (von Wright et a i,  1982). 
The use of lower, non-cytotoxic concentrations was, therefore, obligatory for Shiitake 
mutagenicity studies. The observed negative mutagenic response in all four bacterial 
strains, both in the absence and presence of an activation system, may therefore imply
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that Shiitake extracts do not contain mutagens. The possibility, however, that the 
mutagenic activity is masked by the toxicity of the extracts cannot be excluded. In 
contrast to these findings, von Wright and coworkers showed weak, direct-acting 
mutagenicity in the strain TA 100 which decreased upon addition of a metabolic 
activation system derived from phenobarbital-induced NMR1 mice, and weak, 
activation-dependent mutagenicity in TA 1535. However, (a) the observed 
mutagenicity could be an artefact due to the presence of free histidine in the mushroom 
extracts, since Shiitake extracts were not mutagenic in the forward mutation assay to 
8-azaguanine resistance in Sû/mflzze/Zti! typhimurium TM 677 (Grüter ef ti/., 1991) and 
(b) geographical, seasonal and strain-specific variations in the content of mutagenic 
material in this mushroom species may account for these differences.
7.4.2 Mutagenicity of extracts from Pleurotus ostreatus
Extracts from Oyster mushrooms displayed weak mutagenicity in all four 
bacterial strains used, indicating the presence of both frameshift as well as base-pair 
substitution mutagens, although the possibility that the same compound is responsible 
for both types of mutations can not be excluded. The presence of an activation system 
derived from the liver of Aroclor 1254-treated rats did not influence the mutagenic 
response, indicating that the mutagens are direct-acting and that the cytochrome P450 1 
and 2B families, which are induced by Aroclor 1254-treatment, play no role in the 
metabolism of Oyster mushroom mutagens. In contrast to this finding, Morales et al. 
(1990a) reported that extracts of fresh Pleurotus ostreatus were mutagenic in TA 98 
only in the presence of an activation system but they were not mutagenic in TA 100. 
However, in those studies aqueous extracts of this mushroom species were used and 
the activation system was obtained from phenobarbital-induced rats. The difference 
may be attributed to the fact that different compounds were extracted by the two 
extraction methods, although this is unlikely. In the same study it was also reported 
that freezing the Oyster mushrooms for 3 months at-20°C enhanced mutagenicity which
146
was, however, not dependent on metabolic activation. Furthermore, the same group of 
workers demonstrated that among four mushroom species preserved by canning, only 
Pleurotus ostreatus was mutagenic in the CHO/HPRT assay in the presence of an 
activation system, although no mutagenicity was detected in the Ames test. The positive 
mutagenic response of Pleurotus ostreatus was attributed to the absence of any added 
antioxidants in the liquid medium of the canned Oyster mushrooms, since the other 
conserved mushrooms species did contain added antioxidants. The authors could not 
explain the reason of the different response of Pleurotus ostreatus.
In order to investigate whether Oyster mushrooms extracts contained 
nitrosamines, the mutagenicity of this fungus was examined in TA 1530, a strain 
particularly sensitive to these chemical carcinogens. Moreover, since many 
nitrosamines are metabolised by cytochrome P450 2E isoenzymes, the mutagenic 
potential of the extracts was also tested in the presence of an activation system 
containing hepatic fractions from isoniazid-treated rats. This activation system was 
employed by virtue of the ability of isoniazid to induce the cytochrome P450 2E 
subfamily. The results indicated an inhibition of the mutagenicity of Oyster mushrooms 
in the presence of IS9 which was a truly enzymic effect since the fungal mutagenicity 
was prevented by dénaturation of the enzymes in the activation system. A possible 
explanation for this finding is that proteins of the cytochrome P450 2E family 
metabolise the mutagen(s) to inactive product(s). Whatever the nature of these Oyster 
mutagens, it is evident that they are not present in Agaricus bisporus or Lentinus 
edodes since the inhibitory effect was only observed with Pleurotus ostreatus extracts.
Despite the different mutagenic response of Oyster mushrooms and Agaricus 
bisporus in TA 1530 in the presence of metabolic activation, the mutagenicity of 
Pleurotus ostreatus in the other bacterial strains was generally similar to that observed 
with Agaricus bisporus, though the latter mushroom species was slightly more 
mutagenic in TA 104. Although the presence of quinones in Agaricus bisporus and the 
possible generation of reactive oxygen species and free radicals from quinone
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metabolism can explain the higher (potency of Agaricus bisporus extracts to TA 104, 
no reports about the presence of such chemical species in Oyster mushrooms are 
available in the literature so as to justify the sensitivity of TA 104 to this mushroom 
species.
It is worth pointing out that an amino acid analysis of the ethanolic extracts of 
Pleurotus ostreatus was not carried out in this study and thus the levels of histidine in 
the extracts are not known. Since (i) a free-histidine level of 285|J.g/ml was found in 
aqueous extracts of Oyster mushroom, a level which mimics weak mutagenic response 
in the Ames test, and (ii) ethanolic mushroom extracts of this fungus were not 
mutagenic in the histidine-independent forward mutation assay to 8-azaguanine 
resistance in the Salmonella typhimurium strain TM 677 (Grüter et al., 1991), it may 
be argued that the observed mutagenicity with Pleurotus ostreatus extracts may only 
reflect the higher histidine levels in the ethanolic extracts giving false positive results. 
Though this might be true for the strains TA 98 and TA 100, it is however unlikely that 
traces of histidine could account for the 4-fold increase of histidine revenants, over the 
spontaneous reversion rate, seen in TA 104. Moreover, the presence of histidine could 
not explain the inhibitory effect observed after incorporation of an activation system in 
TA 1530.
7 .4 .3  Concluding Remarks
In conclusion, the data presented in this study indicated the absence of 
mutagenic activity in Shiitake mushroom extracts and the presence of mutagenic 
material in Oyster mushrooms, but are too limited to provide a clear picture of the risk 
associated with the consumption of Pleurotus ostreatus. Obviously more information is 
needed, not only on the chemistry and properties of the unknown mutagenic 
components of Oyster mushrooms, but also on the effect of storage and processing 
(e.g., cooking, canning) on the mutagenicity of both mushrooms species.
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CHAPTER 8
DISCUSSION
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8.1  Carcinogenic and mutagenic properties of
Agaricus bisporus
In lifespan studies, mice maintained on dietary regiments, which included 
uncooked Agaricus bisporus as the sole food for four days weekly, developed tumours 
at a number of sites (Toth and Erickson, 1986). In contrast, no difference in the 
incidence of tumours was observed between untreated rats and rats which were given a 
diet containing a 30% dry powder for 500 days (Matsumoto et a i, 1991). Moreover, 
extracts from this mushroom species were reported to elicit a positive response in 
various short-term mutagenicity assays (von Wright et a i, 1982; Santa Maria et a i, 
1989; Morales et al., 1990a; Grüter et al., 1991). In view of these findings it was 
considered pertinent to extend the above studies in order to establish any risk to man 
as a result of the consumption of Agaricus bisporus.
The present study confirmed the mutagenicity of Agaricus bisporus. Ethanolic 
mushroom extracts displayed clear, reproducible but weak mutagenicity in Salmonella 
typhimurium strains detecting base-pair and frameshift mutagens. The presence of an 
activation system containing S9 or microsomal fractions derived from various treated or 
untreated animals did not influence mutagenicity. It is, therefore, concluded that (i) 
Agaricus bisporus component(s) function(s) as direct-acting genotoxin(s) and (ii) the 
cytochrome P450 and the FAD-containing monooxygenase systems play no significant 
role in the metabolism of the mushroom mutagens, whether activation or deactivation.
It may be argued that free histidine present in the fungal extracts can interfere 
with the genetic endpoint of the Ames test (the reversion of the bacteria from histidine 
auxotrophy to prototrophy (Maron and Ames, 1983) and mimic a weak mutagenic 
response (Aeschbacher et al., 1983). However, this is very unlikely since the 
extraction of histidine in ethanol would be expected to be very low and not sufficient to 
account for the 4-fold increase in mutagenicity, over the spontaneous reversion rate, 
seen with the bacterial strain TA 104. Moreover, the presence of histidine in the 
system would be expected to influence the apparent number of revenants to the same
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extent in all Salmonella typhimurium strains. Furthermore, it is difficult to envisage 
how cytosolic enzymes and tyrosinase could enhance such a histidine-mediated effect 
(Chapter 3 and 6) or how compounds such as DMSO, glutathione and the enzymes 
catalase and superoxide dismutase could inhibit the mutagenicity (Chapter 6). In 
ad d itio n , h is tid in e  levels w ere reported  to increase  dur ing 
the growth period of the mushroom (Kissmeyer-Nielsen et a i, 1966). In contrast, the 
mutagenic response of extracts from old mushrooms was significantly lower than that 
of younger fruit bodies (Chapter 4). Finally, recent studies undertaken by Grüter et 
a i,  showed that Agaricus bisporus extracts possessed a weak, but distinct mutagenic 
activity in the histidine-independent forward mutagenicity assay to 8-azaguanine 
resistance in Salmonella typhimurium strain TM 677, indicating that the mutagenicity 
of this mushroom species is not due to free histidine present in the fungal extracts 
(Grüter et a i, 1991).
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8 .2  Nature of mushroom mutagens
A number of phenylhydrazine derivatives have been isolated in substantial 
amounts from Agaricus bisporus, agaritine being the most important (Gry and 
Kirsten, 1991). Since almost all hydrazines tested in long-term animal studies and 
short-term mutagenicity assays appear to be carcinogenic and mutagenic, it is 
reasonable to assume that these compounds may, at least partly, be responsible for 
Agaricus bisporus carcinogenicity and mutagenicity. Indeed, agaritine precursors and 
breakdown products are murine carcinogens (Toth et a i, 1978; 1981a; 1982; Lawson 
et al., 1984) and all mushroom phenylhydrazine derivatives possess mutagenic activity 
in the Ames test (Friederich et a i,  1986). However, the present study provides 
unequivocal experimental evidence that agaritine does not mediate the mutagenicity of 
Agaricus bisporus ethanolic extracts: (a) Agaritine, as a hydrazide, would be expected 
to be readily acetylated, and since acétylation is a mechanism for the detoxication of 
hydrazines (Colvin, 1969), to be inactivated. However, supplementation of acetyl 
CoA into the activation system did not affect the mutagenic response of the extracts 
(Chapter 1); (b) Earlier studies demonstrated that storage of mushrooms resulted in a 
marked decrease in agaritine content, the reduction being as much as 76% after two 
weeks of storage (Ross er a l, 1982b; Liu et a i,  1982). In contrast, the mutagenic 
activity of extracts from mushrooms stored for 9 or 15 days was higher than that of 
fresh mushrooms (Chapter 4 ); (c) Freezing of mushroom extracts for 30 days with 
subsequent thawing did not affect mutagenicity (Chapter 3), though a 74% loss of 
agaritine was previously reported by such treatment (Liu et al., 1982); (d) Although a 
tendency for higher mutagenic potential of extracts from mushrooms harvested from the 
later breaks was observed, which was, however, statistically not significant (Chapter 
4), agaritine levels are significantly higher in the mushrooms from the later breaks 
(Speroni et al., 1983); (e) Low temperature-long time treatment favours the breakdown 
of agaritine when compared to the high temperature-short time treatment (Speroni et a i, 
1985; Sastry et a i, 1985), but the reverse was true for the mutagens in the ethanolic
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mushroom extracts (Chapter 4); (f) Use of prostaglandin H synthase as the activation 
system gave rise to only a slight increase in the mutagenic activity of the fungal 
extracts which was evident in TA 98 but not in TA 104, the most sensitive strain for the 
ethanolic mushroom extracts. This enzyme was previously reported to catalyse the 
conversion of agaritine to the highly mutagenic 4-hydroxymethylbenzene diazonium ion 
(Lawson, 1987); (g) Very similar mutagenic response was observed in mushroom 
strains whose agaritine content ranged from 0.3 to 1.7 g/kg fresh mushroom and, 
moreover, the lowest mutagenic response was displayed by the mushroom type which 
contained 6.5g agaritine per kg fresh mushroom (Chapter 5); (h) Inclusion of y- 
glutamyl transpeptidase as an activation system did not enhance the mutagenicity of the 
mushroom extracts. This enzyme removes the substituent of agaritine to form the 
ultimate mutagen 4-hydroxymethylbenzene diazonium ion (Friederich et al., 1986); 
(i) Chemically-synthesised agaritine was mutagenic in a narrower range of Salmonella 
typhimurium strains than the mushroom extracts; (j) Agaritine, at the levels encountered 
in the mushroom extracts, gave a lower mutagenic response than the extracts; and (k) 
cytosolic activation systems markedly enhanced the mutagenic activity of the mushroom 
extracts but did not affect agaritine mutagenicity (Chapter 5).
It is also worth pointing out that (a) agaritine was not carcinogenic to mice 
(Toth et a i, 1981b, Toth and Sornson , 1984), in contrast to the mushroom (Toth and 
Erickson, 1986) and (b) agaritine breakdown products induced tumours in mice at 
different sites from the tumours induced by feeding uncooked Agaricus bisporus 
(Toth et a i, 1978; 1981a,b; 1982; Toth and Erickson , 1986).
In view of this overwhelming experimental evidence it may be inferred that 
Agaricus bisporus contains additional mutagenic components, possibly more potent 
than agaritine, under the assay conditions employed.
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8.3 Phenols, quinones and reactive oxygen 
species in Aearicus bisporus mutagenicity
The fact that the bacterial strain TA 104, a strain which is particularly reverted 
by oxidative mutagens such as quinones, H2O2 and other reactive oxygen species 
(Levin et ai, 1982 ) was the most sensitive to the Agaricus bisporus ethanolic extracts 
gave the first indication that the phenols/quinones present in this mushroom, as well as 
reactive oxygen species, possibly generated by their metabolism, may contribute to the 
mushroom mutagenicity. Subsequent studies provided strong evidence for the 
participation of such chemicals in the mushroom mutagenic response: (i) Tyrosinase, 
the enzyme involved in the conversion of phenols to quinones within the mushroom, 
markedly enhanced the mutagenic response of the extracts; (ii) DT-diaphorase, the 
enzyme which catalyses the two-electron reduction of quinones, was shown to play a 
significant role in the cytosol-mediated activation of the extracts; and (Hi) the enzymes 
catalase and superoxide dismutase that detoxicate H2O2 and O2 " respectively, 
glutathione which detoxicates H2O2 to H2O, and DMSO, a scavenger of radical 
species including OH-, all inhibited both the direct-acting and cytosol-mediated 
mutagenic response of the mushroom extracts.
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8.4  Proposed sequence of events which m ay  
account for the mutagenic and carcinogenic 
properties of Aearicus bisporus
As discussed above, agaritine and its breakdown products have, at best, a very 
restricted role in the mutagenicity of Agaricus bisporus extracts whereas phenols, 
quinones and reactive oxygen species may be important contributors to the mushroom 
mutagenicity. However, the findings from previous studies which demonstrated that 
(i) phenylhydrazine derivatives present in Agaricus bisporus are mutagenic and, apart 
from agaritine, genotoxic carcinogens (Friederich et a i, 1986; Toth et al., 1978; 
1981a,b; 1982; Toth and Sornson, 1984; Toth, 1986; McManus et a l, 1987) and (ii) 
Agaricus bisporus mushrooms were carcinogenic to mice but not to rat, further 
complicates the issue (Toth and Erickson, 1986; Matsumoto et al., 1991).
Attempts to explain these contradictions in relation to the findings from this 
study were made. The following sequence of events is proposed to account for the 
mutagenic potential of Agaricus bisporus and explain the contradictions (Figure 8.1):
The two groups of mushroom components with mutagenic and carcinogenic 
properties, i.e., phenylhydrazines and phenols/quinones are formed within the 
mushroom from the same precursors (La Rue, 1977; Tsuji et al., 1981). Conversion 
of 4-aminobenzoic acid to 4-carboxyphenylhydrazine leads to the biosynthetic pathway 
of agaritine (La Rue, 1977), while the formation o f 4-hydroxybenzene by 
decarboxylative hydroxylation of 4-aminobenzoic acid, catalysed by an FAD- 
dependent monooxygenase (Tsuji et a i,  1985), results in the production of 
phenols/quinones. These two pathways may also be inter-related by virtue of the 
ability of y-glutamyltransferase to cleave the glutamyl moiety from agaritine and 
subsequently to transfer it to 4-hydroxybenzene (Gigliotti and Levenberg, 1964). As a 
consequence, the monophenol y-glutaminyl-4-hydroxybenzene and the hydrazine 
4-hydroxymethylphenylhydrazine, a more potent mutagen than agaritine, are produced. 
The latter may form the highly mutagenic 4-hydroxymethylbenzene diazonium ion.
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The diazonium can also be formed directly from agaritine via a one-step mechanism. 
In isolation, the fungal hydrazine derivatives can exert cytotoxicity and carcinogenicity. 
However, in the presence of other mushroom constituents, which is the case within the 
mushroom and when mushroom extracts are prepared, their mutagenic and 
carcinogenic properties are possibly inhibited or masked by interaction with 
nucleophiles. This can explain (i) their limited role in the mutagenicity of Agaricus 
bisporus extracts and (ii) the finding that feeding of uncooked mushrooms to mice 
gave rise to the induction of tumours at different sites than those induced by the fungal 
hydrazines, the only exception being the induction of lung tumours, seen after oral 
administration of both 4-hydroxymethylphenylhydrazine and raw mushrooms to mice.
In the presence of tyrosinase, y-glutaminyl-4-hydroxybenzene, formed as 
described above, is hydroxylated to produce agaridoxin, which, via a semiquinone 
intermediate, is converted to y-L-glutaminyl-3,4-benzoquinone and eventually to the 
490 and 360 quinones. The semiquinone may interact with molecular oxygen to yield 
reactive oxygen species. It is also possible that 4-aminocatechol is generated in a 
reaction catalysed by y-glutamyltransferase which is then autooxidised to 490 quinone 
with the simultaneous liberation of reactive oxygen species (Boekelheide etaL, 1980c). 
However, a further possibility merits consideration. Since phenylhydrazine was 
previously shown to exert its toxic effects via 0% ", H2O2, and OH- (Jain and 
Hochstein, 1979; 1980; Hochstein and Jain, 1981) it is likely that the mushroom 
phenylhydrazines could also make a small contribution to the generation of reactive 
oxygen species. Consequently, all these metabolic pathways could account for the 
direct-acting mutagenicity of Agaricus bisporus extracts.
In the presence of a hepatic cytosolic activation system it is likely that the 
cytosolic enzyme DT-diaphorase catalyses the reduction of y-L-glutaminyl-3,4- 
benzoquinone, via a semiquinone intermediate, to generate agaridoxin which is actually 
the hydroquinone of y-L-glutaminyl-3,4-benzoquinone. Through this reaction, higher
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amounts of agaridoxin and reactive oxygen species are formed which may account for 
the cytosolic activation of the mushroom extracts.
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It may be argued that DT-diaphorase is not involved in the cytosol-mediated 
activation of the mushroom extracts since it is an inducible enzyme (Prochaska and 
Talalay, 1986; Segura-Aquilar and Lind, 1987; Talalây and Prochaska, 1987), 
whereas in the present study the cytosolic activation of the mushroom mutagens was 
not affected by previous treatment of the rats with Aroclor 1254 (Chapter 3). 
However, the existence of multiple forms of this enzyme, each with distinct 
characteristics (Pochaska and Talalay, 1986) can explain this discrepancy. In addition, 
the inhibition of the cytosol-mediated activation of the extracts by dicoumarol and 
menadione, the most potent inhibitor and the best substrate for this enzyme 
respectively, gives unequivocal evidence for the involvement of DT-diaphorase in the 
activation of the mushroom extracts.
At present it is difficult to identify which of the fungal phenols and quinones are 
the actual genotoxins but it is likely that agaridoxin is one of the mushroom mutagens. 
Moreover, in view of the effectiveness of the various compounds and/or enzymes 
which detoxicate the reactive oxygen species to inhibit the mutagenic responce (Chapter 
6), it seems likely that among O]-', OH- and H2O2, the latter contributes more to the 
mushroom mutagenicity.
The involvement of reactive oxygen species in mushroom mutagenicity can 
explain the induction of tumours seen in mice but not in rats following oral 
administration of Agaricus bisporus. In the detoxication of electrophiles, two major 
families of conjugases are involved. These are the epoxide hydrolases, which use water 
as the conjugating material, and the glutathione S-tranferases which use glutathione 
(GSH), the ultimate defence against the toxicity of chemical oxidants and oxygen 
radicals. In mice, the ratio of glutathione S-transferase to epoxide hydrolase activities 
is much higher than in rats (Table 8.1) and thus the mouse, instead of using water, it 
consumes GSH which may not be replenished fast enough. Consequently, in mice, 
hepatic glutathione is readily depleted in the detoxication of reactive species and thus 
mice are more susceptible than rats to the tumour promotion effects of oxygen radicals.
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Table 8.1: Hepatic drug-metabolising acitivities in rodents
Species Enzyme activities 
(nmol product/min/mg protein)
Microsomal Cytosolic GSH S-
epoxide GSH S- transferase/epoxide
hydrolase transferase hydrolase
Rat 85±0.3 1,380±11 150
Mouse 2+0.2 5,290±430 2,600
From Lorenz ef al., 1984
Noteworthy is also the finding that feeding of uncooked Agaricus bisporus to 
mice gave rise to an increased incidence of tumours in bone, liver, lung and 
forestomach, the induction being more significant in the latter organ. This can be 
partly attributed to H2O2 which was previously reported to produce lesions and 
tumours in forestomach (Ito et a i, 1982) but also to the high reactivity of the oxygen 
species which are expected to exert their maximal effect at the sites of application. In 
addition, the induction of liver tumours is possibly related to the fact that DT- 
diaphorase is more abundantly found in liver and consequently the conversion of 
y-L-glutaminyl-3,4-benzoquinone to the postulated ultimate mutagen, agaridoxin, is 
more profound in this organ. Lastly, the increase in the incidence of tumours in lungs 
can be ascribed partly to the murine lung carcinogen 4-hydroxymethylphenylhydrazine 
(Toth et a i, 1978) with the likelihood that this compound exerts its effect via oxygen 
radical species.
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8.5 Conclusions
Despite the fact that the proposed sequence of events described above gives 
some insight into the mutagenic and carcinogenic properties of Agaricus bisporus, 
there remain many uncertainties regarding the mechanism of action of the mushroom 
mutagens. Moreover, the possibility that other fungal components are also contributors 
to the mushroom mutagenicity can not be excluded.
Attempts (i) to fractionate the mushroom extracts using Bond elut extraction 
cartridges with various sorbent materials and (ii) to couple HPLC analysis with the 
Ames test, to fractionate the extracts further, so as to identify and characterise the 
fraction(s) in which mutagenicity resides were not successful; the fractions obtained 
after the chromatographic analysis were too dilute and with no apparent mutagenic 
activity in the Ames test.
The positive results for the mushroom mutagenicity derived from this study are 
a cause of concern but our data are too limited to provide a clear picture of the risk 
associated with the consumption of Agaricus bisporus. Moreover, the design of the 
carcinogenicity studies conducted by the group of Toth (Toth et a i, 1978; 1981a, b; 
1982; Toth and Nagel, 1981; Toth and Sornson,1984; Toth, 1986; Toth and 
Erickson, 1986; McManus et al., 1987) did not meet the requirements laid down in 
recent guidelines. That is, only one strain of mice was employed in these studies 
(Swiss albino mouse) without further characterisation of the strain, while the two- 
species rodent assay using rats and mice is currently required by most national and 
international regulatory bodies. In addition, when a chemical provokes an increase in 
tumours in mice but not in rats, the positive results in mice may be due to physiological 
and biochemical characteristics unique to mice. This is probably the case with 
Agaricus bisporus mutagenicity. In this situation, further testing of this mushroom in 
other animals species, such as hamster and/or guinea pig would be recommended.
In addition, an improved understanding of the properties of the mushroom 
components, of the effect of preservation and culinary methods and a good knowledge
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of the level of exposure are needed for an estimate of the health risk involved in 
consumption of Agaricus bisporus.
The contribution of Agaricus bisporus consumption to human cancer is 
difficult to evaluate. However, bearing in mind that (i) the mutagenic response is weak 
and that diet contains much more potent mutagens, exemplified by IQ (2-amino-3- 
methylimidazo f4,5-fj quinoline) and related compounds; (ii) a mutagen detectable in 
vitro may not be stable in vivo ; (iii) the direct-acting fungal mutagen(s) must gain 
entry into the cell to exert their effect and (iv) the mutagen(s) are likely to be 
deactivated by other constituents in the diet (e.g., vitamin C, vitamin E, antimutagens) 
(Grüter et al., 1990) or during transport to the target cell, it is unlikely that this fungus 
is a major contributor to the aetiology of human cancer. Moreover, the fact that the 
mutagens are not highly lipophilic (mutagenicity could not be extracted with either 
chloroform or ethyl acetate (Chapter 3), indicate that absorption through the 
gastrointestinal tract may not occur readily. In contrast, their hydrophilicity will 
facilitate their rapid excretion. Furthermore, the human enzymes DT-diaphorase or 
tyrosinase may not metabolise the mushroom mutagens. It should also be born in 
mind that vegetarian populations which consume large amounts of mushrooms have 
generally lower incidence of cancer than the rest of the population. Finally, the fact 
that tumour induction in mice by high Agaricus bisporus intake does not occur at sites 
commonly encountered in humans, e.g., breast and colon, lends support to this 
conclusion.
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